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The Atlantic salmon (Salmo salar L.) aquaculture industry is in a state of rapid expansion, and 
requires solutions to mitigate the increasing restrictions surrounding dietary ingredient 
availability and a changing environment. The work presented herein, has generated a body of 
original and novel, quantitative information detailing the effects of diet and season on a wide 
range of commercially relevant outcomes in post-smolt Atlantic salmon with a specific focus 
on fatty acid metabolism and nutritional quality in large fish. A particular focus is placed on 
omega-3 long-chain polyunsaturated fatty acids (n-3 LC PUFA) due to the essential nutrition 
they provide fish and the widely accepted health benefits associated with their consumption 
in humans (Tocher 2015; Turchini et al. 2010). It is envisaged that this information, scarce for 
market-sized fish, will enhance the viability of Atlantic salmon aquaculture through nutritional 
based solutions. 
 
The first experiment (Chapter 3) consisted of a systematic review and subsequent analysis of 
published nutritional data from long-term growth trials using post-smolt Atlantic salmon to 
provide a summary of currently available information and to identify the most significant 
drivers of omega-3 long-chain polyunsaturated fatty acids (n-3 LC PUFA) levels in Atlantic 
salmon fillet tissue. Overall, there were relatively few studies which met the selection criteria 
resulting in a relatively small dataset. However, statistically significant regression models 
were created for fillet 22:6n-3 and fillet n-3 LC PUFA. Fish weight was a significant predictor 
in both models and dietary 22:6n-3 was, as expected, a predictor of fillet 22:6n-3. 
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Furthermore, dietary 20:5n-3 and dietary 22:1 isomers were significant predictors of fillet n-
3 LC PUFA. 
 
The second experiment (Chapter 4) was an on-farm, Atlantic salmon growth trial conducted 
in Tasmania, Australia over the final year of grow-out (323 days), consisting of a ‘summer 
phase’ and a ‘winter phase’. Poultry by-product oil, canola oil and tallow were fed at high (80 
%) dietary lipid inclusion levels to assess growth, fillet fatty acid composition and sensorial 
attributes. In the summer phase, the tallow diet more adequately provided metabolic energy 
resulting in significantly higher fillet n-3 LC PUFA and a significantly lower n-6:n-3 ratio, 
despite lower final weight and a reduced apparent lipid digestibility. The following winter 
phase results suggested all treatments more adequately provided metabolic energy and n-3 
LC PUFA concentrations were comparable. Additionally, this Chapter highlights the 
importance of a well-considered experimental design and subsequent statistical 
interpretation, which are a particularly challenging consideration for commercial scale, on-
farm feeding trials. Ultimately, this research Chapter demonstrates the importance of 
seasonally tailored diets for Atlantic salmon, using high terrestrial oil inclusion, under 
environmentally challenging Australian farming conditions. 
 
The third experiment (Chapter 5) recorded the effect of replacing n-3 LC PUFA rich dietary 
fish oil with C18 n-3 PUFA rich camelina oil at two inclusion levels in commercial-like diets fed 
to market-sized Atlantic salmon. This assessment was achieved by an analysis of industry 
relevant production parameters including growth performance, fatty acid composition and 
metabolism, nutrient digestibility and consumer acceptance (liking and attribute analysis of 
fillet). The trial was conducted over the final 150 days of an on-farm grow-out period in 
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seawater. The dietary replacement of n-3 LC PUFA with C18 n-3 PUFA resulted in a significant 
decrease in fillet n-3 LC PUFA and a poorer growth performance. However, in the absence of 
fish oil, the inclusion of camelina oil at high levels (40 %) contributed to an improved n-6:n-3 
ratio and partially ameliorated low dietary n-3 LC PUFA by providing added substrate for 
endogenous n-3 LC PUFA synthesis in comparison to a 20% camelina oil inclusion. 
Furthermore, consumer acceptance of Atlantic salmon was unaffected by the dietary addition 
of camelina oil.  
 
The fourth experiment (Chapter 6) compared two iso-energetic diets with varied protein: lipid 
ratios by an assessment of growth, fatty acid utilisation, nutritional quality, nitrogenous waste 
output and bio-economic considerations. The trial, conducted over the final 150 days of an 
on-farm grow-out period found minimal differences in growth, fatty acid utilisation and fillet 
quality. A decreased dietary protein: lipid ratio showed a more efficient protein utilisation 
both in terms of digestibility and assimilation into fish and, therefore, nitrogenous waste 
output was reduced. However, due to small differences in feed utilisation, the cost of fish 
production was found to be higher.     
 
The final experimental chapter (Chapter 7) complements Chapter 5, by quantifying the extent 
of n-3 LC PUFA biosynthesis and the resultant effect on fillet nutritional quality in large, 
market size Atlantic salmon. The effects of diets on fatty acid metabolism, specifically, in vivo 
bioconversion were discussed in Chapters 4-6; however, there are limitations when applying 
mass balance calculations, namely the whole-body fatty acid balance method, on-farm, 
specifically, a decreased ability of accurately measuring fatty acid intake. Accordingly, in 
contrast to Chapter 5, this experiment was laboratory based. Four diets were manufactured 
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providing altered levels of dietary omega-3 substrate, namely 18:3n-3, and end-product, 
namely, 20:5n-3 and 22:6n-3. After 283 days of feeding, fish grew to over 3000 g and no 
differences in growth performance or biometrical parameters were recorded. An analysis of 
fatty acid composition and in vivo metabolism revealed that post-smolt Atlantic salmon have 
the potential to endogenously produce n-3 LC PUFA when provided with a substantial amount 
of dietary omega-3 substrate. Moreover, the extent of endogenous production resulted in 
fillet levels of n-3 LC PUFA comparable to fish fed a diet with added fish oil. Another major 
finding was that the presence of abundant dietary omega-3 substrate with the addition of 
dietary omega-3 end-product (i.e. fish oil) had a positive effect on final fillet levels of n-3 LC 
PUFA. This was likely the result of the preferential β-oxidation of dietary C18 n-3 PUFA 
resulting in an apparent conservation of n-3 LC PUFA from catabolism. Ultimately, this 
Chapter highlights the potential for endogenous synthesis of n-3 LC PUFA to, at least partially, 
support a substantial reduction in the amount of dietary fish oil in diets for market sized 
Atlantic salmon reared in seawater. 
 
Finally, Chapter 8 provides a summary and consolidated discussion of each of the 
experimental chapters and offers directions for future research and areas which will enhance 
the overall viability of the Atlantic salmon aquaculture industry. Together, the experimental 
chapters presented herein, comprise a comprehensive body of research which will assist the 
facilitation of the further expansion of the industry in a manner which is both environmentally 
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1. General Introduction 
 
Aquaculture has been in a state of rapid growth and now produces over 50% of total available 
seafood (FAO 2015), however, its further expansion is limited by the cost and the availability 
of suitable dietary oil sources (Tacon & Metian 2015; Tocher 2015; Turchini et al. 2009). 
Historically, the Atlantic salmon (Salmo salar) aquaculture industry has relied upon the 
utilisation of fish oil (FO) - a rich source of omega-3 long-chain polyunsaturated fatty acids (n-
3 LC PUFA) -, but given the implementation of strict quota based systems for the capture of 
marine forage fish its supply cannot expand. Additionally, competition for FO originating 
outside of aquaculture, including the nutraceutical and agricultural industries has increased 
(Hixson et al. 2017; Subasinghe et al. 2009; Tocher 2015; Ytrestøyl et al. 2015). At the same 
time, the global population is increasingly reliant upon aquaculture to supply edible n-3 LC 
PUFA despite a series of step-wise reductions in their dietary provision in commercial 
aquafeed formulations (Sprague et al. 2016; Subasinghe et al. 2009; Tocher 2015). 
Resultantly, dietary formulations for aquafeed are constantly evolving and the incorporation 
of alternative dietary lipids is commonplace but these can impact the growth performance, 
nutritional quality and consumer acceptance of the final product (Bendiksen et al. 2011; 
Henriques et al. 2014; Nichols et al. 2014; Sprague et al. 2016; Tocher 2015; Turchini et al. 
2010). Accordingly, previous research into aquaculture nutrition has aimed at elucidating the 
effect of FO replacement in aquafeed for many species, nevertheless, there remains 




1.1 Omega-3 fatty acids in Atlantic salmon 
 
Lipids, and particularly, their constituent fatty acids play a major role in providing metabolic 
energy to fish. Furthermore, omega-3 (where the first double bond in the carbon chain is 
three carbon atoms from the methyl terminus of the fatty acid molecule) long-chain (≥20 
carbon atoms) polyunsaturated (two or more double bonds) fatty acids (n-3 LC PUFA) play 
important roles in both fish and human nutrition (Tocher 2003). The Atlantic salmon (Salmo 
salar L.) aquaculture industry is constantly balancing the expectation of producing fish with 
high levels of health promoting n-3 LC PUFA whilst relying on dietary ingredients which are 
subject to intense market volatility (Oglend 2013; Sprague et al. 2016; Troell et al. 2014; 
Turchini et al. 2009). Therefore, the continuous evolution of dietary lipid and fatty acid 
compositions in aquafeed formulations is often the direct response to the need of balancing 
fishes’ and consumers’ nutritional requirements and the fluctuations in cost and availability 
of dietary oil sources (Bendiksen et al. 2011; Hardy 2010; Sprague et al. 2016; Tacon & Metian 
2015; Tocher 2015). A major trend in recent years has been the increasing level of substitution 
of marine derived oil sources, such as FO, with more readily available oils of terrestrial origin 
(Bendiksen et al. 2011; Sprague et al. 2016; Tacon & Metian 2015; Turchini et al. 2010). Whilst 
this has enabled the continual growth of the Atlantic salmon aquaculture industry, it has 
resulted in compromises in product quality, and specifically in the reduction in the level of n-
3 LC PUFA deposited in the fillet (Henriques et al. 2014; Nichols et al. 2014; Sprague et al. 
2016). In order to further develop nutritional solutions to enhance the viability of Atlantic 
salmon aquaculture, both industry and academia routinely engage in experimental dietary 
growth trials. Within industry, these trials are essential to the uptake of more cost-effective 
and sustainable aquafeed formulations; however, much of the quantitative data remains in-
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house and is rarely re-produced for publication in academic journals or other publically 
available platforms (Henriksson et al. 2012). On the other hand, despite significant research 
interest in Atlantic salmon, university and research and development provider-based 
experiments are subject to severe financial and logistical limitations, including facility 
availability and the high cost of lengthy trials. From a biological perspective, confidence in 
recorded nutritional data is reliant on the assumption that dietary fatty acids have been 
assimilated into fillet tissues, which, is both time and growth dependent (Jobling 2003; Jobling 
2004). In response, Rosenlund et al. (2016) has advocated for a greater representation of 
long-term growth trials in the published literature to better elucidate n-3 LC PUFA utilisation 
in Atlantic salmon. Furthermore, methods in data reporting often vary between research 
groups creating inconsistencies when attempting to evaluate relevant quantitative data (Sales 
& Glencross 2011a). Resultantly, there have been few attempts to collate and quantify 
published nutritional information on Atlantic salmon (Collins et al. 2013; Sales & Glencross 
2011a). A potential strategy to quantify the dietary effects on fillet n-3 LC PUFA concentration 
in Atlantic salmon reported in published literature is via meta-analytic methods. Such 
methods are used to combine information from multiple studies to more accurately, and at 
the same time more broadly, evaluate or estimate an overall effect (Tweedie 2001). Analyses 
of this kind have traditionally been popular in the sociological and medical sciences, however, 
they are more recently being utilised as an effective quantitative tool to measure outcomes 
in numerous disciplines, including fish nutrition (Collins et al. 2013; Sales & Glencross 2011a; 
Tweedie 2001). Specifically, Sales and Glencross (2011a) quantified the effects of FO 
substitution on growth performance and fatty acid composition in Atlantic salmon. However, 
despite elucidating relationships between vegetable oils and fish performance, further 
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extrapolation of results was hindered by a lack of uniformity and replication in the collected 
numerical data (Sales & Glencross 2011a). Therefore, further work is warranted. 
 
1.2 Dietary lipid and season 
 
Climate change is having an increasing effect on sea surface temperatures in the southern 
hemisphere (Last et al. 2011; Oliver et al. 2017) and recent years have seen unprecedented 
marine heatwaves in waters surrounding Tasmania (Last et al. 2011). As mentioned, the fatty 
acid composition of Atlantic salmon is heavily influenced by the dietary lipid and relatedly the 
fatty acid composition of the aquafeed. Nevertheless, other factors, such as, water 
temperature, and its direct impact on overall fish physiology, specifically that of fatty acid 
metabolism, influences how different dietary lipids are utilised by Atlantic salmon (Handeland 
et al. 2000; 2008; Huguet et al. 2015; Jobling & Bendiksen 2003; Kullgren et al. 2013; Ng et al. 
2004; Norambuena et al. 2015b). Water temperatures in excess of the species optimum 
(~13oC) (Handeland et al. 2008) negatively affect the intake and digestibility of fatty acids 
(Bendiksen et al. 2003b; Bendiksen & Jobling 2003; Hevrøy et al. 2012; Huguet et al. 2015; 
Kullgren et al. 2013). Sub-optimal water temperatures have been shown to increase energetic 
cost, resulting in the preferential β-oxidation of certain fatty acids, affecting the fillet lipid 
composition (Viant et al. 2003). Southern hemisphere salmonid culture conditions are typified 
by mild winter conditions contrasted with summer water temperatures which regularly 
exceed optimum, that in recent years has had a negative impact on the aquaculture industry 
(Last et al. 2011; Oliver et al. 2017). Furthermore, the occurrence of sub-optimal growing 
conditions is likely to increase concomitantly with rising sea temperatures across temperate 
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regions in Australia and globally (Cochrane et al. 2009; Hobday et al. 2011; Last et al. 2011; 
Oliver et al. 2017). Accordingly, there is a requirement for diets to be specifically formulated 
with respect to seasonal impact. Optimal seasonally tailored diets must effectively utilise 
alternative lipid sources to provide adequate metabolic energy whilst preserving nutritionally 
valuable fatty acids such as n-3 LC PUFA, particularly during sub-optimal summer grow-out 
conditions. 
 
Owing to its comparatively low cost and widespread availability, poultry by-product oil (PbO) 
is a frequently utilised oil source in Australian, North American and South American salmonid 
aquafeed formulations (Bureau & Meeker 2010; Codabaccus et al. 2012a; Hatlen et al. 2014; 
Turchini et al. 2009). Where used, it typically accounts for over 50% of the dietary lipid source 
(Codabaccus et al. 2012) without compromising lipid digestibility or fish growth performance 
(Hatlen et al. 2014; Liu et al. 2004; Rosenlund et al. 2001b; Turchini et al. 2013b). However, the 
increased utilisation of PbO by the aquafeed sector and the pet-food industry has seen its 
availability steadily diminishing; therefore, further alternatives require investigation (Emery et 
al. 2016; Emery et al. 2014). A potential candidate is tallow (TAL), rendered beef and lamb fat, 
which has received recent attention, owing to its reasonable price, abundant and constant 
supply, and lack of competition with food and traditional terrestrial feed sectors (2016; Emery 
et al. 2014). Additionally, the potential of TAL as a suitable dietary lipid source in aquafeed 
formulations stems from its capacity to ‘spare’ n-3 LC PUFA from catabolism, as documented 
previously (Emery et al. 2016; Gause & Trushenski 2013). This characteristic has been 
reported to be facilitated by the relatively high content of saturated fatty acids (SFA) and 
monounsaturated fatty acids (MUFA) that are reported to be preferentially β-oxidised for 
metabolic energy, thus preserving valuable n-3 LC PUFA from catabolism and increasing their 
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deposition into the fillet (Francis et al. 2014a; Turchini et al. 2011a). Furthermore, in 
comparison to the majority of other alternative oils tested and/or implemented in aquafeed 
formulations, TAL is characterised by extremely low levels of omega-6 polyunsaturated fatty 
acids (n-6 PUFA), which, if deposited into the fillet, may contribute negatively toward the anti-
inflammatory properties of the final aquaculture product for human consumption via a 
deteriorated n-6:n-3 ratio (Baum et al. 2012; Kris-Etherton et al. 2002; Ruxton et al. 2004; 
Simopoulos 2002, 2008).  
 
As mentioned, the suitability of alternative oils is influenced by the capacity to provide 
metabolic energy as well as market availability (Turchini et al. 2010). Canola oil (CAN) 
(rapeseed oil with low erucic acid and glucosinolates) possesses these qualities and remains a 
cost-effective alternative oil (Higgs et al. 2006), rich in MUFA, particularly 18:1n-9, making it 
easily digestible and a good substrate for β-oxidation in Atlantic salmon (Bell et al. 2001b; 
2003a; 2003b; Higgs et al. 2006). Additionally, due to high availability and consumer and 
legislative demands which restrict the use of animal products in animal feeds, CAN is currently 
the primary alternative oil source in European Atlantic salmon aquafeed (Bellagamba et al. 
2015; Higgs et al. 2006; Karalazos et al. 2007; Turchini et al. 2010). 
 
Despite current widespread use of animal and plant-based lipid sources in aquafeed 
formulations, the vast majority of published research concerning the use of alternative oils in 
Atlantic salmon aquaculture has been conducted in small scale laboratory trials, with limited 
information relevant to on-farm application across a major proportion of the grow-out cycle 
(Rosenlund et al. 2016; Sales & Glencross 2011b; Thorarensen et al. 2015).  Likewise, in most 
instances published investigations place a major focus on the Northern Hemisphere, where 
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thermal minima and maxima vary greatly in comparison to Southern Hemisphere systems, 
which as mentioned, are subjected to sub-optimal summer grow-out conditions (Hobday et 
al. 2011). Hence, nutritional strategies rely on applicable on-farm research to elucidate the 
effect of growing season on the efficient utilisation of alternative lipid sources. 
 
1.3 Dietary long-chain vs shorter-chain n-3 PUFA 
 
Concomitant with the volatility of FO supply, the use of terrestrial oilseed crops rich in C18, 
shorter-chain, n-3 PUFA as a dietary lipid source in aquafeed has increased (Bell et al. 2004; 
Bell et al. 2001a; Turchini et al. 2010). n-3 LC PUFA, including key constituents 20:5n-3 and 
22:6n-3, play contrasting physiological roles and are metabolised differently in fish and 
humans in comparison to C18 PUFA (Fard et al. 2018; Turchini et al. 2011c). Therefore, the 
growing trend of ‘replacing’ n-3 LC PUFA with shorter-chain n-3 PUFA increases the 
pertinence of investigating the resultant metabolic and product quality impacts on cultured 
fish species. 
 
The Atlantic salmon aquaculture industry is a heavy consumer of marine derived n-3 LC PUFA 
and has addressed unstable FO supply via the incorporation of various terrestrial oil sources 
into aquafeed formulations (Turchini et al. 2009). Camelina (Camelina sativa; CAM) oil is one 
such oil which has been afforded recent attention, and similar to linseed/flaxseed oil, and to 
a lesser extent to canola oil, is characterised by high levels of 18:3n-3 (Hixson et al. 2014a; 
Hixson et al. 2014b). This fatty acid is considered essential, as it cannot be synthesised by 
animals or humans, and is the precursor of longer-chain, more unsaturated fatty acids, 
namely, 20:5n-3 and 22:6n-3 which reportedly possesses numerous health benefits, in-part 
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due to anti-inflammatory and cardio-protective properties (Baum et al. 2012; Nestel et al. 
2015; Turchini et al. 2011c). Whilst the main dietary source of n-3 LC PUFA for humans is fish 
and seafood, 18:3n-3 can be consumed from a wide variety of terrestrial dietary sources 
(Abedi & Sahari 2014; Garg et al. 2006; Simopoulos 2000). It is known that in the absence of 
added n-3 LC PUFA, several fish species, including Atlantic salmon, have the capacity to 
endogenously produce 20:5n-3 and 22:6n-3 when provided 18:3n-3 as a substrate for in vivo 
bioconversion via the n-3 LC PUFA elongation desaturation enzymatic pathway (Figure 1.1) 
(Nakamura & Nara 2004; Tocher 2003). However, the extent of endogenous n-3 LC-PUFA 
production is limited and dependent on: i) both substrate (18:3n-3) and end-product (22:6n-
3) availability; ii) on the physiological requirement for 22:6n-3, which itself is influenced by a 
number of factors including developmental stage and water temperature (Tocher et al. 2003; 
Torstensen et al. 2004a; Turchini & Francis 2009; Turchini et al. 2011c); and iii) on other 
external factors, such as, amongst others, dietary co-enzyme and co-factor availability (Giri et 
al. 2016; Lewis et al. 2013; Senadheera et al. 2012a, 2012b) and the presence of promoters 
or inhibitors of desaturase and elongase enzymatic activity (Pickova et al. 2010). 
Nevertheless, the endogenous production of 22:6n-3 from 18:3n-3 is not considered 
sufficient to substantially enrich the fillet with 22:6n-3 to the same extent as dietary FO 
(Cleveland et al. 2012; Francis et al. 2007; Tocher et al. 2003; Turchini & Francis 2009). Owing 
to the aforementioned reported health benefits of n-3 LC PUFA (Garg et al. 2006; Kris-
Etherton et al. 2002; Ruxton et al. 2004; Valfré et al. 2003), health agencies have long iterated 
the importance of fish consumption (Colquhoun et al. 2008; Meyer 2016). Furthermore, an 
enhanced holistic approach regarding the ‘healthy’ consumption of fatty acids advocates the 
consumption of a diet which also minimises the n-6 to n-3 fatty acid ratio (Calder 2010; Nestel 
et al. 2015; Simopoulos 2008; Turchini et al. 2011c). The balance of these fatty acids has 
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become a relative measure of the health promoting benefit of oil sources due to reported 
anti-inflammatory properties and resultant risk reduction of cardiovascular disease achieved 
by diets with a reduced n-6:n-3 ratio (Abedi & Sahari 2014; Harris et al. 2009; Simopoulos 
2008). Despite the aforementioned functional differences between 18:3n-3 and 22:6n-3, the 
reported n-6:n-3 ratio in fish often does not distinguish between long and short-chain n-3 
fatty acids and as a result has the potential to mislead consumers, who fail to make this 
technical distinction (Turchini et al. 2011c). If left unaddressed, this may result in the 
consumption of food which has a lower nutritional value than is implied or assumed by the 
consumer. 
 
1.4 Altered dietary protein: lipid ratios 
 
The central objective for aquafeed manufacturers is to achieve the lowest cost of production 
for farmers, balancing formulation cost while maintaining optimal fish performance. This can 
be realised via optimising the utilisation efficiency of dietary nutrients whilst simultaneously 
reducing the inclusion of increasingly expensive marine-derived ingredients. The resultant 
dietary formulations inevitably involve a series of ‘trade-offs’ between the cost of added 
macronutrients, adequate provision of nutrients for both anabolism (growth and tissue 
synthesis) and catabolism (metabolic energy), nutritional and organoleptic quality of the final 
product and limiting the negative impacts on the surrounding aquatic environment 
(Bendiksen et al. 2011; Bureau 2004; Tocher 2015; Turchini et al. 2010).   
 
A common strategy for aquafeed manufacturers has been the utilisation of relatively large 
concentrations of terrestrial oil sources to produce diets with a high energy content. 
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Traditionally referred to as ‘protein sparing’ (Einen & Roem 1997; Francis & Turchini 2017; 
Karalazos et al. 2011b; Kaushik & de Oliva Teles 1985), the provision of high fat diets promotes 
the utilisation of energy from lipid, thus increasing the amount of dietary protein available for 
tissue synthesis. The protein sparing concept has been particularly popular in salmonid 
aquaculture, given the innate ability of this species to efficiently use large concentrations of 
dietary lipid as an energy source. Thus, coupled with the historically lower price of dietary 
lipid in comparison to protein sources, high energy formulations are widely favoured in 
Atlantic salmon aquafeed (Bendiksen et al. 2011; Einen & Roem 1997; Pratoomyot et al. 2010; 
Turchini et al. 2010). However, various lipid sources are now as, if not more, expensive than 
protein sources, in particular those rich in n-3 LC PUFA such as FO. At the same time, the well-
documented health benefits of n-3 LC PUFA consumption have influenced consumer 
expectations of farmed fish to provide a dependable source of edible n-3 LC PUFA 
(Christenson et al. 2017; Tur et al. 2012; Turchini et al. 2011b). The Atlantic salmon 
aquaculture industry sits at the centre of this paradox given their reputation as reliable source 
of edible n-3 LC PUFA whilst itself consuming a relatively high proportion of globally available 
FO. Given the increased value placed on dietary sources of n-3 LC PUFA, attempts have been 
made to retro-engineer the protein sparing concept, in order to conserve n-3 LC PUFA from 
catabolism in Atlantic salmon via the provision of high protein diets (Francis & Turchini 2017). 
It is known that dietary n-3 LC PUFA are readily β-oxidised for metabolic energy when in 
excess of physiological requirements (Tocher 2003). Hence, it has been hypothesised that in 
contrast to the protein sparing concept, an increase in the protein: lipid ratio would increase 
the utilisation of dietary protein for catabolic processes and thus favour the retention of 
dietary fatty acids, in particular, n-3 LC PUFA. However, to date results have been inconclusive 
and further investigation has been suggested (Francis & Turchini 2017). Despite this, an 
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increase in the dietary protein: lipid ratio has been shown to improve the feed conversion 
ratio in farm reared Atlantic salmon (Weihe et al. 2018). 
 
Importantly, however, any variation of the dietary protein: lipid ratio in aquafeed would not 
only affect the growth and nutritional quality of Atlantic salmon, but a sub-optimal digestible 
protein : digestible lipid ratio would decrease nitrogen retention efficiency. This would 
stimulate the catabolism of protein for energy, resulting in an increase of dissolved 
nitrogenous waste, predominantly, ammonia (Crab et al. 2007; Hardy & Gatlin 2002; 
Karalazos et al. 2011a; Kaushik & Cowey 1991). Poor dietary protein retention causes an 
increased output of undigested nitrogen entering the surrounding aquatic environment, 
eliciting potentially deleterious effects on water quality, including eutrophication, particularly 
in close proximity to the farming operation (Amirkolaie 2011; Crab et al. 2007; Rabalais 2002; 
Wu 1995). Meanwhile, aquaculture operations are subject to enhanced scrutiny to limit 
nitrogenous waste effluent, and as a result, effective nutritional strategies are being sought 
(Australian Government  2015; Cho & Bureau 2001; Crab et al. 2007; Hardy & Gatlin 2002). 
Various approaches have been implemented by aquaculture operations to address this, 
including; reducing uneaten feed and tailoring the digestible protein : digestible lipid ratio to 
limit the amount of protein which is undigested or catabolised for metabolic energy (Bureau 
2004; Cho & Bureau 1997; Cho et al. 1994; Crab et al. 2007). Specifically, a decrease in the 
dietary protein: lipid ratio has been shown to significantly reduce nitrogenous waste output 
in intensive aquaculture systems due to an increase in nitrogen retention efficiency (Crab et 




1.5 Quantification of in vivo n-3 PUFA bioconversion  
 
The aquaculture industry has been active in adopting terrestrial plant and animal protein and 
lipid sources for the incorporation into aquafeed, however, most of these ingredients contain 
none, or considerably lower levels of the health beneficial fatty acids (Sprague et al. 2016; 
Tocher 2015; Turchini et al. 2009). Resultantly, maximising the deposition efficiency of 
increasingly limited dietary n-3 LC PUFA into the final edible product will prove integral to 
ensure the ongoing viability of the aquaculture sector (Emery et al. 2016; Francis & Turchini 
2017; Nuez Ortin et al. 2015; Torstensen et al. 2004a). The possible solutions available to 
address this challenge are based on the knowledge that changes to the fatty acid composition 
of the aquafeed influence not only the final fatty acid composition of fish fillets, but also 
various aspects of fatty acid metabolism, including in vivo fatty acid β-oxidation and 
bioconversion (Hixson et al. 2017; Norambuena et al. 2015b; Tocher 2003; Torstensen et al. 
2000). Concomitant with an increased understanding of fatty acid metabolism within popular 
cultured species in recent years, dietary formulations have been manipulated in order to 
promote the sparing of n-3 LC PUFA from catabolism as well as stimulate endogenous 
production via the n-3 LC PUFA biosynthetic pathway (Francis & Turchini 2017; Hixson et al. 
2017; Karalazos et al. 2011b; Torstensen et al. 2004a). The n-3 LC PUFA biosynthetic pathway 
is facilitated by desaturase and elongase enzymes found fish and mammalian species 
(Monroig et al. 2010; Nakamura & Nara 2004; Tocher 2003). However, the activity and 
efficiency of these enzymes in converting shorter (C18), less unsaturated fatty acids into longer 
(C20-22), more unsaturated fatty acids is not uniform across species (Castro et al. 2016; Tocher 
2003). Specifically, marine species of fish are purported to have a severely limited capacity to 
biosynthesise 22:6n-3 from 18:3n-3 dietary substrate (Monroig et al. 2011; Morais et al. 2009; 
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Venegas-Calerón et al. 2010). It is hypothesised that the abundance of n-3 LC PUFA in marine 
ecosystems, which originate in lower trophic eukaryotes and prokaryotes (Kabeya et al. 2018), 
has rendered the n-3 LC PUFA biosynthetic pathway largely redundant (Monroig et al. 2011; 
Morais et al. 2009; Nakamura & Nara 2004; Tocher 2003). Conversely, freshwater and 
anadromous fish have adapted to a relative paucity of available dietary n-3 LC PUFA and 
exhibit a much higher capacity to biosynthesise physiologically required n-3 LC PUFA from 
dietary 18:3n-3 (Bell et al. 2001a; Ruyter & Thomassen 1999; Sissener et al. 2016a; Turchini 
et al. 2013a). 
 
As highlighted previously, Atlantic salmon have a demonstrated ability to bioconvert 18:3n-3 
to 22:6n-3 ('The health benefits of omega-3 polyunsaturated fatty acids: a review of the 
evidence'  2007; Nakamura & Nara 2004; Tocher 2003). Resultantly, numerous metabolic 
responses to dietary fatty acid changes have been elucidated in this species (Bell et al. 2001a; 
Giri et al. 2016; Monroig et al. 2010; Norambuena et al. 2015b; Nordgarden et al. 2003; Nuez 
Ortin et al. 2015; Ruyter & Thomassen 1999; Tocher et al. 2002; Torstensen et al. 2000). It has 
been shown that endogenous production of 22:6n-3 in Atlantic salmon is heavily influenced 
by the dietary ratio of shorter-chain to long-chain n-3 PUFA. Specifically, an increase in 
substrate (18:3n-3) availability appears to enhance the activity of the ∆-6 desaturase enzyme 
necessary for the first and one of the last steps of the n-3 PUFA bioconversion pathway 
(Glencross et al. 2014a; Hixson et al. 2017; Thanuthong et al. 2011; Thomassen et al. 2012; 
Turchini & Francis 2009). Oppositely, the presence of end-product (22:6n-3) may elicit a 
negative feedback mechanism on the pathway (Thomassen et al. 2012). The extent of 
endogenous synthesis of 22:6n-3 in Atlantic salmon may only occur to an extent that satisfies 
a minimum physiological requirement, which itself, is dictated by changing environmental 
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conditions and life history stage (Mellery et al. 2016; Tocher 2003; Torstensen et al. 2004a). 
For instance, n-3 LC PUFA synthesis is generally more efficient in the juvenile stages, and then 
decreases in the seawater growth phase (Glencross 2009). Therefore, endogenous synthesis 
has been documented not to be able to enrich the fillet tissue with n-3 LC PUFA to the same 
extent as dietary added FO in Atlantic salmon (Kjær et al. 2016; Leaver et al. 2008; Sissener et 
al. 2016a; Tocher et al. 2003; Torstensen et al. 2000; Turchini et al. 2011c; Xue et al. 2015). 
Nevertheless, there remains multiple, interrelated dietary and environmental factors which 
dictate the final concentration of n-3 LC PUFA that can be synthesised de novo  (Giri et al. 
2016; Hixson et al. 2017; Lewis et al. 2013; Senadheera et al. 2012a, 2012b; Zheng et al. 2005). 
 
  
Figure 1.1 Pathway of biosynthesis of C20 and C22 polyunsaturated fatty acids from n-3 C18 
precursor (18:3n-3). Δ5, Δ6 fatty acyl desaturates; Elong, fatty acyl elongases [Figure 





1.6 Thesis structure 
 
The thesis presented herein is formatted as a ‘thesis by publication’. As such, it constitutes a 
series of submitted manuscripts and manuscripts in preparation for publication. The materials 
and methods applicable to multiple chapters are summarised in Chapter 2, whereas materials 
and methods specific to each chapter appear within that chapter only. Chapters 3 to 7 
constitute the five experimental research chapters which have been adapted from submitted 
manuscripts and those in preparation for submission. Each experimental chapter provides a 
clear introduction, a methods section, and detailed results and discussion.  
 
Initially, Chapter 3 provides a summary and analysis of pre-existing published nutritional data 
specific to long-term growth trials conduction in seawater focussing on factors affecting 
omega-3 composition in post-smolt Atlantic salmon. Chapters 4-6 present comprehensive 
results from a long-term on farm growth trial of post-smolt Atlantic salmon conducted in 
seawater, including fish performance and nutritional quality. Specifically, Chapter 4 compares 
three dietary lipid sources of terrestrial origin. Chapter 5 details the effects of dietary 
replacement of long-chain omega-3 fatty acids with shorter C18 omega-3 fatty acids and 
Chapter 6 covers the effects of an alteration in the dietary protein: lipid ratio. Chapter 7 
describes the results of a laboratory experiment investigating in vivo fatty acid metabolism 
and the resultant effect on nutritional quality in large Atlantic salmon via the manipulation of 
dietary omega-3 fatty acids. Penultimately, Chapter 8 provides a general, consolidated 
discussion of the key research findings and finally Chapter 9 provides a general conclusion 
and directions for future research. 
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2. General Methodology 
 
2.1 Growth, feed utilisation and biometrical calculations 
 
Standard formulae were used to assess growth, feed utilisation and biometrical data. These 
included initial and final average weight, total feed consumption, total and % gain in weight, 
specific growth rate (SGR), feed conversion ratio (FCR), feed ration % (relative to body mass), 
dress-out percentage (DP %), fillet yield percentage (FY %), hepatosomatic index (HSI %), 
viscera-somatic index (VSI %), condition factor (K), net protein utilisation (NPU %), protein 
growth ratio (PGR) and fat deposition rate (FDR). 
 
1. Gain = (final weight) - (initial weight) 
2. Gain (%) = (final weight - initial weight)/(initial weight) X 100 
3. Specific growth rate (% / day): SGR = [Ln(final weight) - Ln(initial weight)]/(number of days) 
X 100 
4. Feed conversion ratio: FCR = (dry feed fed)/(wet weight gain) 
5. Feed ration (% / day)= (body weight fed / number of days)  
6. Dress-out (%): DP = (gutted fish weight)/(total fish weight) X 100 
7. Fillet Yield (%): FY  = (weight of fillets)/(total fish weight) X 100 
8. Hepatosomatic index (%): HSI= (weight of liver)/(total fish weight) X 100 
9. Viscerosomatic index (%): VSI = (weight of viscera)/(total fish weight) X 100 
10. Condition factor: K = 100 X [final weight (g)]/[fork length (cm)]3 
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11. Net protein utilisation (%): NPU = (final body protein - initial body protein)/(protein intake) 
X 100 
12. Protein growth ratio: PGR = [Ln(final protein) - Ln(initial protein)]/(number of days) 
13. Fat deposition rate: FDR = [Ln(final lipid) - Ln(initial lipid)]/(number of days) 
 
2.2 Proximate analysis 
 
The chemical composition of the experimental diets, faeces and fish samples including; whole 
body and fillet (whole body data not presented in this study), were determined via proximate 
composition analysis according to standard methods (AOAC 1990); codes 930.15; 942.05; 
955.04.  Briefly, moisture was determined by drying samples in an oven at 80°C to a constant 
weight. Ash was determined by incinerating samples in a muffle furnace (S.E.M. SA Pty. Ltd., 
Australia) at 550°C for 18 h. Protein content (Kjeldahl nitrogen: N × 6.25) was determined 
using an automated Kjeltech 2300 (Foss Tecator, Geneva, Switzerland), while lipid was 
determined by dichloromethane: methanol extraction (2/1) (Folch et al. 1957) where 
dichloromethane was used to replace chloroform for safety considerations. Nitrogen free 
extract (NFE), the soluble carbohydrate fraction in the feed, such as starch and sugar, was 
calculated by the difference (% NFE = % Dry Matter - % Crude Protein - % Total Lipid - % Ash). 
 
2.3 Fatty acid composition 
 
Following lipid extraction, fatty acids were esterified into methyl esters using an acid-
catalysed methylation method and then analysed by gas chromatography. Briefly, a known 
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aliquot of C23:0 was added to each sample as an internal standard (Sigma-Aldrich, Inc., St. 
Louis, MO, USA). Fatty acid methyl esters were isolated and identified using an Agilent 
Technologies GC 7890A (Agilent Technologies, Santa Clara, California, USA) equipped with a 
BPX70 capillary column (120 m, 0.25 mm internal diameter, 0.25-μm film thickness; SGE 
Analytical Science, Ringwood, Victoria, Australia), a flame ionisation detector (FID), an Agilent 
Technologies 7693 autosampler injector, and a split injection system (split ratio 50:1). Fatty 
acids were identified relative to known external standards, and resulting peaks were 
corrected by the theoretical relative FID response factors and for methyl transformation, and 
then quantified relative to the internal standard. 
 
2.4 Nutrient digestibility and fatty acid metabolism calculations  
 
Evaluation of digestibility was determined following methods in Atkinson (1984), using ash 
instead of acid insoluble ash, where: 
 
1. Apparent digestibility of dry matter = 100 X (1-(ash in diet / ash in faeces)) 
2. Apparent digestibility of nutrients = 100 X (1-(ash in diet / ash in faeces) X (nutrient in faeces 
/ nutrient in diet)) 
 
Given commercial diets were used for the experiments and contained no internal marker for 
digestibility estimations, a marker already present in the feed was utilised. Acid insoluble ash 
was tested, however, given very small volumes present in our samples and highly variable 
results ash was used and proved more reliable. 
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2.5 Fatty acid metabolism calculations 
 
The calculation of apparent in vivo fatty acid metabolism was performed using the whole-
body fatty acid balance method, as initially proposed and described by Turchini et al. (2007) 
with further development (Turchini et al. 2008; Turchini and Francis, 2009). The results of the 
whole-body fatty acid balance method are reported as nmol g-1 day-1 and percentage of net 
intake. 
 
2.6 Consumer taste analysis 
 
Methods for consumer acceptance testing were based on methods described in Emery et al. 
(2016). A total of 35 regular salmon consumers (20 female, 15 male; age 37 ± 5) were recruited 
from locations adjacent to the Deakin University, Melbourne campus, Australia. All 
participants completed a validated version of the Food Frequency Questionnaire (FFQ) 
developed by Cancer Council Victoria (Hodge et al. 2000), including a specific salmon 
questionnaire which determined that they consumed salmon or salmon products at least 
once every two weeks. This experiment was conducted according to the institutional review 
board regulations of Deakin University (DUREC 2013-156). The experimental protocol was 
also registered under the Australian New Zealand Clinical Trials Registry 
(ACTRN12613000701729). All participants gave written informed consent and were paid to 
participate. Participants attended a single lab session which included training for using the 
hedonic Labelled Magnitude Scale (hedonic LMS) (Lim 2011) (Figure 2.2) and completion of a 
like / dislike questionnaire prior to rating their liking of different salmon products using the 
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hedonic LMS). Procedures were conducted in partitioned sensory booths in the Centre for 
Advanced Sensory Science using Compusense Cloud Software as part of the Compusense 
Academic Consortium (Compusense Inc., Ontario, Canada). The hot smoked and cold smoked 
salmon were prepared and served to assessors after removal from their packages without any 
further treatment, the raw salmon was thawed at room temperature each morning prior to 
assessment. Each participant was first given approximately 15 g of each sample to rate their 
liking using the hedonic LMS. After a one minute break, participants were then given the same 
samples again, but were asked to rate the intensity of fishy, salty and oily attributes using a 
Just About Right scale. In this case a positive value indicated a sample was too high in the 
attribute and a negative score indicated a sample was lacking the attribute. Thereby, for the 
influential attributes, a score close to zero indicated the sample was ‘just about right’. These 
attributes were chosen after prior testing determined they may influence liking. Further, 
participants were given the opportunity to comment on each sample if they chose, or if there 
were additional factors that had influenced their liking. 
 
2.7 Bioeconomic analysis 
 
Differences in production costs factoring in the incorporation of different oils in Atlantic 
salmon diets were estimated using the same approach previously described in Turchini et al. 
(2013c). The costs used for the calculations were based on costs in the Australian market over 
a 12 month period (July 2016 to July 2017) and expressed in $US. The average cost of raw 
materials, excluding oils, as well as the cost of FO, PbO, CAN and TAL was obtained from a 
commodities website and a commercial feed production company (Ridley Aquafeed Ltd). The 
prices used for the following calculations were as follows: FO: $3200; PbO: $1060; CAN: 
30 
 
$1300; TAL: $990 (all prices expressed as $US per tonne). With this information, estimates of 
the feed formulation cost were possible and they were expressed as $US per kg for raw 
materials only. Subsequently, zootechnical (food conversion ratio), biometrical (fillet yield %) 
and chemical parameters (n-3 LC PUFA content of fish fillet) were recorded to estimate the 
cost for raw materials used in the feed for the production of the following: (i) 1 kg feed; (ii) 1 
kg of fish; (iii) 1 kg of edible fillet and iv) 100 g of edible n-3 LC PUFA. The aforementioned 
calculations are based only on costs associated with raw materials used in the diets and 
ignores other potential differences in cost, such as handling of oils at the feed plant or possible 
resulting modifications of the duration of the farming process to reach a specific final 
bodyweight of animals before harvesting at farm level. Accordingly, this analysis should be 
considered purely indicative, and as such, statistical analysis was not implemented on the 




2.8 Figures and Tables 
 
Figure 2.2: Hedonic LMS liking scale used in Compusense for the sensory analysis of liking 
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3. Analysis of dietary effects on omega-3 fatty acid levels in 
post-smolt Atlantic salmon via systematic review and analysis 




Elucidating the specific effects of diet on the fatty acid composition, particularly, health 
beneficial omega-3 long-chain polyunsaturated fatty acids (n-3 LC PUFA), in Atlantic salmon 
(Salmo salar) remains an area of intense commercial interest given the increasing market 
restrictions placed on the supply of fish meal and fish oil (FO) (Tocher 2015; Turchini et al. 
2010). However, additional effort is required to identify the major drivers of fillet n-3 LC PUFA 
content in post-smolt Atlantic salmon and also to assess whether a lack of published 
information is prohibitive to a robust discussion and interpretation of these drivers (Sales & 
Glencross 2011a). The objective of the present Chapter was to utilise existing published data 
from long-term growth trials to i) summarise the extent of published information regarding 
long-term nutritional growth trials conducted on Atlantic salmon in seawater and where 
possible ii) reveal the most significant drivers of fillet n-3 LC PUFA content in seawater reared 
Atlantic salmon. This was achieved by means of a systematic review and the subsequent 





3.2. Material and Methods 
 
3.2.1 Systematic review 
A systematic review of the literature was conducted to identify published studies that 
reported viable data for inclusion in the meta-analysis. The majority of literature was 
identified by entering two search terms 1) “Atlantic salmon fatty acid growth” and 2) “Salmo 
salar fatty acid growth” into the database ‘Web of Science’ with a time constraint of studies 
published post 1950. Manual searching techniques such as scanning of reference lists and 
broad searches using Google Scholar® supplemented database searching to retrieve more 
studies. Articles obtained from database searching (n = 1133) were added to articles obtained 
from manual searching techniques (n = 50) (Figure 3.3). Initial screening of titles and abstracts 
removed duplicates and studies not using the target species. The remaining articles (n = 254) 
were subject to full text assessments against the pre-determined eligibility criteria listed 
below.  
a) Lipid proximate composition of feed must be reported 
b) Lipid proximate composition of fillet must be reported 
c) Fish must be post-smolt and reared in saltwater (not juvenile) 
d) Fish must have had an increased weight of a minimum of 300% 
 
The selection criteria above were agreed upon by a panel comprising of all co-authors and 
additional staff at Deakin University aimed at identifying only studies which would provide 
reliable, relevant data for the meta-analysis. Following methods described in Sales & Glencross 
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(2011a), only peer-reviewed works published in English were considered. Only studies 
presenting lipid proximate compositions of feed and fillet (criteria a and b) were accepted in 
order to reveal direct relationships between feed and body composition, in particular, lipid 
composition and also to allow the conversion of fatty acid data into mg g-1 diet and mg 100 g-
1 fillet. Only studies using post-smolt fish reared in seawater were accepted to maximize 
commercial relevance, considering biological differences in fatty acid uptake and metabolism 
between freshwater and saltwater life stages. Finally, a minimum fish weight increase of 300% 
was agreed upon in order to increase the confidence that the fatty acid composition of the fish 
fillet would be an accurate representation of the experimental diets. Data was extracted from 
studies meeting the pre-determined selection criteria and included; i) growth, feed efficiency 
and biometric data, ii) dietary and fillet proximate composition iii) dietary and fillet fatty acid 
composition and iv) physico-chemical parameters. Where the same growth trial data was 
presented in multiple studies, the study best meeting the selection criteria or with the most 
complete dataset was included. Within studies, individual treatment groups that did not meet 
all requirements of the selection criteria were omitted from inclusion in the database. To 
accommodate for changes to dietary proximate composition concomitant with increasing fish 
size within treatments, where necessary, the dietary proximate composition was reported as 
the average fed to experimental fish based on the percentage of total fish growth at each 
dietary proximate composition level.  
 
3.2.2 Unit conversion 
All fatty acid data used in the present Chapter was converted to mg g-1 of diet and mg 100g-1 
fillet for diet and fillet fatty acid data, respectively. Due to a large number of studies reporting 
fatty acid data as % of total fatty acids, two separate conversion factors were applied to the 
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data. Based on studies by Emery et al. (2014) and Norambuena et al. (2015a) a conversion 
factor of 0.76678 was applied to dietary fatty acid data reported in % of fatty acids to convert 
to mg g-1 lipid. Similarly, based on studies by Emery et al. (2014) and Wilke et al. (2015) a 
conversion factor of 0.78831 was used to convert fillet fatty acid data reported in % of fatty 
acids to mg g-1 lipid. This is based on the information provided by these studies that there is 
0.76678 and 0.78831 g of fatty acid in 1 g of lipid in diet and fillet samples, respectively.  Finally, 
diet and fillet proximate data was used to make the final conversion in order to report all fatty 
acid data as mg g-1 diet and mg 100 g-1 fillet. 
 
3.2.3 Data analysis 
Although the present Chapter has combined multiple studies and analysed the resultant data, 
it is not, strictly, a meta-analysis as it did not measure outcomes variables in response to a 
common control. Whereas, dietary FO % has been used as a control in a meta-analysis by 
Sales & Glencross (2011a), the present Chapter focussed on the entire suite of dietary 
variables collected as predictors. The analytical procedure applied in the present Chapter is 
described below. 
 
3.2.4 Identification of collinearity 
Initially, 63 variables, each with up to 85 data points, were sorted into independent (36) and 
dependent (27) sets, then de-identified to avoid any bias in the analysis. Variables with fewer 
than 40 data points were removed from the analysis; these were regarded as not having 
enough data to contribute to analyses involving four or more variables. Collinearity amongst 
independent variables was checked by an exploration of a correlation matrix (Figure 3.4). 
Subsequently, a directed graph of variables with common R2 ≥ 0.9 was obtained and collapsed 
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according to principles of least missing data and fewest remaining nodes resulting in twenty-
six independent variables (Dong & Peng 2013). Three pairs had fewer than 40 common data 
points, resulting in twenty-three dependent variables. Histograms of each variable were 
checked for normality by fitting with both normal and lognormal curves. 
 
3.2.5 Principal component analysis 
Initially, an attempt to reduce the multidimensional space of the independent variables was 
made by standardising each variable and using principal component analysis (PCA), imputing 
missing data via the alternating least squares (ALS) algorithm (Takane et al. 1977). Histograms 
of the original and consequent datasets sometimes showed spurious imputation at either 
negative or large values. In most cases, but not all, with respect to larger values, log-normal 
transformation of data eliminated negative values. Probabilistic PCA (PPCA) was trialled, but 
exhibited similar issues. Attempts to not impute data were confounded by a large number 
and distribution of missing data, resulting in fewer than 40 data points covering all variables, 
which, did not meet the threshold for reasonable multidimensional modelling. Similar issues 
occurred when repeating the processes over the dependent variable set. Hence, a reduction 
in dimensionalities via PCA was abandoned as an initial step. 
 
3.2.6 Multiple step-wise regression analysis 
Stepwise linear regression was then separately applied to the independent variables for two 
dependent variables of particular interest: fillet 22:6n-3 and n-3 LC PUFA. However, this 





Therefore, the eight methodological and categorical variables were removed, leaving 18 
purely experimental variables. Stepwise regression was again performed for fillet 22:6n-3 and 
n-3 LC PUFA. Resultantly, statistically significant models with three and five independent 
variables were created for fillet 22:6n-3 and fillet n-3 LC PUFA, respectively. PCA with ALS over 
these identified variables again gave spurious values for imputed data, so basic PCA was 
carried out over the points with data for all variables (Figure 3.5). 
 
In both cases, the three variables with the largest contributions to explaining the overall 
dataset variance were identified, and multiple regressions for each dependent variable of 
interest were performed (Figure 3.6 and Figure 3.7). These figures show multiple perspectives 
on the three-dimensional spaces mapped by the surviving independent variables. Colour is 





The systematic review resulted in the full text assessment of 254 peer reviewed articles, of 
which, 15 passed the pre-determined selection criteria, constituting 85 different dietary 
treatments (Figure 3.3). The studies included consisted of a variety of farm and laboratory 
based studies. A brief summary of the relevant data extracted from the selected studies in 
presented below. 
 
3.3.1 Water temperature, feed intake and biometry 
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A summary of experimental water temperature, feed intake and biometry measures are 
presented in Table 3.1. The studies consisted of a variety of on-farm and laboratory based 
trials and where reported, water temperature was given as temperature range or average or 
both (Table 3.1). The average water temperature combining studies was 10.9oC. Minimum and 
maximum final weights of fish ranged from 342 g to 3833 g in studies by Bell et al. (2001a) 
and Roselund et al. (2016), respectively and the average combining studies was 2001 ± 112 g. 
The average food conversion ratio combining studies was 1.1. 
 
3.3.2 Diet fish oil percentage, proximate composition and fatty acid composition 
A summary of FO percentage, proximate composition and protein: energy ratios is presented 
in Table 3.2. FO (expressed as % of dietary oil) varied from 0 to 100 % and averaged 37.6 %. 
Dietary protein and lipid (expressed as mg g-1 diet) averaged 438.3 and 303.2, respectively. 
Dietary fatty acid composition of the 85 dietary treatments was expectedly varied (Table 3.3). 
Minimum and maximum SFA content ranged from 20.9 to 101.8 mg g-1 diet, presented in 
Torstensen et al. (2004b) and Bell et al. (2002), respectively and averaged 46.3 mg g-1 diet 
across all dietary treatments. The level of dietary n-3 PUFA also varied amongst studies, 
concomitant with individual experimental aims. Dietary 18:3n-3 levels ranged from negligible 
amounts to in excess of 100 mg g-1, however, the average across all treatments was 23.9 mg 
g-1 diet. Levels of both 20:5n-3 and 22:6n-3 varied, consistent with FO inclusion level and 
averaged 10.1 and 10.8 mg g diet-1, respectively. The minimum and maximum sum of n-3 LC 
PUFA ranged from 3.8 to 59.1 mg g-1 diet in dietary treatments presented in Torstensen et al. 
(2005) and Friesen et al. (2015), respectively. The average dietary n-3 LC PUFA level was 21.9 




3.3.3 Fillet proximate and fatty acid composition 
In line with the selection criteria, all studies included reported the lipid proximate 
composition of the fillet and ranged from 37.7 to 165 mg g-1 fillet tissue across the 85 
treatments (Table 3.4). As expected, fillet fatty acid composition varied considerably among 
the 85 dietary treatments. Average fillet SFA content was 1443.8 mg 100 g-1 fillet and the 
minimum and maximum recorded levels ranged from 595.1 to 2540 mg 100 g-1 fillet tissue in 
treatments presented in Bell et al. (2001a) and Roselund et al. (2001a), respectively. 
Reporting of individual MUFA was often incomplete and, as such, the sum of MUFA was not 
included in the dataset, however, the predominant fatty acid, 18:1n-9, was generally reported 
and ranged from 650.8 to 3804.5 mg 100 g-1 fillet tissue. Fillet levels of 22:1 (isomers not 
differentiated) were also consistently reported, averaging 318.0 mg 100 g-1 fillet tissue and 
showed large variation between treatments, with minimum and maximum recorded values 
ranging from 18.9 to 1488.2 mg 100 g-1 fillet tissue in treatment groups reported in Friesen et 
al. (2015) and Torstensen et al. (2001), respectively. Consistent with their relative importance 
in nutritional growth trials, n-3 PUFA was consistently reported and varied in accordance with 
dietary inclusion levels. Minimum and maximum fillet levels of 22:6n-3 (mg 100 g-1 fillet 
tissue) ranged from 198.0 to 1332.1 in Bell et al. (2004) and Bell et al. (2010a), respectively 
and averaged 514.0 mg 100 g-1 fillet across all 85 dietary treatments. The sum of n-3 LC PUFA 
was not always reported and, where necessary, was taken as the sum of 20:5n-3 + 22:5n-3 + 
22:6n-3. Fillet levels averaged 850.2 mg 100 g-1 fillet with minimum and maximum recorded 
values ranging from 303.2 and 2216.7 mg 100 g-1 fillet tissue in treatments presented in Bell 
et al. (2002) and Bell et al. (2010a), respectively.  
 
3.3.4 Modelling of fillet 22:6n-3 and n-3 LC PUFA 
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Step-wise multiple regression analysis was used to model both 22:6n-3 content and n-3 LC 
PUFA content. As mentioned, statistically significant models for both fillet 22:6n-3 and fillet 
n-3 LC PUFA were created using the three independent variables with the largest 
contributions to explaining the overall dataset variance. For both fillet 22:6n-3 and fillet n-3 
LC PUFA, final weight as an independent variable explained a large amount of the total 
variance (Figure 3.5). The independent variables used to predict fillet 22:6n-3 were: i) final 
weight, ii) diet 18:3n-3 and iii) diet 22:6n-3 (Figure 3.6). The independent variables used to 
predict fillet n-3 LC PUFA were: i) final weight, ii) diet 22:1, and iii) diet 20:5n-3 (Figure 3.7). 
The resulting models were as follows: 
  
1) Fillet 22:6n-3 = (5.48) + (-0.001053 x final weight) + (-0.016158 x diet 18:3n-3) + 
(0.39596 x diet 22:6n-3); R2 = 0.96854; F = 646.6061; p = 3.0028 x 10-47 
  
2) Fillet n-3 LC PUFA = (-90.3347) + (0.14154 x final weight) + (9.615 x diet 22:1) + (47.752 
x diet 20:5n-3) 
R2 = 0.85066; F = 119.6209; p = 5.7426 x 10-26 
 
The three dimensional models used highlight the variability in relationships between the 
independent and the dependent variables. Although for both models, particularly fillet 22:6n-







A recognition of the continued resource volatility affecting dietary formulations in Atlantic 
salmon aquafeed has led to a considerable amount of research effort focussing on elucidating 
the impacts on fillet nutritional quality, especially, levels of n-3 LC PUFA. However, It has been 
demonstrated that long-term growth trials are needed to ensure that the effects of dietary 
lipid manipulation are accurately reflected in the fillet tissue of post-smolt Atlantic salmon 
(Rosenlund et al. 2016; Sissener et al. 2016b). The first salient finding of the present Chapter 
is that there is a manifest paucity of industry relevant peer reviewed published data from 
long-term growth trials conducted in seawater. Therefore, the authors assert this is a current 
limitation to the uptake of more efficient aquafeed formulations necessary to ensure the 
long-term viability of the aquaculture sector.  
 
With respect to the present research Chapter, an extensive search of peer reviewed 
literature, including the full-text assessment of 254 published articles, uncovered only 15 
studies with recorded nutritional data in post-smolt Atlantic salmon experiencing > 300 % 
growth on a single experimental diet during the growth trial period. Shorter trials may risk 
type II error, via an incomplete ‘dilution’ of the pre-trial fatty acid composition, hence, 
partially obscuring the actual influence of the administered dietary treatment (Jobling 2003). 
Additionally, ontogenetic change concurrent with a seawater life stage in Atlantic salmon 
affects fatty acid uptake and metabolism (Tocher 2010). Therefore, an enhanced focus on 
post-smolt Atlantic salmon subject to relatively long growth periods is warranted in order to 
maximise the commercial relevance and hence, as mentioned, increase the uptake of novel 
aquafeed formulations in part based on available nutritional data. It is recognised that long-
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term growth trials in seawater are logistically constrictive to research groups due to high costs 
and scarcity of suitable trial facility infrastructure. However, these limitations can be, at least 
partially overcome by, successful industry collaboration via an increased access to on-farm 
facilities that complement the necessary analytical capabilities typically available in research 
institutions (Hardy 1999; Perkmann & Walsh 2007). Hence, the present Chapter advocates 
the continued progression of strong industry-academia partnerships within the aquaculture 
sector. 
 
Despite a limited dataset, a stringent statistical approach was implemented in order to 
minimise multi-collinearity within the resultant models. Consequently, statistical integrity 
was prioritised in order to confidently discuss the biological relevance of the resultant models. 
Final weight was a significant predictor for both fillet 22:6n-3 and fillet n-3 LC PUFA. Although 
counterintuitive as a ‘predictor’, the final weight of a fish is often pre-determined in both a 
commercial and laboratory setting (Dunham 2011; Glencross et al. 2014b). As such, final 
weight should be considered a controllable input variable for the purpose of the present 
discussion. Given the highly variable final weights in the dataset, final weight was responsible 
for a large amount of the variance within the dataset and therefore, unsurprisingly, was 
identified by PCA. Biologically speaking, however, relationships between fish size and fillet 
proximate composition, including, lipid level are known to exist in many species, including 
Atlantic salmon (Einen & Roem 1997; Kaufman et al. 2007; Salam & Davies 1994; Shearer et 
al. 1994; Shearer 1994). Specifically, fish size is often positively correlated with fillet lipid 
composition (Shearer et al. 1994). Given fillet fatty acid composition in the present Chapter is 
reported in mg 100g-1 fillet, as this is the ultimate goal from a consumer nutritional 
information viewpoint, dietary lipid level, and by extension, final weight would be expected 
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to have a positive relationship with fillet 22:6n-3 and n-3 LC PUFA. Furthermore, dietary n-3 
LC PUFA has been reported as essential to optimal growth in seawater reared Atlantic salmon 
(Hixson et al. 2017; Rosenlund et al. 2016). Despite this, final weight was both negatively and 
positively correlated with fillet 22:6n-3 and fillet n-3 LC PUFA, respectively. The dataset was 
limited with respect to the reporting of final weight and often only a single number was 
reported as an experiment mean across dietary treatments. Therefore, despite a change in 
other independent variables, such as fillet proximate and fatty acid compositions within a 
study, final weight was sometimes clustered at a single value. Consequently, further 
extrapolation of the biological relationship between final weight and fillet 22:6n-3 and n-3 LC 
PUFA composition is reserved. 
 
Dietary 22:6n-3 was positively correlated with fillet 22:6n-3 as is intuitive, given the well 
reported ‘mirroring’ effect between dietary and fillet fatty acids, and in particular even more 
so for 22:6n-3 itself (Bendiksen et al. 2011; Sales & Glencross 2011a; Tocher 2015; Turchini et 
al. 2009). Dietary 22:6n-3 is, indeed, generally unaffected by factors which can obscure or 
further modulate this mirroring effect, such as preferential β-oxidation and is, therefore, well 
conserved (Bell et al. 2003b; Bransden et al. 2003; Francis & Turchini 2017; Mourente et al. 
2005; Pratoomyot et al. 2010). Finally, with respect to the fillet 22:6n-3 model, dietary 18:3n-
3 was negatively correlated with fillet 22:6n-3, and this was somewhat unexpected and not 
so intuitive. In contrast to dietary 22:6n-3, dietary 18:3n-3 is readily β-oxidised by salmonids 
(Bell et al. 2001a; Mourente et al. 2005; Stubhaug et al. 2007; Tocher et al. 2002; Turchini & 
Francis 2009) and under certain dietary and environmental conditions, such as the absence 
of dietary 22:6n-3, can be converted to longer and more unsaturated fatty acid homologues 
(Bell et al. 2001a; Ruyter & Thomassen 1999; Sissener et al. 2016a; Tocher 2003; Turchini et 
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al. 2013a). Owing to these properties, dietary lipid sources with relatively high concentrations 
of 18:3n-3, such as rapeseed/canola oil, linseed/flaxseed oil and CAM have been routinely 
used as a substitute for dietary FO both commercially and experimentally (Bell et al. 2003b; 
Collins et al. 2013; Higgs et al. 2006; Hixson et al. 2017; Turchini et al. 2010). Despite the 
recorded potential of endogenous production of 22:6n-3 from dietary 18:3n-3 in salmonids, 
it is not expected to fully compensate for an absence of dietary added 22:6n-3 sources, such 
as FO. In the present Chapter, 11 out of the 15 studies in the analysis, including Bell et al. 
(2001a), Bell et al. (2003b), Bell et al. (2004), Bell et al. (2010a), Friesen et al. (2015), Liland et 
al. (2013), Rosenlund et al. (2001a), Rosenlund et al. (2016), Sissener et al. (2016a), 
Torstensen et al. (2004b) and Torstensen et al. (2005) substituted dietary FO with lipid sources 
containing high concentrations of 18:3n-3 (>50%). Consequently, this may partially explain 
the negative correlation between dietary 18:3n-3 and 22:6n-3 in the present Chapter. 
 
Understandably, n-3 LC PUFA are the subject of high scientific interest in fish nutrition studies 
owing to their extensively reported health benefits for consumers (Kris-Etherton et al. 2002; 
Nestel et al. 2015; Ruxton et al. 2004; Simopoulos 2008). However, fillet concentrations of 
MUFA, in particular, 22:1n-9 and 22:1n-11 receive considerably less attention. Despite this, 
the sum of 22:1 isomers often contributes substantially to the overall fatty acid composition 
of the fillet tissue in Atlantic salmon (Bell et al. 2010a; Bell et al. 2003b; Rosenlund et al. 
2001a; Torstensen et al. 2005; Torstensen et al. 2001) and was identified as a significant 
predictor of fillet n-3 LC PUFA in the present research Chapter. The activity of the ∆-9 
desaturase enzyme, responsible for catalysing the synthesis of monounsaturated fatty acids, 
has been well described in marine invertebrates (Monroig et al. 2013) and is considered 
important for cold water adaptation in warm water fish such as grass carp (Ctenopharyngodon 
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idella) and Nile tilapia (Oreochromis niloticus) (Tiku et al. 1996; Zerai et al. 2010). However, 
despite the potential for ∆-9 desaturation of saturated fatty acids to biosynthesise 22:1 
isomers, the vast majority of these fatty acids in Atlantic salmon are believed to be of marine 
dietary origin, specifically, due to an abundance of these fatty acids present in capelin and 
herring oil originating in the Northern Hemisphere (Ackman et al. 1988; Bell et al. 2003b; 
Halver & Hardy 2002). Therefore, the positive relationship between dietary 22:1 and fillet n-
3 LC PUFA is likely an effect of treatment diets containing FO sourced from the Northern 
Hemisphere, that are concomitantly high in 22:1 and n-3 LC PUFA. However, it should also be 
noted that 22:1 has been reported as a preferential substrate for catabolic processes (fatty 
acid β-oxidation) in salmonids and thus a larger dietary availability might directly contribute 
to increased n-3 LC PUFA retention by sparing them from catabolism (Henderson & Sargent 
1985; Henderson et al. 1982; Stubhaug et al. 2007). 
 
The final significant predictor included in the fillet n-3 LC PUFA model was dietary 20:5n-3 
which had an expectedly positive relationship with fillet n-3 LC PUFA. Although physiologically 
essential, dietary 20:5n-3 is often not as well conserved as 22:6n-3 in Atlantic salmon 
(Codabaccus et al. 2011; Stubhaug et al. 2007; Tocher 2010). Nevertheless, its overall 
contribution to fillet n-3 LC PUFA and importance in predicting final fillet levels of n-3 LC PUFA 
is hereby recognised by the model. 
 
Research that provides a snapshot of the current state of information has the ability to 
highlight areas in which the available information is sparse. This chapter revealed, in 
agreement with Sales and Glencross (2011a), that the conclusiveness of meta-analytic 
approaches in aquaculture nutrition can be hindered by a relatively small dataset and 
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incomplete or inconsistent data reporting. Nevertheless, this chapter identified some major 
dietary drivers of fillet 22:6n-3 and n-3 LC PUFA content in Atlantic salmon via a systematic 
review and subsequent analysis of published data in some studies. Given the increasing value 
of n-3 LC PUFA in aquaculture this is an important task. It is asserted that continued 
collaborative efforts between academia and industry are likely to increase the amount and 
transparency of recorded nutritional information and therefore, support the development of 
sophisticated mechanistic models that can accurately predict fillet n-3 LC PUFA in Atlantic 
salmon across a wider variety of environmental and dietary variables.   
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3.5 Figures and Tables 
Figure 3.3 caption: 
Schematic of systematic review procedure showing number of articles at each stage; i) 
identification of articles matching search terms and identified via ad-hoc searching 
techniques, ii) screening to remove duplicate articles and articles not on the study species, iii) 
articles subject to full text assessment against the pre-determined eligibility criteria and, iv) 
articles included in the data analysis. 
 
Figure 3.4 caption: 
Correlation matrix across all (de-identified) variables. 
 
Figure 3.5 caption: 
Principal components analyses on stepwise regression outputs for fillet 22:6n-3 (labelled as 
DHA) (left) and fillet n-3 LC PUFA (right) across all non-methodological independent 
variables.  Upper plots are biplots showing the relative contributions of each variable to each 
principal component; lower plots show the proportion of total variance explained by each 
principal component. 
 
Figure 3.5 caption: 
Multiple regression of fillet 22:6n-3 (labelled as DHA) on the three strongest predictors from 
the PCA.  Upper left is a perspective view of the 3D regression; dot colours show the actual 
data values of fillet 22:6n-3 whilst rings show the regression model's predictions.  The other 
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three subfigures show perspectives along each axis.  The regression model and various 
statistics are shown. 
 
Figure 3.7 caption: 
Multiple regression of fillet n-3 LC PUFA on the three strongest predictors from the PCA 
(left).  Upper left is a perspective view of the 3D regression; dot colours show the actual data 
values of fillet n-3 LC PUFA whilst rings show the regression model's predictions.  The other 
three subfigures show perspectives along each axis.  The regression model and various 





Experimental temperature, feed intake and biometry of Atlantic salmon fed 85 different diets from 15 studies. 
Study/year Temperature range (oC) Temperature average Initial weight (g) Final Weight (g) Weight gain (g) Feed intake (g) FCR Final length (cm) Fillet yield (%) Condition factor (K) 
(Bell et al. 2001a) 7.9-14.2 11.7 83 342 259 339 1.3 30.2 − 1.2 
(Bell et al. 2001a) 7.9-14.2 11.7 83 342 259 339 1.3 30.2 − 1.2 
(Bell et al. 2001a) 7.9-14.2 11.7 83 342 259 339 1.3 30.2 − 1.2 
(Bell et al. 2001a) 7.9-14.2 11.7 83 342 259 339 1.3 30.2 − 1.2 
(Bell et al. 2001a) 7.9-14.2 11.7 83 342 259 339 1.3 30.2 − 1.2 
(Bell et al. 2002) 5.9-14.7 11.0 55 410 354 549 1.6 33.3 − 1.1 
(Bell et al. 2002) 5.9-14.7 11.0 53 417 364 535 1.5 33.7 − 1.1 
(Bell et al. 2002) 5.9-14.7 11.0 57 394 337 509 1.5 33.1 − 1.1 
(Bell et al. 2002) 5.9-14.7 11.0 56 419 363 544 1.5 33.2 − 1.1 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2100 1980 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2300 2180 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2300 2180 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2100 1980 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2000 1880 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2400 2280 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2600 2480 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2400 2280 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 2300 2180 − − − − − 
(Bell et al. 2003b) 5.5-19.6 10.8 120 1900 1780 − − − − − 
(Bell et al. 2004) 5.0-16.8 10.8 127 1790 1663 2245 1.4 − − − 
(Bell et al. 2004) 5.0-16.8 10.8 127 1890 1763 2274 1.3 − − − 
(Bell et al. 2004) 5.0-16.8 10.8 127 1900 1773 2500 1.4 − − − 
(Bell et al. 2004) 5.0-16.8 10.8 127 1870 1743 2248 1.3 − − − 
(Bell et al. 2004) 5.0-16.8 10.8 127 1870 1743 2353 1.4 − − − 
(Bell et al. 2010a) 5.5-17.0 11.5 81 3120 3039 3738 1.2 65.3 − 1.1 
(Bell et al. 2010a) 5.5-17.0 11.5 90 3030 2941 4087 1.4 63.7 − 1.2 
(Bell et al. 2010a) 5.5-17.0 11.5 92 3180 3088 3335 1.1 63.9 − 1.2 
(Bell et al. 2010a) 5.5-17.0 11.5 84 2840 2756 3279 1.2 62.5 − 1.2 
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(Bell et al. 2010a) 5.5-17.0 11.5 53 2750 2697 2913 1.1 63.1 − 1.1 
(Bell et al. 2010a) 5.5-17.0 11.5 52 2890 2838 3009 1.1 62.8 − 1.2 
(Friesen et al. 2015) 7.9-13.2 − 83 558 475 380 0.8 36.1 − 1.2 
(Friesen et al. 2015) 7.9-13.2 − 84 578 494 395 0.8 36.2 − 1.2 
(Friesen et al. 2015) 7.9-13.2 − 86 595 510 414 0.8 36.6 − 1.2 
(Friesen et al. 2015) 7.9-13.2 − 84 611 527 415 0.8 36.9 − 1.2 
(Friesen et al. 2015) 7.9-13.2 − 98 637 539 418 0.8 37.1 − 1.3 
(Friesen et al. 2015) 7.9-13.2 − 84 534 450 381 0.8 35.0 − 1.3 
(Friesen et al. 2015) 7.9-13.2 − 84 545 460 393 0.9 35.5 − 1.2 
(Larsson et al. 2014) 3.0-16.0 8.7 105 3100 2995 2980 1.0 59.6 72.7 1.5 
(Larsson et al. 2014) 3.0-16.0 8.7 105 3100 2995 2980 1.0 60.0 72.4 1.5 
(Liland et al. 2013) 9.9 9.9 840 3398 2558 2982 1.2 60.2 − 1.6 
(Liland et al. 2013) 9.9 9.9 804 3459 2655 2748 1.0 59.3 − 1.6 
(Liland et al. 2013) 9.9 9.9 792 3475 2683 2759 1.0 59.5 − 1.7 
(Liland et al. 2013) 9.9 9.9 825 3267 2442 2573 1.1 58.3 − 1.6 
(Rosenlund et al. 2001a) 5-15 − 120 2700 2580 − − − − − 
(Rosenlund et al. 2001a) 5-15 − 120 2700 2580 − − − − − 
(Rosenlund et al. 2001a) 5-15 − 120 2700 2580 − − − − − 
(Rosenlund et al. 2001a) 5-15 − 120 2700 2580 − − − − − 
(Rosenlund et al. 2001a) 5-15 − 120 2700 2580 − − − − − 
(Rosenlund et al. 2001a) 5-15 − 120 2700 2580 − − − − − 
(Rosenlund et al. 2016) 12.0 12.0 161 2780 2619 2671 1.0 − − 1.6 
(Rosenlund et al. 2016) 12.0 12.0 163 3085 2922 2864 1.0 − − 1.5 
(Rosenlund et al. 2016) 12.0 12.0 161 3056 2895 3011 1.0 − − 1.6 
(Rosenlund et al. 2016) 12.0 12.0 163 3057 2894 2952 1.0 − − 1.6 
(Rosenlund et al. 2016) 12.0 12.0 163 3074 2911 2707 0.9 − − 1.6 
(Rosenlund et al. 2016) 12-6 9.1 161 3249 3088 3242 1.1 − − 1.8 
(Rosenlund et al. 2016) 12-6 9.1 163 3764 3601 3457 1.0 − − 1.7 
(Rosenlund et al. 2016) 12-6 9.1 161 3833 3672 3599 1.0 − − 1.8 
(Rosenlund et al. 2016) 12-6 9.1 163 3639 3476 3406 1.0 − − 1.7 
(Rosenlund et al. 2016) 12-6 9.1 163 3556 3393 3088 0.9 − − 1.7 
(Sissener et al. 2016a) 12.0 12.0 190 764 574 443 0.8 36.8 − 1.5 
(Sissener et al. 2016a) 12.0 12.0 192 780 588 444 0.8 36.7 − 1.6 
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(Sissener et al. 2016a) 12.0 12.0 189 760 571 448 0.8 36.8 − 1.5 
(Sissener et al. 2016a) 12.0 12.0 189 765 576 443 0.8 36.3 − 1.5 
(Sissener et al. 2016a) 12.0 12.0 190 767 577 436 0.8 36.9 − 1.5 
(Sissener et al. 2016a) 12.0 12.0 189 777 588 464 0.8 37.1 − 1.6 
(Torstensen et al. 2001)  8.2 148 697 549 494 0.9 − − − 
(Torstensen et al. 2004b) 3.9-15.3 − 143 1463 1320 1406 1.1 − − − 
(Torstensen et al. 2004b) 3.9-15.3 − 143 1463 1320 1406 1.1 − − − 
(Torstensen et al. 2004b) 3.9-15.3 − 143 1463 1320 1406 1.1 − − − 
(Torstensen et al. 2004b) 3.9-15.3 − 143 1463 1320 1406 1.1 − − − 
(Torstensen et al. 2004b) 3.9-15.3 − 143 1463 1320 1406 1.1 − − − 
(Torstensen et al. 2004b) 3.9-15.3 − 143 1463 1320 1406 1.1 − − − 
(Torstensen et al. 2005) − − 50 2515 2465 2514 1.0 − − − 
(Torstensen et al. 2005) − − 120 2380 2260 3028 1.3 − − − 
(Torstensen et al. 2005) − − 50 2420 2370 2323 1.0 − − − 
(Torstensen et al. 2005) − − 120 2698 2578 3145 1.2 − − − 
(Young et al. 2006) − − 52 2075 2023 − − − − − 
(Young et al. 2006) − − 52 1975 1923 − − − − − 
(Young et al. 2006) − − 52 2562 2510 − − − − − 
(Young et al. 2006) − − 52 2168 2116 − − − − − 
(Young et al. 2006) − − 52 1936 1884 − − − − − 
(Young et al. 2006) − − 52 2458 2406 − − − − − 
(Young et al. 2006) − − 52 2113 2061 − − − − − 
(Young et al. 2006) − − 52 2193 2141 − − − − − 




Fish oil (%), proximate composition (mg g-1 diet), and protein: energy ratio of 85 diets from 15 studies 
fed to Atlantic salmon during experimental trials. 
Study/year 
Fish oil (% of total 
added lipid) Protein Moisture Lipid Ash 
Dry 
matter NFE 




(Bell et al. 2001a) 100 467.0 78.0 277.0 98.0 922.0 80.0 23.3 2.0 
(Bell et al. 2001a) 90 463.0 81.0 264.0 96.0 919.0 96.0 23.0 2.0 
(Bell et al. 2001a) 75 448.0 82.0 263.0 96.0 918.0 111.0 22.9 2.0 
(Bell et al. 2001a) 50 456.0 75.0 257.0 97.0 925.0 115.0 22.9 2.0 
(Bell et al. 2001a) 0 469.0 68.0 256.0 97.0 932.0 110.0 23.1 2.0 
(Bell et al. 2002) 100 464.0 55.0 288.0 84.0 945.0 109.0 24.2 1.9 
(Bell et al. 2002) 75 455.0 63.0 279.0 81.0 937.0 122.0 23.9 1.9 
(Bell et al. 2002) 50 465.0 49.0 287.0 82.0 951.0 117.0 24.3 1.9 
(Bell et al. 2002) 0 466.0 45.0 282.0 83.0 955.0 124.0 24.3 1.9 
(Bell et al. 2003b) 100 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 66 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 33 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 0 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 66 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 33 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 0 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 0 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 0 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2003b) 33 444.0 72.0 273.0 79.9 928.0 131.1 23.5 1.9 
(Bell et al. 2004) 100 441.0 59.0 294.0 71.0 941.0 135.0 24.3 1.8 
(Bell et al. 2004) 75 441.0 59.0 294.0 71.0 941.0 135.0 24.3 1.8 
(Bell et al. 2004) 50 441.0 59.0 294.0 71.0 941.0 135.0 24.3 1.8 
(Bell et al. 2004) 25 441.0 59.0 294.0 71.0 941.0 135.0 24.3 1.8 
(Bell et al. 2004) 0 441.0 59.0 294.0 71.0 941.0 135.0 24.3 1.8 
(Bell et al. 2010a) 100 410.0 46.0 349.0 60.0 954.0 135.0 25.8 1.6 
(Bell et al. 2010a) 0 405.0 51.0 335.0 60.0 949.0 149.0 25.4 1.6 
(Bell et al. 2010a) 100 410.0 46.0 349.0 60.0 954.0 135.0 25.8 1.6 
(Bell et al. 2010a) 0 405.0 51.0 335.0 60.0 949.0 149.0 25.4 1.6 
(Bell et al. 2010a) 100 410.0 46.0 349.0 60.0 954.0 135.0 25.8 1.6 
(Bell et al. 2010a) 0 405.0 51.0 335.0 60.0 949.0 149.0 25.4 1.6 
(Friesen et al. 2015) 100 453.0 43.0 265.0 90.0 957.0 149.0 23.7 1.9 
(Friesen et al. 2015) 50 465.0 45.0 264.0 85.0 955.0 141.0 24.2 1.9 
(Friesen et al. 2015) 25 452.0 45.0 260.0 87.0 955.0 156.0 23.9 1.9 
(Friesen et al. 2015) 25 453.0 50.0 260.0 88.0 950.0 149.0 24.0 1.9 
(Friesen et al. 2015) 25 454.0 42.0 264.0 88.0 958.0 152.0 24.1 1.9 
(Friesen et al. 2015) 25 450.0 43.0 255.0 91.0 957.0 161.0 23.4 1.9 
(Friesen et al. 2015) 25 449.0 50.0 261.0 86.0 950.0 154.0 24.1 1.9 
(Larsson et al. 2014) 73 353.0 73.0 351.0 54.0 927.0 169.0 25.1 1.4 
(Larsson et al. 2014) 73 353.0 73.0 351.0 54.0 927.0 169.0 25.1 1.4 
(Liland et al. 2013) 100 411.0 70.0 341.0 53.0 930.0 125.0 25.3 1.6 
(Liland et al. 2013) 20 408.0 60.0 336.0 52.0 940.0 144.0 25.4 1.6 
(Liland et al. 2013) 20 413.0 70.0 345.0 52.0 930.0 120.0 25.4 1.6 
(Liland et al. 2013) 20 406.0 70.0 332.0 52.0 930.0 140.0 25.1 1.6 
(Rosenlund et al. 2001a) 40-50 426.0 34.8 338.0 54.3 965.3 147.0 25.9 1.6 
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(Rosenlund et al. 2001a) 40-50 426.0 34.8 338.0 54.3 965.3 147.0 25.9 1.6 
(Rosenlund et al. 2001a) 40-50 426.0 34.8 338.0 54.3 965.3 147.0 25.9 1.6 
(Rosenlund et al. 2001a) 40-50 426.0 34.8 338.0 54.3 965.3 147.0 25.9 1.6 
(Rosenlund et al. 2001a) 40-50 426.0 34.8 338.0 54.3 965.3 147.0 25.9 1.6 
(Rosenlund et al. 2001a) 40-50 426.0 34.8 338.0 54.3 965.3 147.0 25.9 1.6 
(Rosenlund et al. 2016) 0 436.4 58.8 365.1 79.9 941.2 59.9 25.7 1.7 
(Rosenlund et al. 2016) 2 431.1 58.0 363.8 79.9 942.0 67.3 25.7 1.7 
(Rosenlund et al. 2016) 4 431.6 60.2 363.8 79.9 939.8 64.6 25.7 1.7 
(Rosenlund et al. 2016) 6 429.7 62.3 361.5 79.9 937.7 66.6 25.6 1.7 
(Rosenlund et al. 2016) 8 431.0 65.5 366.2 79.9 934.5 57.5 25.6 1.7 
(Rosenlund et al. 2016) 0 436.4 58.8 365.1 79.9 941.2 59.9 25.7 1.7 
(Rosenlund et al. 2016) 2 431.1 58.0 363.8 79.9 942.0 67.3 25.7 1.7 
(Rosenlund et al. 2016) 4 431.6 60.2 363.8 79.9 939.8 64.6 25.7 1.7 
(Rosenlund et al. 2016) 6 429.7 62.3 361.5 79.9 937.7 66.6 25.6 1.7 
(Rosenlund et al. 2016) 8 431.0 65.5 366.2 79.9 934.5 57.5 25.6 1.7 
(Sissener et al. 2016a) 20 489.1 39.0 275.8 79.9 961.0 116.3 24.4 2.0 
(Sissener et al. 2016a) 20 500.5 41.0 280.5 79.9 959.0 98.1 24.6 2.0 
(Sissener et al. 2016a) 20 502.1 44.0 288.7 79.9 956.0 85.3 24.7 2.0 
(Sissener et al. 2016a) 20 502.6 45.0 277.5 79.9 955.0 95.0 24.5 2.1 
(Sissener et al. 2016a) 20 520.3 39.0 278.9 79.9 961.0 81.9 24.7 2.1 
(Sissener et al. 2016a) 20 522.5 43.0 294.7 79.9 957.0 60.0 25.0 2.1 
(Torstensen et al. 2001) 100 450.0 50.0 323.8 65.0 950.0 111.2 25.3 1.8 
(Torstensen et al. 2004b) 75 450.0 60.0 300.0 70.0 940.0 120.0 24.5 1.8 
(Torstensen et al. 2004b) 50 450.0 60.0 300.0 70.0 940.0 120.0 24.5 1.8 
(Torstensen et al. 2004b) 25 450.0 60.0 300.0 70.0 940.0 120.0 24.5 1.8 
(Torstensen et al. 2004b) 0 450.0 60.0 300.0 70.0 940.0 120.0 24.5 1.8 
(Torstensen et al. 2004b) 50 450.0 60.0 300.0 70.0 940.0 120.0 24.5 1.8 
(Torstensen et al. 2004b) 100 450.0 60.0 300.0 70.0 940.0 120.0 24.5 1.8 
(Torstensen et al. 2005) 100 421.0 70.0 314.0 70.0 930.0 125.0 24.5 1.7 
(Torstensen et al. 2005) 100 421.0 70.0 314.0 70.0 930.0 125.0 24.5 1.7 
(Torstensen et al. 2005) 25 412.0 64.0 328.0 71.0 936.0 125.0 24.8 1.7 
(Torstensen et al. 2005) 0 429.0 65.0 313.0 66.0 935.0 127.0 24.7 1.7 
(Young et al. 2006) 13.7 427.1 80.5 211.3 89.7 919.5 191.5 21.7 2.0 
(Young et al. 2006) 13.8 423.3 81.6 208.5 84.5 918.4 202.1 21.7 2.0 
(Young et al. 2006) 14.3 418.2 80.3 205.7 86.3 919.7 209.6 21.6 1.9 
(Young et al. 2006) 19.9 406.8 70.8 278.2 84.5 929.3 159.8 23.3 1.7 
(Young et al. 2006) 19.9 411.5 71.3 267.4 86.3 928.7 163.5 23.1 1.8 
(Young et al. 2006) 20.4 412.5 71.2 269.7 83.4 928.8 163.3 23.2 1.8 
(Young et al. 2006) 26.2 413.5 54.4 336.1 86.1 945.6 109.9 24.9 1.7 
(Young et al. 2006) 26.4 420.7 55.4 322.7 92.4 944.6 108.8 24.5 1.7 





Fatty acid composition of 85 diets from 15 studies fed to Atlantic salmon during experimental trials (mg g-1 diet). 
Study/year 14:0 16:0 18:0 SFA 20:1 22:1 18:1n-9 18:2n-6 20:4n-6 18:3n-3 18:4n-3 20:4n-3 20:5n-3 22:5n-3 22:6n-3 n-3 LC PUFA 
(Bell et al. 2001a) − − − 50.8 17.2 25.3 26.1 5.1 1.3 3.4 − − 18.1 − 25.3 43.3 
(Bell et al. 2001a) − − − 43.3 15.0 20.9 38.1 10.3 0.8 5.9 − − 13.8 − 20.4 34.2 
(Bell et al. 2001a) − − − 39.1 12.7 16.5 47.0 14.3 0.8 7.7 − − 13.1 − 17.5 30.7 
(Bell et al. 2001a) − − − 34.3 10.8 13.6 58.3 18.5 0.6 9.7 − − 10.2 − 13.4 23.6 
(Bell et al. 2001a) − − − 23.4 5.9 4.5 86.2 30.2 0.4 15.9 − − 5.1 − 5.5 10.6 
(Bell et al. 2002) 11.5 38.9 5.3 59.8 9.3 14.1 38.0 7.9 1.3 4.6 7.1 1.5 18.1 2.2 30.0 50.3 
(Bell et al. 2002) 9.4 47.7 6.0 66.1 7.7 11.1 45.4 11.3 1.1 3.6 5.6 1.3 14.1 1.9 23.5 39.6 
(Bell et al. 2002) 7.7 58.5 6.8 75.5 6.6 9.5 55.7 15.0 0.9 2.9 4.4 0.9 11.4 1.5 19.1 32.1 
(Bell et al. 2002) 3.7 88.2 8.4 101.8 3.2 4.3 67.5 20.3 0.2 1.1 1.3 0.2 3.5 0.6 6.1 10.2 
(Bell et al. 2003b) 11.7 28.5 5.2 50.2 20.1 27.6 31.6 9.4 1.3 3.6 5.9 1.7 15.3 2.5 22.0 41.4 
(Bell et al. 2003b) 7.5 24.3 6.1 42.3 12.6 17.2 33.7 16.5 0.8 38.9 3.8 1.3 11.1 2.1 17.6 32.0 
(Bell et al. 2003b) 4.6 20.1 7.1 35.0 7.7 10.0 34.3 23.9 0.6 69.1 2.1 0.6 6.9 1.3 11.1 19.9 
(Bell et al. 2003b) 2.3 15.9 7.5 27.6 4.0 4.8 34.7 28.5 0.4 95.0 1.0 0.2 3.8 0.6 5.7 10.3 
(Bell et al. 2003b) 7.7 24.5 4.8 41.7 13.6 17.4 55.9 19.9 1.0 9.8 4.0 1.3 11.9 2.3 18.2 33.7 
(Bell et al. 2003b) 4.8 19.7 4.2 32.4 9.6 11.3 78.5 29.3 0.6 13.8 2.3 0.8 8.2 1.3 12.4 22.6 
(Bell et al. 2003b) 2.5 15.1 4.0 23.9 6.3 5.7 101.1 37.5 0.4 18.6 0.8 0.2 4.0 0.6 6.1 10.9 
(Bell et al. 2003b) 2.5 16.1 6.3 27.2 4.6 5.4 54.2 30.6 0.4 68.9 0.8 0.4 4.6 0.8 7.1 13.0 
(Bell et al. 2003b) 2.3 15.9 5.0 22.8 5.4 5.7 77.2 34.2 0.4 42.3 0.8 0.2 4.4 0.8 7.3 12.8 
(Bell et al. 2003b) 4.0 18.4 5.7 31.2 7.3 9.0 60.3 28.7 0.4 46.1 1.9 0.4 6.5 1.0 10.3 18.2 
(Bell et al. 2004) 14.2 27.3 2.5 44.9 40.4 34.7 26.8 9.5 0.5 2.0 6.5 0.9 13.3 − 11.3 24.6 
(Bell et al. 2004) 10.6 23.9 3.8 38.8 29.5 26.2 30.7 16.7 0.5 31.6 4.7 0.7 10.4 − 9.0 19.4 
(Bell et al. 2004) 7.7 21.0 4.7 34.0 20.3 18.3 34.0 22.1 0.2 57.7 3.6 0.5 7.9 − 7.7 15.6 
(Bell et al. 2004) 4.5 18.3 6.1 29.3 11.3 10.8 36.1 27.7 0.2 85.2 2.0 0.5 5.0 − 5.4 10.4 
(Bell et al. 2004) 0.9 13.8 7.0 23.7 2.5 2.7 38.3 34.0 0.2 113.6 0.5 0.2 2.3 − 3.4 5.6 
(Bell et al. 2010a) 15.5 40.1 8.0 69.8 22.7 36.7 27.0 9.4 1.1 4.3 9.4 1.6 22.7 2.1 27.0 51.9 
(Bell et al. 2010a) 2.3 40.8 9.0 55.7 10.3 4.1 96.6 42.4 0.3 25.7 1.0 0.3 3.1 0.3 3.9 7.2 
(Bell et al. 2010a) 15.5 40.1 8.0 69.8 22.7 36.7 27.0 9.4 1.1 4.3 9.4 1.6 22.7 2.1 27.0 51.9 
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(Bell et al. 2010a) 2.3 40.8 9.0 55.7 10.3 4.1 96.6 42.4 0.3 25.7 1.0 0.3 3.1 0.3 3.9 7.2 
(Bell et al. 2010a) 15.5 40.1 8.0 69.8 22.7 36.7 27.0 9.4 1.1 4.3 9.4 1.6 22.7 2.1 27.0 51.9 
(Bell et al. 2010a) 2.3 40.8 9.0 55.7 10.3 4.1 96.6 42.4 0.3 25.7 1.0 0.3 3.1 0.3 3.9 7.2 
(Friesen et al. 2015) 15.2 36.2 7.1 60.1 − 2.6 25.2 12.6 3.3 2.0 4.9 1.6 38.2 4.3 16.7 59.1 
(Friesen et al. 2015) 8.1 39.9 9.9 58.9 − 1.6 56.1 22.1 2.0 3.4 2.4 0.8 18.4 2.2 8.5 29.1 
(Friesen et al. 2015) 6.2 40.5 9.8 57.4 − 1.0 60.6 24.9 1.2 5.8 1.8 0.6 13.2 1.8 7.4 22.3 
(Friesen et al. 2015) 5.0 18.7 7.4 31.7 − 0.8 30.5 27.1 1.0 73.0 1.6 0.4 12.4 1.6 6.6 20.5 
(Friesen et al. 2015) 5.3 19.2 4.9 29.8 − 0.8 77.3 34.6 1.0 16.2 1.6 0.4 12.6 1.6 6.7 20.9 
(Friesen et al. 2015) 5.1 18.0 4.7 28.4 − 1.0 74.3 33.4 1.2 14.9 1.8 0.6 13.1 1.6 5.9 20.5 
(Friesen et al. 2015) 5.4 18.6 4.8 29.2 − 1.0 76.0 34.2 1.0 15.4 1.8 0.4 13.2 1.6 6.0 20.8 
(Larsson et al. 2014) − − − − − − − − − − − − − − − − 
(Larsson et al. 2014) − − − − − − − − − − − − − − − − 
(Liland et al. 2013) 17.8 41.6 7.6 70.1 14.6 26.7 31.1 7.1 1.3 3.7 6.8 1.8 21.2 − 26.1 − 
(Liland et al. 2013) 3.9 31.9 8.5 46.4 3.6 5.2 129.6 31.2 0.3 10.6 1.3 0.5 4.9 − 5.9 − 
(Liland et al. 2013) 5.3 20.6 6.6 34.9 6.3 7.4 113.0 41.8 0.5 20.6 1.9 0.5 6.6 − 7.9 − 
(Liland et al. 2013) 4.3 37.7 9.7 54.0 3.6 5.6 54.7 95.5 0.3 11.2 1.5 0.5 5.1 − 6.1 − 
(Rosenlund et al. 2001a) − 30.1 − − 19.3 22.0 95.0 41.9   34.5 − − 11.8 − 10.8 22.6 
(Rosenlund et al. 2001a) − 51.4 − − 3.7 2.7 56.8 34.1   76.4 − − 20.3 − 16.6 36.8 
(Rosenlund et al. 2001a) − 45.3 − − 14.5 15.5 92.6 35.2   10.8 − − 13.5 − 11.8 25.4 
(Rosenlund et al. 2001a) − 54.8 − − 16.6 21.0 62.9 32.1   57.5 − − 11.8 − 10.8 22.6 
(Rosenlund et al. 2001a) − 42.9 − − 41.9 51.0 35.5 12.8   3.7 − − 25.4 − 19.3 44.6 
(Rosenlund et al. 2001a) − 49.7 − − 4.4 3.7 52.1 88.2   10.8 − − 25.4 − 19.9 45.3 
(Rosenlund et al. 2016) 1.8 41.8 6.8 52.2 3.7 2.2 − 46.3 0.0 35.0 0.4 0.0 2.2 0.3 2.1 4.6 
(Rosenlund et al. 2016) 3.3 41.6 6.5 53.6 4.6 3.7 − 43.9 0.3 32.0 1.0 0.3 4.0 0.6 3.7 8.3 
(Rosenlund et al. 2016) 4.3 41.9 6.3 54.4 5.4 4.7 − 41.6 0.3 30.7 1.2 0.3 5.1 0.6 4.6 10.4 
(Rosenlund et al. 2016) 5.1 41.7 6.4 55.4 6.1 5.7 − 40.0 0.3 28.4 1.7 0.3 6.4 0.8 5.7 12.9 
(Rosenlund et al. 2016) 6.4 42.1 6.4 56.9 7.0 6.9 − 38.7 0.5 27.4 2.0 0.5 7.9 1.1 7.0 16.0 
(Rosenlund et al. 2016) 1.8 41.8 6.8 52.2 3.7 2.2 − 46.3 0.0 35.0 0.4 0.0 2.2 0.3 2.1 4.6 
(Rosenlund et al. 2016) 3.3 41.6 6.5 53.6 4.6 3.7 − 43.9 0.3 32.0 1.0 0.3 4.0 0.6 3.7 8.3 
(Rosenlund et al. 2016) 4.3 41.9 6.3 54.4 5.4 4.7 − 41.6 0.3 30.7 1.2 0.3 5.1 0.6 4.6 10.4 
(Rosenlund et al. 2016) 5.1 41.7 6.4 55.4 6.1 5.7 − 40.0 0.3 28.4 1.7 0.3 6.4 0.8 5.7 12.9 
(Rosenlund et al. 2016) 6.4 42.1 6.4 56.9 7.0 6.9 − 38.7 0.5 27.4 2.0 0.5 7.9 1.1 7.0 16.0 
(Sissener et al. 2016a) 4.5 15.0 4.1 25.8 7.7 9.1 80.9 29.7 0.2 18.5 1.8 − 4.9 − 5.7 10.6 
60 
 
(Sissener et al. 2016a) 4.7 35.7 6.0 48.3 6.8 8.5 71.2 24.3 0.2 20.4 1.7 − 4.5 − 5.2 9.7 
(Sissener et al. 2016a) 3.8 41.9 7.8 55.4 3.6 5.3 52.3 52.1 0.2 22.0 1.3 − 4.0 − 5.3 9.3 
(Sissener et al. 2016a) 2.8 23.4 6.5 34.9 3.5 4.7 40.4 77.6 0.2 21.7 1.0 − 3.7 − 4.7 8.5 
(Sissener et al. 2016a) 4.1 19.1 5.3 30.2 6.8 8.2 57.5 52.0 0.2 19.9 1.6 − 4.5 − 4.9 9.5 
(Sissener et al. 2016a) 3.9 34.4 6.5 46.9 4.5 5.4 64.4 48.2 0.2 21.8 1.3 − 4.3 − 5.6 9.9 
(Torstensen et al. 2001) 17.1 33.3 4.7 55.9 29.8 43.9 26.1 4.0 1.2 2.7 − 1.5 18.1 2.5 24.3 44.9 
(Torstensen et al. 2004b) 15.4 26.7 2.3 46.9 41.9 35.2 51.8 17.5 0.7 6.9 5.1 0.7 10.4 0.7 8.5 19.6 
(Torstensen et al. 2004b) 11.5 23.0 2.8 40.0 32.2 26.9 74.5 26.5 0.2 10.8 3.7 0.5 7.8 0.5 6.9 15.2 
(Torstensen et al. 2004b) 8.3 20.5 3.2 34.3 23.9 19.8 97.5 35.4 0.0 15.2 2.1 0.0 4.8 0.5 4.8 10.1 
(Torstensen et al. 2004b) 4.8 17.3 3.7 28.8 15.0 12.0 123.3 44.9 0.0 19.8 0.5 0.0 1.6 0.0 2.3 3.9 
(Torstensen et al. 2004b) 0.9 13.1 3.9 20.9 4.8 3.5 85.8 17.7 0.5 6.0 3.5 0.5 7.4 0.7 6.7 14.7 
(Torstensen et al. 2004b) 7.8 26.9 4.4 41.4 22.1 15.0 25.8 8.1 0.7 2.5 6.4 0.9 13.6 0.9 10.6 25.1 
(Torstensen et al. 2005) 14.9 34.9 5.8 56.8 26.7 39.7 31.8 8.7 1.2 2.9 6.0 1.7 15.6 2.2 24.1 41.9 
(Torstensen et al. 2005) 14.9 34.9 5.8 56.8 26.7 39.7 31.8 8.7 1.2 2.9 6.0 1.7 15.6 2.2 24.1 41.9 
(Torstensen et al. 2005) 5.5 40.5 7.5 54.1 9.6 12.8 88.5 31.9 0.5 22.6 2.0 0.5 6.0 0.8 9.3 16.1 
(Torstensen et al. 2005) 1.4 36.7 6.5 46.6 3.1 1.9 103.2 41.0 0.0 32.2 0.5 0.0 1.4 0.0 2.4 3.8 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 





Proximate composition of fillet tissue of Atlantic salmon fed 85 different diets from 15 studies (mg g-1 of 
fillet tissue). 
  
Study/year Protein Moisture Lipid Ash 
(Bell et al. 2001a) 185 747 54 15 
(Bell et al. 2001a) 189 751 48 17 
(Bell et al. 2001a) 191 752 46 14 
(Bell et al. 2001a) 191 752 45 17 
(Bell et al. 2001a) 195 742 51 14 
(Bell et al. 2002) 203 728 57 15 
(Bell et al. 2002) 199 739 47 16 
(Bell et al. 2002) 202 742 41 15 
(Bell et al. 2002) 205 741 38 17 
(Bell et al. 2003b) − − 86 − 
(Bell et al. 2003b) − − 76 − 
(Bell et al. 2003b) − − 95 − 
(Bell et al. 2003b) − − 75 − 
(Bell et al. 2003b) − − 81 − 
(Bell et al. 2003b) − − 78 − 
(Bell et al. 2003b) − − 70 − 
(Bell et al. 2003b) − − 70 − 
(Bell et al. 2003b) − − 75 − 
(Bell et al. 2003b) − − 69 − 
(Bell et al. 2004) − − 81 − 
(Bell et al. 2004) − − 81 − 
(Bell et al. 2004) − − 81 − 
(Bell et al. 2004) − − 81 − 
(Bell et al. 2004) − − 81 − 
(Bell et al. 2010a) 194 − 116 − 
(Bell et al. 2010a) 199 − 128 − 
(Bell et al. 2010a) 191 − 132 − 
(Bell et al. 2010a) 192 − 129 − 
(Bell et al. 2010a) 193 − 123 − 
(Bell et al. 2010a) 195 − 113 − 
(Friesen et al. 2015) − − 65 − 
(Friesen et al. 2015) − − 70 − 
(Friesen et al. 2015) − − 68 − 
(Friesen et al. 2015) − − 60 − 
(Friesen et al. 2015) − − 66 − 
(Friesen et al. 2015) − − 64 − 
(Friesen et al. 2015) − − 73 − 
(Larsson et al. 2014) 234 − 143 − 
(Larsson et al. 2014) 236 − 143 − 
(Liland et al. 2013) − − 131 − 
(Liland et al. 2013) − − 150 − 
(Liland et al. 2013) − − 142 − 
(Liland et al. 2013) − − 134 − 
(Rosenlund et al. 2001a) 203 680 106 14 
(Rosenlund et al. 2001a) 204 688 97 13 
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(Rosenlund et al. 2001a) 205 682 103 14 
(Rosenlund et al. 2001a) 200 676 113 14 
(Rosenlund et al. 2001a) 204 669 117 13 
(Rosenlund et al. 2001a) 200 662 127 13 
(Rosenlund et al. 2016) − − 165 − 
(Rosenlund et al. 2016) − − 152 − 
(Rosenlund et al. 2016) − − 159 − 
(Rosenlund et al. 2016) − − 142 − 
(Rosenlund et al. 2016) − − 150 − 
(Rosenlund et al. 2016) − − 137 − 
(Rosenlund et al. 2016) − − 143 − 
(Rosenlund et al. 2016) − − 130 − 
(Rosenlund et al. 2016) − − 138 − 
(Rosenlund et al. 2016) − − 133 − 
(Sissener et al. 2016a) 210 669 124 − 
(Sissener et al. 2016a) 213 674 117 − 
(Sissener et al. 2016a) 210 673 121 − 
(Sissener et al. 2016a) 213 672 112 − 
(Sissener et al. 2016a) 210 673 118 − 
(Sissener et al. 2016a) 210 671 115 − 
(Torstensen et al. 2001) − − 130 − 
(Torstensen et al. 2004b) 207 − 66 − 
(Torstensen et al. 2004b) 207 − 71 − 
(Torstensen et al. 2004b) 207 − 81 − 
(Torstensen et al. 2004b) 212 − 70 − 
(Torstensen et al. 2004b) 204 − 64 − 
(Torstensen et al. 2004b) 209 − 66 − 
(Torstensen et al. 2005) − − 126 − 
(Torstensen et al. 2005) − − 87 − 
(Torstensen et al. 2005) − − 116 − 
(Torstensen et al. 2005) − − 98 − 
(Young et al. 2006) − − 95 − 
(Young et al. 2006) − − 113 − 
(Young et al. 2006) − − 151 − 
(Young et al. 2006) − − 92 − 
(Young et al. 2006) − − 102 − 
(Young et al. 2006) − − 131 − 
(Young et al. 2006) − − 93 − 
(Young et al. 2006) − − 105 − 







Fatty acid composition of fillet tissue of Atlantic salmon fed 85 different diets from 15 studies (mg 100g-1 of fillet). 
Study/year 14:0 16:0 18:0 SFA 20:1 22:1 18:1n-9 18:2n-6 20:4n-6 18:3n-3 18:4n-3 20:4n-3 20:5n-3 22:5n-3 22:6n-3 n-3 LC PUFA 
(Bell et al. 2001a) 165.1 732.4 114.3 1037.3 321.8 376.8 724.0 105.8 21.2 59.3 84.7 63.5 245.6 88.9 626.6 961.1 
(Bell et al. 2001a) 149.8 685.3 101.1 962.5 235.9 250.9 876.3 179.8 15.0 78.6 56.2 41.2 157.3 52.4 434.4 644.1 
(Bell et al. 2001a) 124.4 567.0 102.4 815.8 208.5 219.5 951.1 226.8 14.6 106.1 47.6 43.9 168.3 62.2 424.4 654.8 
(Bell et al. 2001a) 92.2 450.6 99.3 663.4 195.1 198.7 1011.1 287.4 14.2 141.9 42.6 39.0 152.6 60.3 397.4 610.2 
(Bell et al. 2001a) 56.3 414.2 108.6 595.1 164.9 104.5 1572.2 494.6 16.1 225.2 28.1 28.1 112.6 44.2 289.5 446.3 
(Bell et al. 2002) 189.4 802.7 130.8 1168.0 216.5 216.5 825.3 153.3 22.5 81.2 90.2 67.6 257.1 85.7 735.1 1077.8 
(Bell et al. 2002) 122.8 744.3 122.8 1019.6 160.0 148.9 822.4 182.3 18.6 55.8 59.5 48.4 182.3 63.3 561.9 807.5 
(Bell et al. 2002) 86.4 694.6 108.8 912.3 128.0 112.0 806.6 192.1 12.8 38.4 38.4 35.2 134.4 48.0 467.3 649.8 
(Bell et al. 2002) 47.6 701.5 110.0 867.9 101.1 53.5 1105.7 315.1 11.9 14.9 11.9 11.9 56.5 17.8 228.9 303.2 
(Bell et al. 2003b) 297.4 956.8 181.0 1493.4 523.7 646.5 982.7 284.5 32.3 90.5 109.9 103.4 362.0 161.6 827.5 1454.6 
(Bell et al. 2003b) 219.8 834.0 213.3 1318.9 375.0 465.5 995.6 459.0 25.9 969.7 77.6 97.0 252.1 116.4 614.2 1079.6 
(Bell et al. 2003b) 148.7 711.1 219.8 1118.4 239.2 271.5 1047.3 601.2 19.4 1706.7 71.1 97.0 174.6 84.0 439.6 795.2 
(Bell et al. 2003b) 77.6 588.3 245.7 943.9 129.3 122.8 1079.6 756.4 6.5 2417.9 64.6 103.4 103.4 38.8 271.5 517.2 
(Bell et al. 2003b) 219.8 808.1 174.6 1254.2 407.3 459.0 1609.8 549.5 25.9 245.7 77.6 84.0 258.6 122.8 646.5 1112.0 
(Bell et al. 2003b) 155.2 698.2 168.1 1066.7 329.7 278.0 2211.0 769.3 19.4 342.6 45.3 58.2 168.1 77.6 459.0 762.9 
(Bell et al. 2003b) 84.0 575.4 168.1 879.2 252.1 129.3 2683.0 943.9 12.9 439.6 38.8 45.3 97.0 38.8 323.2 504.3 
(Bell et al. 2003b) 77.6 575.4 206.9 892.2 161.6 122.8 1648.6 846.9 12.9 1706.7 71.1 84.0 109.9 38.8 297.4 530.1 
(Bell et al. 2003b) 84.0 588.3 187.5 905.1 213.3 142.2 2139.9 879.2 12.9 1066.7 58.2 77.6 116.4 45.3 303.9 543.1 
(Bell et al. 2003b) 148.7 711.1 193.9 1099.0 290.9 297.4 1622.7 691.8 19.4 1008.5 58.2 77.6 161.6 71.1 452.5 762.9 
(Bell et al. 2004) 274.2 752.6 110.9 1161.0 968.5 577.6 933.5 227.5 17.5 46.7 87.5 70.0 250.9 87.5 472.6 811.0 
(Bell et al. 2004) 270.6 811.7 159.6 1255.8 825.6 506.5 1207.2 471.8 13.9 797.9 90.2 97.1 208.1 76.3 423.2 707.7 
(Bell et al. 2004) 185.2 683.3 178.8 1053.7 555.6 344.9 1124.0 549.2 12.8 1283.6 83.0 95.8 159.7 63.9 338.5 562.0 
(Bell et al. 2004) 51.1 613.1 198.0 938.8 306.5 191.6 1124.0 702.5 6.4 1922.2 76.6 102.2 115.0 38.3 274.6 427.9 
(Bell et al. 2004) 44.7 530.0 229.9 811.0 102.2 70.2 1187.8 836.6 6.4 2471.4 76.6 115.0 83.0 25.5 198.0 306.5 
(Bell et al. 2010a) 411.6 1371.8 237.8 2066.9 695.1 777.4 1618.8 448.1 36.6 164.6 155.5 155.5 530.4 265.2 1198.1 1993.7 
(Bell et al. 2010a) 141.3 1322.0 292.7 1806.4 524.8 201.8 3804.6 1412.8 20.2 676.1 70.6 90.8 171.6 90.8 403.7 666.0 
(Bell et al. 2010a) 478.7 1561.1 281.0 2372.8 780.5 874.2 1852.4 509.9 41.6 197.7 187.3 176.9 593.2 291.4 1332.1 2216.7 
(Bell et al. 2010a) 152.6 1393.4 305.1 1912.1 518.7 223.8 3793.6 1352.7 20.3 640.7 81.4 91.5 193.2 91.5 427.2 711.9 
(Bell et al. 2010a) 436.4 1493.4 271.5 2240.1 707.9 785.5 1794.0 484.9 38.8 174.6 145.5 155.2 533.4 271.5 1231.6 2036.5 
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(Bell et al. 2010a) 133.6 1229.4 285.1 1683.8 454.4 178.2 3305.3 1184.9 17.8 552.4 62.4 71.3 169.3 80.2 400.9 650.4 
(Friesen et al. 2015) 317.7 876.3 184.5 1414.4  − 71.7 650.8 287.0 41.0 51.2 87.1 66.6 738.0 235.7 666.2 1639.9 
(Friesen et al. 2015) 193.2 998.9 253.9 1479.1  − 38.6 1528.7 579.5 27.6 82.8 44.2 38.6 358.7 121.4 397.4 877.5 
(Friesen et al. 2015) 155.5 981.1 252.0 1404.6  − 21.4 1635.2 611.2 32.2 117.9 32.2 32.2 225.2 91.1 375.3 691.6 
(Friesen et al. 2015) 108.8 506.2 184.5 818.4  − 18.9 1036.0 624.4 18.9 1088.0 47.3 52.0 198.7 75.7 302.7 577.1 
(Friesen et al. 2015) 119.7 562.0 187.3 884.6  − 20.8 1790.0 759.7 20.8 431.9 41.6 46.8 223.8 83.3 322.6 629.6 
(Friesen et al. 2015) 126.1 539.9 151.4 832.6  − 20.2 1781.2 761.9 25.2 328.0 45.4 30.3 227.1 80.7 302.7 610.5 
(Friesen et al. 2015) 132.4 604.3 178.4 932.4 −  23.0 2077.7 851.8 28.8 385.6 40.3 40.3 264.7 92.1 351.1 707.9 
(Larsson et al. 2014) − − − 1989.9 − − − − − − − − − 213.1 − − 
(Larsson et al. 2014) − − − 2127.5 − − − − − − − − − 192.8 − − 
(Liland et al. 2013) − − − − − − − − − − − − 745.7 − 1252.8 1998.5 
(Liland et al. 2013) − − − − − − − − − − − − 234.2 − 600.8 834.9 
(Liland et al. 2013) − − − − − − − − − − − − 257.5 − 585.5 843.0 
(Liland et al. 2013) − − − − − − − − − − − − 200.7 − 486.0 686.7 
(Rosenlund et al. 2001a) − 996.4 − 1537.0 614.8 455.8 3360.2 1208.4 − 710.2 − − 307.4 − 551.2 858.6 
(Rosenlund et al. 2001a) − 1280.4 − 1930.3 184.3 106.7 1784.8 911.8 − 1736.3 − − 378.3 − 640.2 1018.5 
(Rosenlund et al. 2001a) − 1194.8 − 1874.6 597.4 432.6 3069.4 968.2 − 309.0 − − 298.7 − 597.4 896.1 
(Rosenlund et al. 2001a) − 1627.2 − 2282.6 621.5 531.1 2531.2 1017.0 − 1446.4 − − 316.4 − 553.7 870.1 
(Rosenlund et al. 2001a) − 1439.1 − 2258.1 1415.7 1368.9 1544.4 468.0 − 105.3 − − 631.8 − 900.9 1532.7 
(Rosenlund et al. 2001a) − 1612.9 − 2540.0 215.9 114.3 2095.5 3048.0 − 368.3 − − 647.7 − 990.6 1638.3 
(Rosenlund et al. 2016) 91.1 1626.1 416.3 2224.5 299.2 104.1 − 1678.1 26.0 897.6 234.2 104.1 130.1 52.0 273.2 455.3 
(Rosenlund et al. 2016) 131.8 1545.9 371.5 2157.1 323.6 143.8 − 1474.0 24.0 814.9 155.8 95.9 143.8 59.9 299.6 503.3 
(Rosenlund et al. 2016) 163.0 1642.2 388.6 2306.6 363.5 188.0 − 1541.9 25.1 877.5 163.0 87.8 163.0 62.7 376.1 601.7 
(Rosenlund et al. 2016) 179.1 1444.2 335.9 2060.0 347.1 190.3 − 1332.3 22.4 761.3 134.3 89.6 156.7 67.2 380.6 604.6 
(Rosenlund et al. 2016) 224.7 1561.1 354.8 2247.0 390.3 248.3 − 1360.0 23.7 816.0 130.1 94.6 201.0 82.8 461.2 745.0 
(Rosenlund et al. 2016) 75.6 1306.9 334.8 1793.0 248.4 75.6 − 1425.8 32.4 723.7 216.0 97.2 118.8 54.0 216.0 388.8 
(Rosenlund et al. 2016) 124.0 1386.7 349.5 1927.9 304.4 124.0 − 1465.7 22.5 777.9 169.1 101.5 146.6 67.6 259.3 473.5 
(Rosenlund et al. 2016) 143.5 1281.2 317.7 1814.1 307.5 143.5 − 1301.7 20.5 717.5 133.2 92.2 143.5 61.5 276.7 481.7 
(Rosenlund et al. 2016) 174.1 1349.1 293.8 1893.1 348.2 174.1 − 1360.0 21.8 772.5 119.7 97.9 185.0 76.2 359.0 620.2 
(Rosenlund et al. 2016) 199.2 1310.7 304.1 1897.9 346.0 209.7 − 1258.3 21.0 713.0 115.3 94.4 199.2 83.9 408.9 692.1 
(Sissener et al. 2016a) − − − − − − − − − − − − − − − − 
(Sissener et al. 2016a) − − − − − − − − − − − − − − − − 
(Sissener et al. 2016a) − − − − − − − − − − − − − − − − 
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(Sissener et al. 2016a) − − − − − − − − − − − − − − − − 
(Sissener et al. 2016a) − − − − − − − − − − − − − − − − 
(Sissener et al. 2016a) − − − − − − − − − − − − − − − − 
(Torstensen et al. 2001) 593.2 1404.9 239.4 2268.7 1207.2 1488.2 1280.1 166.5 52.0 104.1  − 156.1 572.4 208.1 1259.2 2039.8 
(Torstensen et al. 2004b) 203.2 609.5 112.9 959.4 643.4 440.2 1207.7 372.5 22.6 112.9 20.8 31.2 202.9 79.1 417.8 699.9 
(Torstensen et al. 2004b) 169.6 588.0 124.4 904.7 565.4 361.9 1730.3 554.1 33.9 180.9 16.8 28.0 169.6 67.7 384.6 621.9 
(Torstensen et al. 2004b) 141.2 619.1 141.2 934.0 477.9 282.4 2389.0 771.1 43.4 260.7 19.2 31.9 141.1 65.1 347.4 553.7 
(Torstensen et al. 2004b) 45.0 460.8 134.9 659.1 202.3 101.2 2540.3 831.8 45.0 281.0 11.0 22.1 90.0 33.7 269.9 393.5 
(Torstensen et al. 2004b) 147.8 622.8 126.7 928.9 485.6 306.1 1815.5 337.8 21.1 42.2 15.1 20.2 147.8 63.6 348.2 559.6 
(Torstensen et al. 2004b) 254.6 661.9 101.8 1048.8 824.8 560.1 743.6 203.7 20.4 30.5 36.4 41.6 244.6 102.0 468.3 814.9 
(Torstensen et al. 2005) 496.7 1351.0 258.3 2145.7 1211.9 1261.6 1659.0 327.8 39.7 99.3 139.1 − 447.0 208.6 1092.7 1748.4 
(Torstensen et al. 2005) 336.1 891.7 178.3 1447.3 781.9 843.7 1001.4 226.4 48.0 75.5 102.9 − 315.5 144.0 871.1 1330.7 
(Torstensen et al. 2005) 201.2 1216.4 274.4 1737.7 539.6 429.8 3155.2 942.0 27.4 594.5 64.0 − 201.2 91.5 539.6 832.2 
(Torstensen et al. 2005) 61.8 996.7 239.5 1313.5 208.6 100.4 3191.0 1112.6 69.5 633.6 92.7 − 123.6 46.4 262.7 432.7 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 
(Young et al. 2006) − − − − − − − − − − − − − − − − 








Studies included in meta-analysis (n = 15)
Eligibility
Full text articles asseesed for eligibiliy (n = 254) Full text articles excluded (n = 239)
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Studies not on Atlantic salmon removed (n = 752) Duplicates removed (n = 177)
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4. Seasonal effects on growth and product quality in Atlantic 
salmon fed diets containing terrestrial oils as assessed by a 




Seasonal changes in water temperature affect the utilisation of dietary fatty acids in Atlantic 
salmon (Salmo salar) (Liu et al. 2018; Rosenlund et al. 2016). Furthermore, fatty acid profiles 
of terrestrial oils dictate their suitability in terms of their digestibility, provision of metabolic 
energy and final product quality (Bureau et al. 2002; Emery et al. 2016; Turchini et al. 2010; 
Turchini et al. 2009)Growth performance, fatty acid composition (in particular omega-3 long-
chain polyunsaturated fatty acids [n-3 LC PUFA level]) and sensorial quality (consumer 
preference) in Atlantic salmon remain important product quality measures (Bureau et al. 2008; 
Henriques et al. 2014; Mock et al. 2019). As such, the significant modification of fillet fatty acid 
composition, including n-3 LC PUFA content, resulting from the incorporation of alternative 
lipid sources in aquafeed formulations and seasonal variability in water temperature remain 
an area of research with significant commercial interest (Bell et al. 2003a; Bendiksen et al. 
2011; Bureau & Meeker 2010; Higgs et al. 2006; Turchini et al. 2010). The current trend of high 
(>50 % of added oil) alternate oil inclusion levels in modern aquafeed re-iterates the 
importance of assessing the viability of terrestrial (animal and plant) oil sources in on-farm 
trials that span a significant proportion of the grow-out cycle and account for key aspects in 
seasonality. Therefore, this Chapter implemented a long-term on-farm feeding approach in 
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Southern Tasmania, Australia over the last year of a grow-out cycle with two-separate 
‘phases’ (summer and winter) to assess the viability of three terrestrial oil sources in relation 
to season via an assessment of growth performance, sensorial quality, nutrient digestibility, 
fatty acid composition and metabolism of Atlantic salmon fed commercial-like diets 
containing 20% of fish oil (FO), and either 80% of poultry by-product oil (PbO), tallow (TAL) or 
canola oil (CAN) as the added dietary lipid source. 
 
4.2. Materials and Methods 
 
4.2.1. Location, animals, experimental design and sampling. 
The trial was conducted over the last year of a grow-out period (323 days, 46 weeks) from 
December 1, 2014 to October 20, 2015 in Hideaway bay, Dover, Tasmania (Huon Tasmania, 
Hideaway bay site; 43°15′ 52.2″S 147°04′37.7″E). Immediately preceding the allocation of the 
fish to trial pens, an initial sample of six fish was randomly selected from the trial cohort, 
euthanized in excess anaesthetic (AQUI-S, 0.5 mL L-1) and stored at −20°C for subsequent 
analysis. The trial was split into two separate, yet consecutive, summer and winter ‘phases’. 
At the commencement of the summer phase, 3600 Atlantic salmon (average initial weight 
~600 g) were randomly distributed between 12 floating sea pens (5 m x 5 m x 5 m, 300 fish 
per pen). Each of the pens was then randomly assigned one of three dietary treatments in 
quadruplicate (four pens per treatment; n = 4, N = 12). After the completion of the first 
summer phase, and upon commencement of the second winter phase, the trial was reduced 
to triplicate replication (three pens per treatments; n = 3, N = 9). This partial modification of 
the experimental design was due to logistical reasons and the number of fish was reduced to 
accommodate biomass increases. Briefly, 810 Atlantic salmon (average weight ~2200 g) were 
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subsequently assigned one of nine floating sea pens (5 m x 5 m x 5 m, 90 fish per pen). Fish 
were maintained on the same diet in both phases, the only difference being a decrease in the 
protein/lipid ratio in line with commercial practice to account for a lower digestible 
protein/digestible energy requirement in larger fish and during the colder part of the year 
(Einen & Roem 1997) (Table 4.6). 
 
Over the duration of the entire trial, encompassing both summer and winter phases, fish were 
fed with one of the three experimental diets using a Sterner feeder fitted with a 40 L hopper 
and spinning feed spreading mechanism that dispersed feed over ~80% of the cage surface. 
Fish were fed twice per day to satiation by an automated AQ1 feed system, with the first 
feeding programmed for 15 minutes before sunrise and the second feeding 15 minutes after 
sunset. A 0.5 m diameter, 0.5 m deep cone was positioned at a depth of 4 m to channel 
uneaten feed past an infrared sensor which detected uneaten pellets and automatically 
turned the feeder off. All feeding sessions were overseen by an observer to ensure the 
operation of all automated systems were correct and consistent. Feed consumption, 
mortalities and physico-chemical parameters including water temperature (summer mean ± 
SD: 15.37 ± 1.42 oC, winter mean ± SD: 11.21 ± 0.86 oC) and dissolved oxygen levels (summer 
mean ± SD: 7.11 ± 0.48 mg L-1, winter mean ± SD: 7.85 ± 0.43 mg L-1) were monitored 
throughout the trial and remained within acceptable limits. During the last week of the 
summer and winter feeding phases, ten fish were randomly selected from each pen and 
anaesthetised for faecal collection by hand stripping, after which samples were frozen at -
20 oC for subsequent digestibility analysis. At the completion of the summer phase, all fish 
were anaesthetised with a lethal dose of anaesthetic and weighed, and 24 fish from each 
treatment (six fish per pen) were randomly sampled, separated and allocated into two 
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groups: the first group (12 fish) were used for the chemical analysis of the whole body, while 
the second group (12 fish) were used for the chemical analysis of the fillet. Both groups of fish 
were subjected to biometry measurements. At the completion of the winter phase, fish were 
again anaesthetised with a lethal dose of anaesthetic and weighed, and 21 fish from each 
treatment (seven fish per pen) were randomly sampled, separated and allocated into three 
groups: the first group (nine fish) were used for the chemical analysis of whole body, the 
second group (six fish) for the chemical analysis of fillet, and the third group (six fish) were 
used for sensory analysis by means of a panel taste test. All sampled fish were immediately 
placed in an ice slurry, with fish allocated for chemical analysis frozen and stored at −20 °C for 
subsequent analysis. Fish allocated to panel taste testing were taken from the slurry to be 
processed by Huon Aquaculture Company, Tasmania (see section 2.5). 
 
4.2.2. Diets 
Diets were manufactured by a commercial feed producer using commercial (closed formula) 
salmonid aquafeed formulations (Ridley Aquafeed, Australia). Two batches of pellets with 
identical basal formulations were made, with each batch divided into three sub-batches post-
extrusion and vacuum coated with three different oils. The three diets within each batch were 
iso-proteic, iso-lipidic and iso-energetic and differed only in the added oil source. 
Four lipid sources; FO, PbO, CAN and TAL, were used to formulate the three diets. All diets 
contained 20% FO as a percentage of the added oil and the remaining added dietary lipid was 
made up of either PbO, CAN or TAL, resulting in three diets; PbOd, CANd and TALd. Thus, the 
only difference in dietary formulation between experimental diets, within each phase, was 
the inclusion of either PbO, CAN or TAL, respectively. 
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4.2.3. Statistical analysis 
All data were reported as mean ± standard error of the mean; summer phase (n = 3, N = 12), 
winter phase (n = 3, N = 9). After confirmation of normality and homogeneity of variance, data 
was subjected to one-way ANOVA. Where significant differences were detected, a Tukey’s 
post-hoc test for homogenous subsets was performed using IBM SPSS Statistics v24.0 (SPSS 
Inc., Chicago, IL, USA). Significance was accepted at P < 0.05. Post-hoc power analysis was 





Proximate analysis revealed that the three diets in the summer phase were iso-proteic, iso-
lipidic and iso-energetic. The winter phase diets were iso-energetic but varied slightly in total 
lipid and protein (Table 4.6). 
Total fatty acid concentration was similar within each phase, although individual fatty acids 
varied according to lipid source. TALd was characterised by high levels of SFA, attributable 
largely to 16:0, while CANd was characterised by high levels of MUFA, particularly 18:1n-9. 
PUFA levels were markedly lower in TALd owing to relatively low levels of 18:2n-6 compared 
to the other diets. Additionally, low n-6 PUFA in TALd contributed to a lower n-6:n-3 ratio in 
both phases. CANd exhibited high levels of 18:3n-3 relative to the other diets, contributing to 
higher total n-3 PUFA, however, levels of n-3 LC PUFA were comparable between diets, within 
phases, owing to similar levels of 20:5n-3 and 22:6n-3. 
 
4.3.2. Growth, feed utilisation parameters and biometric data 
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All diets were readily accepted by fish and mortalities were low in both phases (<6 %) 
regardless of dietary treatment. Fish reached commercial size (~5kg) by the end of the trial 
and gained >240 %, >120 % and > 680 %, of initial body weight (~615g) in the summer phase, 
winter phase and in total, respectively, with an average FCR of ~1.3 for all treatments across 
phases and an average SGR of ~0.75 and ~0.5 in the summer and winter phase, respectively 
(Table 4.7). However, final weights of fish varied between treatments and CANd fish were 
significantly larger than TALd fish in the summer phase (2291g vs 2154g, respectively) (P < 
0.05). Biometric parameters showed fish were in good condition with no significant 
differences between treatments, notwithstanding a higher VSI % recorded for CANd fish 
(10.9%) compared to PbOd fish (9.26%) by the end of the winter phase. 
 
4.3.3. Apparent nutrient and fatty acid digestibility 
High nutrient digestibility values (Apparent Digestibility Coefficient – ADC %) were achieved 
across treatments and phases (Table 4.8); however, there was an observable trend toward 
lower digestibility of nutrients in TALd in both the summer and winter phase, including lower 
lipid digestibility (P < 0.05). Additionally, protein digestibility was lower in TALd in the summer 
phase, although observable differences were not as pronounced. In terms of apparent fatty 
acid digestibility, recorded values for the TALd treatment were slightly lower in both phases, 
including lower (P < 0.05) apparent digestibility for both 14:0 and 18:1n-9. In all treatments, 
n-3 fatty acids were highly digested by fish across both phases and recorded no significant 
differences. 
 
4.3.4. Tissue proximate and fatty acid composition 
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Proximate composition of fillet in both phases recorded no statistically significant differences 
between treatments with the exception of fillet moisture which was higher in TALd compared 
to CANd in the winter phase (Table 4.9). Fatty acid composition in fillets (Table 4.9) was 
characterised by higher (P < 0.05) SFA concentrations in PbOd and TALd in both summer 
(2275.2 and 2611.9 mg 100g-1 fillet, respectively) and winter phases (2658.8 and 2814.6 mg 
100g-1 fillet, respectively) whereas CANd recorded higher (P < 0.05) levels of MUFA in both 
phases (5497.3 and 7102.1 mg 100g-1 fillet in summer and winter phases, respectively). 
Additionally, total n-6 PUFA was lower (P < 0.05) in TALd in both phases. Owing to low n-6 
PUFA the TALd treatment recorded a lower n-6:n-3 ratio (1.0 and 0.9 in the summer and 
winter phase, respectively). PbOd, on the other hand, recorded the highest n-6:n-3 ratio in 
both phases (1.4 and 1.7 in the summer and winter phase, respectively) (P < 0.05).  Total n-3 
LC PUFA, despite being higher in TALd (P < 0.05) after the summer phase (893.9 mg 100g-1 
fillet), was similar between treatments after the winter phase; ranging from 681.6 to 718.3 
mg 100g-1 fillet in PbOd and TALd, respectively. Total n-3 PUFA, was higher (P < 0.05) in CANd 
in both phases, as a result of higher 18:3n-3 concentrations. 
Trends were similar across phases when fatty acid data was expressed as µmol g-1 fillet tissue 
(Table 4.10). Total fatty acid in fillet (µmol g-1 of tissue) varied slightly in the winter phase, 
where TALd (351.6 µmol g-1 of tissue) was lower (P < 0.05) than PbOd and CANd (394.5 and 
425.0 µmol g-1 of tissue, respectively). SFA remained highest in TALd and lowest in CANd 
whilst MUFA was highest in CANd. n-3 LC PUFA was higher in TALd and lower in PbOd in the 
summer phase (P < 0.05), however, in the winter phase, despite a similar observable trend, 
results were non-significant. 
 
4.3.5. Apparent in vivo fatty acid metabolism 
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Apparent in vivo fatty acid β-oxidation (expressed as nmol of fatty acid per gram of fish per 
day; nmol g-1 day-1) (Table 4.11) as calculated by the whole-body fatty acid balance method 
was highest for 18:1n-9 and 18:2n-6, roughly in line with dietary inclusion levels. Numerous 
statistically significant differences were observed, and results were noticeably different 
between seasons. In summer, the TALd treatment recorded a considerably higher (P < 0.05) 
total fatty β-oxidation due to high β-oxidation of SFA. CANd recorded significantly higher β-
oxidation of shorter chain n-3 fatty acids including, 18:3n-3, and whilst β-oxidation of 20:5n-
3 was higher in TALd compared to CANd in the summer phase (P < 0.05), there was virtually 
no apparent β-oxidation of 22:6n-3 recorded for any of the treatments. In the winter phase, 
all treatments recorded high β-oxidation of 18:1n-9 and 18:2n-6, and, unlike the summer 
phase, all treatments recorded β-oxidation of SFA, although to a lesser extent in CANd 
compared to the other dietary treatments. β-oxidation of 20:5n-3 was recorded to a similar 
extent for all treatments in the winter phase, which was lower compared to the β-oxidation 
recorded during the summer phase. However, β-oxidation of 22:6n-3 was higher in the winter 
phase compared to the summer phase, and similarly to 20:5n-3, the β-oxidation of 22:6n-3 
was recorded to a similar extent for all treatments. 
Apparent in vivo enzyme activity (elongation, desaturation or chain shortening) (expressed as 
nmol per gram of fish per day; nmol g-1 day-1) (Table 4.12) recorded significant differences 
between treatments in the summer phase, particularly in relation to the apparent de novo 
production of 12:0, and the subsequent elongation of SFA, which was recorded in the PbOd 
and CANd treatments. In contrast, TALd recorded no de novo production or elongation of SFA 
in the summer phase. Additionally, production of 22:6n-3 was observably higher, although 
not significant, in PbOd and CANd in the summer phase and negligible in TALd. In the winter 
phase, ∆-6 desaturation of 18:3n-3 to 18:4n-3, and elongation of 18:4n-3 to 20:4n-3 were 
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higher in the TALd treatment (P < 0.05), although no subsequent production of 20:5n-3 (∆-5 
desaturation of 20:4n-3) was recorded. In contrast to the summer phase, no de novo 
production of 12:0 and no production of 22:6n-3 was recorded in any of the dietary 
treatments. 
 
4.3.6. Sensory analysis 
There were no differences in liking score between dietary treatments for the three 
preparation methods (hot smoked, cold smoked and raw) (Table 4.13) (P > 0.05). Additionally, 
no difference (P > 0.05) in ‘just right’ scores was recorded between treatments for any of the 
influential attributes (fishiness, saltiness and oiliness), with fishiness and oiliness attributes 
scoring close to zero on ‘just right’ scores. For all diet conditions the raw fish lacked saltiness 
as indicated by -20 on the Just About Right scale. 
 
4.3.7 Bioeconomic assessment of feed related production costs 
The cost of diets ($US kg-1) for summer and winter phases both revealed TALd to be marginally 
cheaper to produce (Figure 4.9a and Figure 4.10a, respectively). In the winter phase, this was 
>5 % cheaper to produce in comparison to CANd, however, in terms of cost of fish production 
($US kg-1 of fish) PbOd was cheapest in both phases (Figure 4.9b and Figure 4.10b). Cost for 
fillet production ($US kg-1 and % difference in cost of edible fillet) revealed PbOd was 
markedly less expensive (7.76 and 5.23 % cheaper than CANd and TALd, respectively) at the 
conclusion of the winter phase (Figure 4.10c) owing to a favourable FCR and relatively low cost 
of dietary ingredients. Furthermore, TALd was 11.53 % cheaper than PbOd in terms of n-3 LC 
PUFA production ($US 100g-1 of edible n-3 LC PUFA) in the summer phase (Figure 4.9d), 
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however, after the winter phase PbOd was marginally less expensive than TALd (Figure 4.10d), 
despite being the most expensive after the summer phase (Figure 4.9d). 
 
4.3.8. Power analysis 
Fish fed CANd were larger (P < 0.05) than fish fed TALd at the end of the summer phase (Figure 
4.8), however, there were no statistical differences at the end of the winter phase despite 
observable differences in recorded weights. Scatter plots of statistical power (%) versus 
minimal detectable difference (MDD) (expressed as % difference in final weight) between 
CANd and TALd treatments for both summer and winter phases showed large differences in 
MDD at a commonly used statistical power of 80 % (Cohen 1992), (7.3 and 15.5 %, for the 




The objectives of this research Chapter were to assess the effects of high terrestrial oil 
inclusion on fatty acid metabolism and product quality parameters, with a specific focus on 
the suitability of different alternative oils in relation to season in Atlantic salmon farmed in 
Tasmania, Australia. It is well known that the metabolism of fatty acids in Atlantic salmon is 
heavily influenced by dietary lipid source and seasonal changes in water temperature (Jobling 
& Bendiksen 2003; Kullgren et al. 2013; Ng et al. 2004; Norambuena et al. 2015a; Tocher 
2003). However, there remains a paucity of published information regarding these effects on 
large Atlantic salmon, particularly pertaining to the sub-optimally high water temperatures of 
summer grow-out periods in the southern hemisphere. Accordingly, the effects of dietary lipid 
source on the provision of metabolic energy and deposition of nutritionally valuable fatty 
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acids are discussed herein. A preliminary bioeconomic assessment of costs related to dietary 
ingredients and a taste quality analysis of the fillet product provides added, industry relevant, 
information. 
 
Growth performance over the duration of the trial was good and in line with current 
commercial standards in Tasmania, Australia, with fish growing from 615 g – 5000 g. 
Differences in nutrient digestibility, particularly lipid, during this period may partially explain 
the reduced growth observed in the TALd treatment in comparison to CANd. Despite mixed 
results in previous research regarding the digestibility of rendered animal fats in relation to 
water temperature (Bureau et al. 2002; Emery et al. 2016; Turchini et al. 2009), results 
concerning Tasmanian salmonid grow-out conditions are confined to cooler months (Emery 
et al. 2016). As outlined above, rising sea temperatures along Tasmania’s east coast are 
eliciting detrimental effects on the Atlantic salmon aquaculture industry as water 
temperature spikes to over 19 oC for prolonged periods of time during the summer months 
(Last et al. 2011; Oliver et al. 2017), exceeding the thermal optimum for this species (Elliott & 
Elliott 2010; Handeland et al. 2008). The present research Chapter, indicates that during a 
summer grow-out phase in Tasmanian waters, diets containing a high level of TAL, may induce 
negative effects on growth owing to reduced digestibility of dietary nutrients. Thus, a 
potential solution may be to formulate to a given total digestible lipid, in the same way diets 
are formulated to equal digestible protein content. As such, feeds containing high levels of 
TAL would be formulated with an increased total lipid content, withstanding physical 
limitations, in order to deliver an equal concentration of digestible nutrients. Despite a 
reduction in lipid digestibility, total β-oxidation of fatty acids in TALd during the summer phase 
was clearly higher in comparison to CANd and PbOd, owing to the high β-oxidation of SFA. 
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CANd and PbOd demonstrated little β-oxidation of SFA and alternatively recorded a de novo 
production of SFA, indicating these diets were providing less SFA than the amount required 
by the fish during summer conditions. These results indicate that an increase in dietary TAL 
inclusion would increase total dietary SFA and in turn reduce the need for de novo production 
of SFA, potentially providing improved metabolic performance over the summer grow out 
period (Bell et al. 2002; Henderson 1996; Kiessling & Kiessling 1993; Torstensen et al. 2000). 
However, given the aforementioned reduction in digestibility at high dietary levels, this 
inclusion should be limited or compensated by a proportional increase in the overall inclusion 
of total dietary lipid. 
 
Similar to the summer phase, TALd was outperformed and recorded a reduced digestibility of 
lipids during the winter phase. However, despite observable trends, final weights were not 
statistically different. Additionally, differences in SFA β-oxidation were not as pronounced as 
in the summer phase and there was no de novo fatty acid production recorded. Therefore, it 
appears that in the more optimal conditions of the winter phase, both PbOd and CANd were 
more closely aligned with TALd in terms of provision of metabolic energy, highlighted 
particularly by a greater utilisation of SFA for metabolic energy. Furthermore, differences in 
SFA β-oxidation between diets containing PbO and TAL were similar to results recorded 
previously during a Tasmanian winter grow-out period (Emery et al. 2016). 
 
With regard to growth and provision of metabolic energy from dietary lipids, TAL appears to 
have an advantage in warmer months, in terms of provision of metabolic energy, albeit being 
outperformed by CAN in terms of growth. PbO appears to provide a middle point with respect 
to the dietary provision of digestible fatty acids and good growth performance. As such, future 
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work focussing on a balance of added alternate oils, tested over different seasons is necessary 
to elucidate optimal dietary oil inclusion ratios. 
 
Consistent with extensive research, fillet fatty acid composition reflected the dietary lipid 
source (Bendiksen et al. 2011; Tocher 2015; Turchini et al. 2009). However, season had a clear 
impact on the utilisation of fatty acids between the treatment diets. During the summer 
phase, TALd recorded significantly higher levels of n-3 LC PUFA in the fillet, when reported as 
mg 100 g-1 of fillet. Little in vivo fatty acid bioconversion was observed in the TALd treatment 
in the summer phase, whereas both PbOd and CANd recorded both de novo production of 
SFA and in vivo bioconversion of n-3 LC PUFA, indicating that the TALd diet better met the 
physiological requirements of the fish during the sub-optimal temperatures of the summer 
grow out period, and likely influenced the more efficient retention of n-3 LC PUFA in the 
edible fillet. Despite a similar observed trend in the winter phase, differences in fillet n-3 LC 
PUFA were much less pronounced, although previous research conducted at both 10 and 
12.7 oC in freshwater and saltwater, respectively have produced significantly higher levels of 
n-3 LC PUFA in Atlantic salmon fillet with an increase in dietary TAL inclusion (2016; Emery et 
al. 2014).  The apparent subtle differences recorded in the present Chapter can partially be 
explained by results from the whole-body fatty acid balance method, where β-oxidation of n-
3 LC PUFA was recorded and there was little in vivo biosynthesis of n-3 LC PUFA across all 
treatments, notwithstanding some de novo production of n-3 LC PUFA in TALd. These results 
suggest that all diets more adequately provided for the fishes’ physiological requirements of 
n-3 LC PUFA in the winter grow out period. Moreover, this was reflected in similar 
concentrations of nutritionally valuable n-3 LC PUFA in the final fillet product. Additionally, 
previous research has suggested the potential ‘sparing’ of n-3 LC PUFA, given an increased 
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provision of dietary fatty acids which can be preferentially β-oxidised for metabolic energy 
(Codabaccus et al. 2012a; Francis & Turchini 2017; Gause & Trushenski 2013). Thus the high 
provision of SFA in the TALd treatment, which was heavily catabolised for metabolic energy 
in the summer phase, may be partially responsible for the increased retention of n-3 LC PUFA 
in the fillet. Ultimately, future research is required to better understand the interaction 
between season and fillet fatty acid deposition. However, the present Chapter indicates that 
TAL contributes to a higher retention of n-3 LC PUFA in the fillet during a summer grow out 
period, and that dietary oils with limited SFA content might result in increased metabolic costs 
during the summer period, as fish would have to invest energy into de novo fatty acid 
production to compensate for dietary shortfalls. 
 
Current research indicates that a typical western person can increase the risk of 
inflammatory related conditions such as cardiovascular disease due to the release of pro-
inflammatory n-6 LC-PUFA derived eicosanoids (Calder 2010; Kris-Etherton et al. 2002; Wall 
et al. 2010). Hence, the ratio of n-6 to n-3 fatty acids is a measure of relative “healthiness” 
when comparing food products, particularly fish, given their famed amounts of beneficial, 
and anti-inflammatory, n-3 fatty acids. The high levels of 18:2n-6 in CAN resulted in 
markedly higher final n-6 PUFA content in fish tissues, compared to other treatments. This 
seemed to be partially counterbalanced by the high levels of 18:3n-3 present in CAN, which 
resulted in a higher level of total n-3 PUFA. At this point, it is important to highlight that 
18:3n-3 fulfils different physiological roles compared to the longer, more highly 
unsaturated fatty acids, 20:5n-3 and 22:6n-3, for which the health benefits have been 
widely recognised (Baum et al. 2012; Calder 2010; Turchini et al. 2011c; Valfré et al. 2003; 
Wall et al. 2010). Certain anadromous fish, including salmonids, have demonstrated 
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endogenous production of 22:6n-3 via the ∆-5, ∆-6 desaturase, elongase enzymatic 
pathway, particularly when provided a rich substrate of 18:3n-3 (Cleveland et al. 2012; 
Norambuena et al. 2015b; Thanuthong et al. 2011; Trushenski & Bowzer 2013). However, 
in most cases, the level of endogenous production of n-3 LC PUFA from 18:3n-3 is not 
considered sufficient to compensate for the reduced n-3 LC PUFA content in the diet (Bell et 
al. 2004; Tocher 2003; Turchini et al. 2009). Importantly, current labelling practices for food 
products often fail to distinguish the relative contribution of individual n-3 fatty acids to the 
total amount of ‘omega-3’, potentially misleading the consumer regarding the overall 
‘health benefit’ of the product (Turchini et al. 2011c). Contrastingly, despite low levels of 
18:3n-3, TALd fish had low levels of n-6 PUFA, resulting in a favourable n-6:n-3 ratio (0.9). 
Additionally, 18:1n-9, present in high amounts in TALd fish, has also been linked to lowering 
low density lipoprotein cholesterol, in turn, lowering blood pressure and providing cardio-
protective effects (Baum et al. 2012). Therefore, the present Chapter indicates that for 
consumers relying on fish to ‘re-balance’ their ratio of n-6 to n-3 fatty acid consumption, 
fish fed a high concentration of TAL provide superior nutritional value. This is an important 
finding of the present Chapter and is in agreement with previous research as currently the 
use of TAL in diets for Atlantic salmon has been limited primarily due to the perceived risks 
of decreased digestibility and subsequent reductions in growth (Emery et al. 2016; Gause 
& Trushenski 2013). However, from a final eating quality point of view and in consideration 
of the very competitive price of TAL from a bio-economical point of view, TAL appears to 
have advantages over other oils. 
 
Despite treatment related differences regarding nutritional properties no significant 
difference between treatments in either preference (like/dislike) or influential attributes 
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were found in this study for any of the different salmon preparation types (raw, cold-smoked 
or hot-smoked) in either the summer or winter phase. This is in agreement with previous 
research finding no significant impact on taste and sensorial qualities of salmonid fillets when 
dietary FO is replaced by terrestrial oils in aquafeed (Emery et al. 2016; Hixson et al. 2017; 
Turchini et al. 2013c). Although fish consumption is relatively low in Australia, (8.7 and 10.2 
kg year-1 for males and females, respectively) (Meyer 2016), taste and sensorial quality is a 
major driver (Christenson et al. 2017). The similarity in these criteria indicate taste acceptance 
was not related to dietary lipid source, furthermore, that a range of products may be 
indistinguishable amongst Australian consumers, thus providing valuable information to 
Atlantic salmon producers when assessing the primary dietary lipid source for aquafeed 
formulation. 
 
Proper assessment of the viability of various terrestrial oil sources for use in aquaculture 
requires some analysis of economic factors (Hardy 2010), including the cost associated with 
i) dietary materials and ii) feed efficiency. Seldom has such an analysis been included in 
published data for market sized salmonids (Turchini et al. 2013c). The current Chapter 
revealed the higher cost of CAN had a clear impact by producing the least cost effective fish 
fillet (in terms of $ kg-1 edible fillet) and was almost 8 % more expensive than PbOd in the 
winter phase. The most cost-efficient fillet product (in terms of $ kg-1 of edible fillet) after the 
summer phase was produced by the TALd treatment, however, by the end of the winter 
phase, PbOd outperformed the other treatments owing to a combination of the relatively low 
cost of PbO, good growth efficiency, and high fillet yield. With respect to nutritional quality, 
TALd was the most cost-efficient, particularly in the summer phase (>11 % cheaper than PbO) 
owing to the low cost of TAL and an efficient deposition of n-3 LC PUFA in edible fillet. This 
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information better equips producers to adopt a holistic approach when choosing aquafeed 
and suggests that a blend of added oils may be preferable, particularly in the summer grow 
out period, dependent on the relative ‘value’ placed on production volume vs nutritional 
content of the fillet, or inevitably, a combination of both. Clearly, there are many other 
economic and logistic constraints associated with various terrestrial oils, including materials 
handling costs (Rana et al. 2009), and as such, the bioeconomic assessment presented in this 
Chapter should be interpreted as indicative only. 
 
With respect to the design of fish growth studies, it is often a balance between the physical 
and economic constraints of increasing replication on one hand and the statistical 
ramifications of reducing replication on the other (Thorarensen et al. 2015). As previously 
outlined, statistical differences in final weight were found between CANd and TALd after the 
summer phase, however, were not recorded after the winter phase despite a difference of 
~300g. In light of the apparent disparity between statistically significant results and 
economically significant results in aquaculture studies, enhanced implementation of power 
analysis has been recommend, yet is seldom presented (Searcy-Bernal 1994). Power analysis 
revealed that the summer phase (n = 4) had a vastly reduced chance of incorrectly accepting 
a false null hypothesis (Type II error) of no difference between fish weight compared to the 
winter phase (n = 3). Despite criticisms in ecological studies (Anderson et al. 2000; Carver 
1978), aquaculture remains heavily reliant upon null-hypothesis testing leading to a tendency 
of discarding non-statistically significant results (Searcy-Bernal 1994; Thorarensen et al. 
2015). The widely accepted α-priori significance value (P value) of 0.05, can in simple terms 
be defined as a 5 % chance that the null-hypothesis of no difference between treatments 
means is true. Given the decrease in statistical power due to reduction in replication from 
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quadruplicate to triplicate, as evidenced in the present Chapter, a statistically significant 
result (i.e. P < 0.05) may be difficult to detect. However, given aforementioned logistic and 
economic constraints, the vast majority of fish growth trials are conducted with triplicate 
replication (Thorarensen et al. 2015). Therefore, it is suggested that increasing the α-priori 
significance value to 0.10 (i.e. accepting significance at P < 0.10), may be useful in selected 
circumstances.  Clearly, this would require a cautious approach as the incidence of incorrectly 
rejecting a true null-hypothesis (Type I error) would increase. However, if used in conjunction 
with a power analysis it may result in further investigation of important results which would 
have previously been discarded. This presents two main considerations when designing on-
farm growth trials where statistical significance is relied upon for product comparison: i) non-
statistically significant results (P > 0.05) require further investigation where low replication 
and a resultant decrease in statistical power prevent the detection of statistical difference 
between means and ii) when possible, replication in fish trials should be increased in order to 
narrow the gap between statistical and ‘real-world’ significance. 
 
With respect to the paucity of long-term growth trials in seawater, as demonstrated in 
Chapter 3, the present research presented the results of one of few long-term farm based 
growth trials. In doing so, the effects of different dietary lipid sources on growth, fillet 
nutritional quality, fatty acid metabolism and taste characteristics of Atlantic salmon with an 
emphasis on seasonal differences in lipid utilisation were revealed. Specifically the high 
dietary lipid addition of TAL (80%) increased the deposition of fillet n-3 LC PUFA in the summer 
phase and lowered the fillet n-6:n-3 ratio in both phases, largely due to very low 
concentrations of n-6 fatty acids. The addition of SFA rich TAL also appeared to provide an 
enhanced substrate for metabolic energy in the sub-optimal summer phase conditions as 
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evidenced by elevated SFA and total β-oxidation in TALd fed fish. In contrast to these observed 
benefits, and consistent with previous research, TALd exhibited a reduction in lipid 
digestibility, which resulted in reduced overall fish growth. CANd, on the other hand produced 
better overall results with respect to growth, and fish were significantly larger in the summer 
phase. In the winter phase a lack of de novo fatty acid production of SFA and β-oxidation of 
n-3 LC PUFA was observed, suggesting that all dietary treatments more adequately provided 
for the fishes’ physiological fatty acid requirements under these environmental conditions. It 
was demonstrated that the PbOd treatment was a middle point between CANd and TALd in 
terms of nutritional quality and growth. The PbOd treatment was, however, the most cost-
effective dietary oil by the time fish were market size (~5kg) owing to its relatively low cost, 
good growth efficiency and high fillet yield. Considering heatwave events are likely to become 
more prevalent and water temperatures are predicted to increase, further research is 
required to better elucidate cost-effective, seasonally tailored aquafeed formulations. This 
chapter demonstrates that this may require multiple dietary lipid sources in order to mitigate 
potential negative effects of reduced digestibility and sub-optimal growth whilst 
simultaneously fulfilling the resulting modified metabolic requirements of fish and 
maximising final product quality, including the final n-3 LC PUFA content of farmed fish. 
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4.5 Figures and Tables 
 
Figure 4.8. Final weights of Atlantic salmon fed the three experimental diets for 173 and 150 
days in the summer and winter phase, respectively. Statistical denotations ‘n’ and ‘N’ appear 
in parenthesis for each phase followed by start and finish dates for respective phases. Scatter 
plots above summer and winter phases show increasing statistical power (%) (Y-axis) vs 
percentage difference in final weights (X-axis) between CANd and TALd in the summer and 
winter phase, respectively. 
 
Figure 4.9. Estimated production costs at the end of the summer phase: (a) Costs for feed 
formulation: costs associated only with raw materials used in formulation ($ per kg of diet); 
(b) Costs for fish production: costs associated with feed (costs for feed formulation) needed 
for the production of 1 kg of fish ($US per kg of fish); (c) Costs for fillet production: costs 
associated with feed (costs for feed formulation) needed for the production of 1 kg of edible 
fillet ($US per kg of edible fillet); and (d) Costs for n-3 LC-PUFA production: costs associated 
with feed (costs for feed formulation) needed for the production of 100 g of edible n-3 LC 
PUFA ($US per 100 g of edible n-3 LC PUFA). Values above each bar show percentage 
differences in aforementioned costs between the dietary treatments, with PbOd equated to 
100 %. 
 
Figure 4.10. Estimated production costs at the end of the winter phase: (a) Costs for feed 
formulation: costs associated only with raw materials used in formulation ($ per kg of diet); 
(b) Costs for fish production: costs associated with feed (costs for feed formulation) needed 
for the production of 1 kg of fish ($US per kg of fish); (c) Costs for fillet production: costs 
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associated with feed (costs for feed formulation) needed for the production of 1 kg of edible 
fillet ($US per kg of edible fillet); and (d) Costs for n-3 LC-PUFA production: costs associated 
with feed (costs for feed formulation) needed for the production of 100 g of edible n-3 LC 
PUFA ($US per 100 g of edible n-3 LC PUFA). Values above each bar show percentage 





                 
Proximate composition and total fatty acids and fatty acid (mg g-1 diet) composition of experimental diets 
used in the Atlantic salmon growth trial for 173 and 150 days in summer and winter phases, respectively. 
   
 
 Summer phase dietsa   Winter phase diets 
  PD PbOd(s) CANd(s) TALd(s)   PbOd(w) CANd(w) TALd(w) 
Proximate composition (mg g-1) (dry weight)             
Moisture  36.1 46.4 48.3 51.7   28.9 49.4 44.3 
Protein 469.8 475.1 480.3 480.1   403.9 412.0 402.6 
Lipid 256.4 250.5 246.2 258.5   330.5 365.6 358.2 
NFE 157.4 140.6 144.3 128.7   164.6 102.0 125.0 
Ash 86.2 85.5 83.2 83.8   72.2 71.0 69.9 
Energy (kJ g-1) 23.3 23.1 23.0 23.1   25.4 25.9 25.8 
Total fatty acids and fatty acid (mg g-1 diet) composition 
Total FA (mg g-1 diet)b 209.1 209.2 204.3 208.0   253.1 261.2 250.9 
SFAc 62.4 58.2 31.9 82.3   78.7 44.3 104.1 
14:0 5.4 5.0 3.9 7.9   4.1 2.8 7.9 
16:0 40.3 38.6 18.5 46.0   54.1 26.2 60.8 
18:0 11.8 10.7 6.4 22.9   18.7 12.8 31.2 
Other SFAd 4.9 3.9 3.1 5.5   1.8 2.5 4.2 
MUFAe 99.6 97.1 113.5 89.2   123.8 153.9 115.4 
16:1n-7 11.4 10.0 4.5 9.6   12.2 4.2 10.6 
18:1n-9 76.3 74.7 96.3 66.9   95.9 132.2 86.0 
18:1n-7 5.3 5.4 5.9 4.6   6.2 7.5 5.2 
20:1n-9 1.7 1.8 2.4 1.5   4.2 5.3 4.6 
Other MUFAf 4.9 5.2 4.4 6.6   5.3 4.7 9.0 
Total trans FAg 0.8 1.0 0.4 1.9   1.2 0.6 5.2 
PUFAh 47.1 53.8 58.9 36.4   49.2 62.2 25.9 
18:2n-6 22.9 29.0 27.8 14.0   29.9 34.8 9.4 
20:2n-6 0.5 0.7 0.8 0.6   0.4 0.5 0.5 
20:4n-6 1.0 1.2 0.9 1.1   0.9 0.6 0.7 
Other n-6 PUFAi 1.5 1.9 1.5 2.0   1.8 1.4 1.6 
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n-6 PUFAj 25.9 32.8 31.0 17.7   33.0 37.3 12.2 
18:3n-3 2.8 4.8 11.2 2.3   4.8 15.1 2.0 
20:5n-3 4.8 7.5 7.0 7.4   3.9 3.7 3.9 
22:5n-3 7.6 1.2 1.1 1.2   0.9 0.8 1.0 
22:6n-3 1.2 5.0 4.7 5.2   5.4 5.1 5.8 
n-3 PUFAk 4.9 19.4 26.4 16.8   15.9 24.6 13.3 
Other n-3 PUFAl 1.1 0.9 2.4 0.7   1.0 0.0 0.6 
LC PUFAm 19.5 18.5 18.8 18.4   13.8 12.0 14.0 
n-6 LC PUFAn 14.8 3.5 3.0 3.4   2.9 2.5 2.7 
n-3 LC PUFAo 18.1 14.4 15.1 14.5   10.9 9.5 11.3 
n-6:n-3 ratiop 5.3 1.7 1.2 1.1   2.1 1.5 0.9 
a Diets: PD = 6mm commercial diet fed previous to experimental diets, added oil 20% fish oil and 80% poultry 
by-product oil; PbOd = poultry by-product oil diet, added oil 20% fish oil, 80% poultry by-product oil; CANd = 
canola oil diet, added oil 20% fish oil, 80% canola oil; TALd = tallow diet, added 20% fish oil, 80% tallow.  (s) = 
summer phase diet, (w) = winter phase diet. 
b Total FA = total fatty acids mg g-1 of diet. 
c SFA = saturated fatty acids. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 22:0 and 24:0. 
e MUFA = monounsaturated fatty acids. 
f Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-13, 20:1n-11, 22:1n-11, 22:1n-9 and 24:1n-9. 
g Total trans FA = sum of 18:1n-9t, 18:1n-7t and 18:2n-6t. 
h PUFA = polyunsaturated fatty acids. 
i Other n-6 PUFA = sum of 18:3n-6, 20:2n-6, 20:3n-6, 22:2n-6, 22:4n-6 and 22:5n-6. 
j n-6 PUFA = omega-6 polyunsaturated fatty acids. 
k n-3 PUFA = omega-3 polyunsaturated fatty acids. 
l Other n-3 PUFA = sum of 20:3n-3, 20:4n-3, 24:5n-3 and 24:6n-3. 
m LC-PUFA = long chain (>20C) polyunsaturated fatty acids. 
n n-6 LC PUFA = omega-6 long chain polyunsaturated fatty acids. 
o n-3 LC PUFA = omega-3 long chain polyunsaturated fatty acids. 






               
Growth, feed efficiency and biometry of Atlantic salmon fed the experimental diets for 173 days in summer phase and 150 days in winter 
phase. 
  
Summer Phase dietsa  
    
Winter Phase diets 
  
  PbOd(s) CANd(s) TALd(s)   PbOd(w) CANd(w) TALd(w) 
Initial weight (g) 615 ± 12 615 ± 12 618 ± 12   2219 ± 7 2279 ± 38 2164 ± 37 
Final weight (g) 2217 ± 9ab 2292 ± 36a 2154 ± 31b   5053 ± 33 5138 ± 199 4835 ± 67 
Gain (g) 1602 ± 19ab 1676 ± 36a 1537 ± 31b   2834 ± 28 2858 ± 164 2670 ± 33 
Gain (%) 261 ± 7.71 273 ± 8.42 249 ± 7.56   128 ± 1.12 125 ± 5.37 123 ± 1.16 
Feed (% body weight day-1) 0.86 ± 0.03 0.85 ± 0.02 0.85 ± 0.02  0.65 ± 0.02 0.65 ± 0.07 0.67 ± 0.02 
FCRb 1.31 ± 0.04 1.28 ± 0.02 1.34 ± 0.03   1.26 ± 0.04 1.27 ± 0.16 1.34 ± 0.03 
SGRc 0.74 ± 0.01ab 0.77 ± 0.01a 0.72 ± 0.01b   0.53 ± 0.00 0.53 ± 0.02 0.53 ± 0.00 
Kd 1.62 ± 0.04 1.68 ± 0.04 1.69 ± 0.04   1.82 ± 0.10 1.77 ± 0.09 1.77 ± 0.11 
DP (%)e 89.36 ± 0.26 89.39 ± 0.39 89.32 ± 0.24   90.41 ± 0.52 91.72 ± 2.72 89.71 ± 0.35 
FY (%)f 67.62 ± 0.45 67.95 ± 0.67 68.94 ± 1.09   60.47 ± 0.73 58.80 ± 0.35 60.05 ± 0.67 
HSI (%)g 1.19 ± 0.03 1.24 ± 0.04 1.21 ± 0.09   1.02 ± 0.01 1.98 ± 0.92 1.05 ± 0.08 
VSI (%)h 10.07 ± 0.27 10.05 ± 0.32 10.06 ± 0.25   9.26 ± 0.45a 10.90 ± 0.27b 10.00 ± 0.38ab 
Data are expressed as mean ± S.E.M., summer phase; n = 4, N = 12, winter phase; n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's post-hoc 
test of multiple comparisons, different letters denote statistically significant difference. NB: each phase was analysed independently.  
a See Table 4.6 for experimental diet abbreviations. 
b FCR = food conversion ratio. 
c SGR = specific growth rate.    
d K = condition factor 
e DP (%) = dress-out percentage. 
f FY (%) = fillet yield percentage. 
g HSI (%) = hepatosomatic index. 





Nutrient and fatty acids digestibility (apparent digestibility coefficient - ADC %) of the three experimental diets 
used in both phases in Atlantic salmon. 
  Summer phase dietsa     Winter phase diets   
  PbOd(s) CANd(s) TALd(s)   PbOd(w) CANd(w) TALd(w) 
Nutrientsb               
DMb 64.8 ± 0.8ab 66.4 ± 0.6a 61.6 ± 1.1b   66.3 ± 3.9 69.0 ± 1.2 61.4 ± 4.0 
Protein 80.2 ± 0.6 80.0 ± 0.5 79.2 ± 1.5   75.5 ± 3.1 76.9 ± 0.2 74.1 ± 3.7 
Lipid 92.4 ± 0.8a 94.5 ± 0.9a 82.5 ± 1.5b   88.8 ± 3.3ab 94.2 ± 0.5a 78.5 ± 4.0b 
NFEb 68.7 ± 1.0 68.9 ± 1.3 69.1 ± 1.4   78.3 ± 2.3 70.8 ± 2.3 75.8 ± 1.8 
Energyc 77.4 ± 0.7a 78.8 ± 0.4a 72.6 ± 1.3b   76.8 ± 3.8 81.0 ± 0.9 71.4 ± 4.1 
                
Fatty acidsd               
Total FA (mg g-1 diet) 91.6 ± 1.3 93.3 ± 1.2 89.5 ± 1.3   89.4 ± 3.4ab 95.3 ± 0.4a 76.9 ± 4.5b 
12:0 90.9 ± 0.7 88.8 ± 2.1 91.4 ± 0.4   91.8 ± 2.5 94.7 ± 1.3 84.2 ± 3.4 
14:0 88.8 ± 1.0a 93.0 ± 0.8a 75.1 ± 1.5b   87.6 ± 3.3a 92.5 ± 0.7a 73.3 ± 4.0b 
16:0 88.2 ± 4.3 89.2 ± 1.3 91.7 ± 4.9   79.8 ± 4.1 81.0 ± 2.1 68.4 ± 4.1 
18:0 70.3 ± 1.7a 81.9 ± 1.8b 100e   65.8 ± 6.5 60.8 ± 4.6 56.9 ± 4.3 
16:1n-7 96.9 ± 0.8 96.1 ± 0.8 94.2 ± 1.3   96.4 ± 2.4 99.1 ± 0.0 88.7 ± 4.2 
18:1n-9 96.0 ± 1.3a 95.8 ± 1.2a 90.1 ± 1.6b   94.7 ± 3.2ab 99.2 ± 0.1a 84.0 ± 5.1b 
18:1n-7 94.7 ± 1.3ab 95.8 ± 1.6a 88.5 ± 1.9b   93.9 ± 3.1ab 98.9 ± 0.1a 82.9 ± 5.2b 
20:1n-9 100 100 99.4 ± 0.6   92.9 ± 3.6 98.2 ± 0.2 82.4 ± 5.6 
18:2n-6 97.5 ± 0.8 96.8 ± 0.8 94.3 ± 0.9   96.1 ± 2.6 99.4 ± 0.1 85.5 ± 5.3 
20:2n-6 94.5 ± 2.1 97.1 ± 0.6 92.5 ± 2.1   93.0 ± 2.6 96.9 ± 0.1 85.9 ± 3.9 
20:4n-6 97.1 ± 0.7 96.3 ± 0.6 94.3 ± 2.0   95.7 ± 2.1 98.3 ± 0.2 86.6 ± 5.4 
18:3n-3 98.0 ± 0.7 97.6 ± 0.7 95.4 ± 0.7   96.7 ± 2.3 99.7 ± 0.1 88.1 ± 4.6 
20:5n-3 98.8 ± 0.3 98.2 ± 0.4 97.7 ± 0.6   97.6 ± 1.6 99.4 ± 0.0 90.5 ± 4.4 
22:5n-3 95.7 ± 0.7 95.7 ± 0.4 94.0 ± 1.2   96.1 ± 2.6 99.1 ± 0.1 86.5 ± 5.6 
22:6n-3 97.0 ± 0.7 96.8 ± 0.5 94.3 ± 2.1   96.3 ± 2.1 98.7 ± 0.1 87.8 ± 5.1 
Data are expressed as mean ± S.E.M., summer phase; n = 4, N = 12, winter phase; n = 3, N = 9. P < 0.05; one-way 
ANOVA with Tukey's post-hoc test of multiple comparisons, different letters denote statistically significant 
difference. NB: each phase was analysed independently.  
a See Table 4.6 for experimental diet abbreviations. 
b Nutrients: DM, dry matter; NFE, nitrogen-free extract. 
c Calculated on the basis of 23.6, 39.5 and 17.2 kJ g-1 of protein, fat and carbohydrate, respectively. 
d Total FA = total fatty acids   




               
Proximate (g 100g-1) and fatty acid composition (as mg 100g-1 edible fillet and % of total fatty acids in brackets and italics) of Atlantic salmon fed the three experimental diets in 
summer and winter phases, (173 and 150 days, respectively). 
  Summer phase dietsa      Winter phase diets     
  PbOd(s) CANd(s) TALd(s)   PbOd(w) CANd(w) TALd(w) 
Proximate composition (g 100g-1 fillet)             
Moisture 64.33 ± 0.62 63.71 ± 0.42 64.74 ± 0.27   64.45 ± 0.62ab 63.65 ± 0.32a 66.12 ± 0.59b 
Protein  22.77 ± 0.14 22.25 ± 0.26 22.44 ± 0.3   21.97 ± 0.52 21.86 ± 0.06 21.28 ± 0.52 
Lipid  10.71 ± 0.44 11.61 ± 0.41 11.17 ± 0.13   13.22 ± 0.59 14.02 ± 0.07 12.29 ± 0.42 
Ash 1.29 ± 0.06 1.29 ± 0.06 1.28 ± 0.03   0.99 ± 0.02 0.97 ± 0.01 0.95 ± 0.04 
Fatty acids (mg 100g-1 fillet and % of total FA in brackets)           
20:5n-3 208.1 ± 6.8a (2.2) 222.5 ± 6.8ab (2.2) 236.4 ± 3.1b (2.5)   136.1 ± 3.7 (1.2) 147.8 ± 4.6 (1.2) 147.9 ± 3.8 (1.5) 
22:5n-3 97.9 ± 4.9 (1.0) 99.3 ± 1.3 (1.0) 109.1 ± 0.7 (1.1)   66.9 ± 3.0 (0.6) 62.3 ± 1.9 (0.5) 72.9 ± 2.6 (0.7) 
22:6n-3 421.2 ± 6.5a (4.5) 444.6 ± 11.1ab (4.3) 474.6 ± 5.1b (5.0)   395.1 ± 22.5 (3.6) 386.4 ± 22.8 (3.3) 414.8 ± 7.7 (4.3) 
SFAb 2275.2 ± 99.2a (24.1) 1936.8 ± 50.6b (18.7) 2611.9 ± 54.5c (27.2)   2658.8 ± 151.2a (24.1) 1889.9 ± 80.1b (15.6) 2814.6 ± 79.5a (28.7) 
MUFA 4498 ± 158.8a (48.3) 5497.3 ± 162.4b (53.8) 4631.2 ± 53.6a (48.8)   5762.5 ± 256.1a (52.4) 7102.1 ± 258.4b (59.3) 5227.8 ± 83.0a (53.4) 
PUFA 2532.4 ± 73.1a (27.0) 2796.1 ± 72.9b (27.2) 2223.6 ± 17.5c (23.3)   2521.6 ± 100.8a (22.5) 2945 ± 114.3b (24.3) 1644.7 ± 16.1c (16.4) 
LC-PUFA 1049 ± 23.4a (11.2) 1061 ± 18.7ab (10.3) 1119.3 ± 5.0b (11.7)   925.8 ± 43.2 (8.0) 908.1 ± 40.7 (7.3) 879.7 ± 12.8 (8.6) 
trans 33.4 ± 1.0a (0.4) 31.1 ± 3.0a (0.3) 53.6 ± 3.6b (0.6)   47.2 ± 2.1a (0.4) 28.4 ± 1.0b (0.2) 71.8 ± 2.1c (0.7) 
n-6 PUFA 1456.5 ± 50.9a (15.5) 1495.8 ± 40.6a (14.5) 1089.8 ± 14.3b (11.4)   1561.8 ± 77.4a (14.2) 1693.7 ± 65.1a (14.1) 743.0 ± 8.7b (7.7) 
n-6 LC PUFA 252.4 ± 7.9a (2.7) 223.4 ± 3.6b (2.2) 225.5 ± 4.9b (2.4)   244.2 ± 9.7a (2.0) 210.3 ± 9.8a (1.6) 161.4 ± 2.6b (1.4) 
n-3 PUFA 1022.4 ± 20a (10.9) 1242.6 ± 29.8b (12.1) 1068.9 ± 7a (11.2)   907.1 ± 24.1a (8.0) 1204.8 ± 47.8b (9.9) 850.4 ± 9.6a (8.3) 
n-3 LC PUFA 796.6 ± 16.4a (8.5) 837.6 ± 16.5a (8.1) 893.9 ± 6.5b (9.4)   681.6 ± 34.2 (6.0) 697.8 ± 31.0 (5.7) 718.3 ± 10.8 (7.2) 
n-6:n-3 ratio 1.4 ± 0.0a 1.2 ± 0.0b 1.0 ± 0.0c   1.7 ± 0.1a 1.4 ± 0.0b 0.9 ± 0.0c 
Data are expressed as mean ± S.E.M., summer phase; n = 4, N = 12, winter phase; n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's post-hoc test of multiple comparisons, 
different letters denote statistically significant difference. NB: each phase was analysed independently.  
a See Table 4.6 for experimental diet abbreviations. 




Fatty acid composition (µmol g-1 tissue) of fillets of Atlantic salmon fed the three experimental diets in summer and 
winter phases, (173 and 150 days, respectively). 
  Summer phase dietsa   Winter phase diets 
  PbOd(s) CANd(s) TALd(s)   PbOd(w) CANd(w) TALd(w) 
Fatty acids (µmol g-1 of tissue)             
Total FAb 335.2 ± 12.0 366.0 ± 10.1 342.7 ± 4.3   394.5 ± 18.4ab 425 ± 16.1a 351.6 ± 6.6b 
SFAc 87.2 ± 3.8a 74.0 ± 1.9b 100.2 ± 2.1c   102.2 ± 5.8a 72.2 ± 3.1b 108.3 ± 3.0a 
14:0 8.7 ± 0.4a 8.5 ± 0.3b 11.4 ± 0.2c   8.2 ± 0.4a 6.8 ± 0.2b 11.3 ± 0.2c 
16:0 57.6 ± 2.7a 45.9 ± 1.3b 62.2 ± 1.3a   71.5 ± 4.4a 46.4 ± 2.1b 69.6 ± 1.9a 
18:0 15.6 ± 0.7a 13.7 ± 0.3a 20.3 ± 0.6b   19.0 ± 0.9a 14.5 ± 0.6b 22.7 ± 0.8c 
Other SFAd 5.4 ± 0.1a 5.9 ± 0.1b 6.2 ± 0.1b   3.5 ± 0.1a 4.5 ± 0.1b 4.6 ± 0.2b 
MUFA 160.8 ± 5.7a 195.5 ± 5.8b 165.9 ± 1.9a   204.3 ± 9.2a 250.3 ± 9.1b 185.6 ± 3.0a 
16:1n-7 14.9 ± 0.7a 10.6 ± 0.2b 16.3 ± 0.2a   19.1 ± 0.9a 9.0 ± 0.4b 17.6 ± 0.4a 
18:1n-9 124.4 ± 4.3a 160.4 ± 4.9b 127.1 ± 1.6a   158.6 ± 7.6a 210.8 ± 7.7b 141.9 ± 2.1a 
18:1n-7 9.9 ± 0.3a 11.3 ± 0.3b 10 ± 0.2a   11.7 ± 0.7ab 13.1 ± 0.5a 10.5 ± 0.2b 
20:1n-9 5.5 ± 0.2a 6.6 ± 0.2b 5.7 ± 0.1a   8.9 ± 0.0a 10.6 ± 0.4b 8.8 ± 0.1a 
Other MUFAe 6.0 ± 0.1a 6.6 ± 0.2ab 6.8 ± 0.1b   6.0 ± 0.2 6.9 ± 0.2 6.8 ± 0.2 
Total trans FA 1.2 ± 0.0a 1.1 ± 0.1a 1.9 ± 0.1b   1.7 ± 0.1a 1.0 ± 0.0b 2.5 ± 0.1c 
PUFA 86.0 ± 2.5a 95.4 ± 2.5a 74.7 ± 0.6b   86.1 ± 3.4a 101.4 ± 3.9b 54.9 ± 0.5c 
18:2n-6 42.2 ± 1.5a 44.6 ± 1.3a 30.3 ± 0.4b   46.7 ± 2.5a 52.5 ± 2.0a 21.1 ± 0.2b 
20:2n-6 3.1 ± 0.1a 2.8 ± 0.1ab 2.4 ± 0.0b   3.3 ± 0.2a 3.2 ± 0.1a 1.9 ± 0.0b 
20:4n-6 1.8 ± 0.0a 1.6 ± 0.0b 1.9 ± 0.0a   1.6 ± 0.1a 1.1 ± 0.1b 1.4 ± 0.1ab 
Other n-6 PUFAf 3.9 ± 0.1 3.5 ± 0.1 3.5 ± 0.2   4.1 ± 0.2a 3.4 ± 0.2b 2.3 ± 0.1c 
n-6 PUFA 51.0 ± 1.8a 52.5 ± 1.4a 38.1 ± 0.5b   55.6 ± 2.8a 60.3 ± 2.3a 26.7 ± 0.3b 
n-6 LC PUFA 8.1 ± 0.3a 7.2 ± 0.1b 7.2 ± 0.2b   7.8 ± 0.3a 6.8 ± 0.3a 5.2 ± 0.1b 
18:3n-3 8.0 ± 0.2a 14.4 ± 0.5b 6.3 ± 0.1c   7.8 ± 0.7a 18.2 ± 0.7b 3.8 ± 0.0c 
20:5n-3 6.9 ± 0.2a 7.4 ± 0.2ab 7.8 ± 0.1b   4.5 ± 0.1 4.9 ± 0.2 4.9 ± 0.1 
22:5n-3 3.0 ± 0.1 3.0 ± 0.0 3.3 ± 0.0   2.0 ± 0.1 1.9 ± 0.1 2.2 ± 0.1 
22:6n-3 12.8 ± 0.2 13.5 ± 0.3 14.4 ± 0.2   12.0 ± 0.7 11.8 ± 0.7 12.6 ± 0.2 
Other n-3 PUFAg 2.2 ± 0.0 2.3 ± 0.1 2.3 ± 0.1   2.9 ± 0.1a 3.2 ± 0.1ab 3.6 ± 0.1b 
n-3 PUFA 32.9 ± 0.6a 40.6 ± 1b 34.1 ± 0.2a   29.3 ± 0.7a 40.0 ± 1.6b 27.1 ± 0.3a 
n-3 LC PUFA 24.8 ± 0.5a 26.1 ± 0.5a 27.8 ± 0.2c   21.2 ± 1.1 21.8 ± 1.0 22.3 ± 0.3 
LC PUFA 32.9 ± 0.7 33.2 ± 0.6 35.0 ± 0.1   29 ± 1.3 28.5 ± 1.3 27.5 ± 0.4 
Data are expressed as mean ± S.E.M., summer phase; n = 4, N = 12, winter phase; n = 3, N = 9. P < 0.05; one-way 
ANOVA with Tukey's post-hoc test of multiple comparisons, different letters denote statistically significant 
difference. NB: each phase was analysed independently.  
a See Table 4.6 for experimental diet abbreviations. 
b Total FA = total fatty acids µmol g-1 of tissue. 
c See 4.6 for fatty acid classes and abbreviations. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 21:0, 22:0 & 24:0. 
e Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-11, 22:1n-11 & 24:1n-9. 
f Other n-6 PUFA = sum of 18:3n-6, 20:3n-6, 22:2n-6, 22:4n-6, 22:5n-6. 






The apparent in vivo fatty acid β-oxidation (nmol g-1 day-1 and % of total intake in brackets and italics) in Atlantic salmon fed the three experimental diets in summer and 
winter phases, (173 and 150 days, respectively). 
  Summer phase dietsa       Winter phase diets     
  PbOd(s) CANd(s) TALd(s)   PbOd(w) CANd(w) TALd(w) 
12:0 0.62 ± 0.62a (10.0) ─ 13.94 ± 0.43b (63.1)   3.25 ± 0.8ab (56.0) 1.55 ± 0.36a (49.8) 4.99 ± 0.19b (61.1) 
14:0 8.95 ± 8.95 (4.7) ─ 26.91 ± 4.99 (8.7)   57.8 ± 10.83ab (44.2) 25.66 ± 7.92a (27.2) 82.86 ± 4.45b (31.6) 
16:0 11.78 ± 11.78a (0.9) ─ 744.31 ± 31.57b (46.3)   501.09 ± 83.55a (32.9) 26.19 ± 14.55b (3.3) 465.92 ± 19.08a (25.9) 
18:0 ─d ─ 472.59 ± 13.06 (65.5)   82.72 ± 22.09a (17.5) 84.34 ± 7.69a (24.8) 328.86 ± 6.1b (39.5) 
20:0 0.19 ± 0.19 (1.3) ─ 0.12 ± 0.12 (0.8)   ─ ─ ─ 
22:0 13.31 ± 0.68 (45.9) ─ 12.49 ± 1.01 (46.8)   6.02 ± 0.58a (0.6) 20.75 ± 0.66b (81.9) 8.22 ± 0.3a (18.9) 
24:0 0 ± 0 0.9 ± 0.07 (10.1) ─   ─ 3.05 ± 0.4 (27.2) ─ 
SFAb,c 34.84 ± 22.19a 0.9 ± 0.07a 1270.37 ± 50.57b   650.87 ± 117.76a 161.54 ± 30.87b 890.86 ± 29.91a 
14:1n-5 5.11 ± 0.59a (45.6) 2.39 ± 0.1b (45.6) 15.97 ± 0.6c (57.1)   9.1 ± 0.68a (65.6) 1.69 ± 0.11b (53.3) 32.29 ± 1.08c (59.3) 
16:1n-7 129.25 ± 12.61a (38.1) 22.48 ± 3.75b (14.7) 119.88 ± 5.12a (35.3)   180.25 ± 26.16a (52.2) 59.18 ± 5.58b (47.7) 138.91 ± 6.67a (43.8) 
18:1n-7 27.36 ± 5.19ab (16.6) 34.53 ± 0.97a (18.9) 13.66 ± 3.48b (9.4)   62.01 ± 15.14ab (39.2) 86.23 ± 6.06a (43.3) 30.15 ± 3.41b (21.7) 
18:1n-9 582.49 ± 53.1a (25.5) 673.04 ± 21.04a (22.7) 394.97 ± 43.68b (18.6)   1145.91 ± 198.01ab (46.8) 1607.9 ± 97.56a (45.6) 755.65 ± 48.64b (32.7) 
20:1n-9 ─ ─ ─   17.58 ± 11.55 (18.2) 24.8 ± 3.57 (19.1) 6.08 ± 2.18 (5.4) 
22:1n-9 4.71 ± 0.5a (23.5) 0.54 ± 0.45b (2.9) 3.17 ± 0.22a (18.3)   8.26 ± 2.34a (30.9) 0.81 ± 0.41b (3.1) 7.14 ± 0.68a (24.3) 
24:1n-9 7.93 ± 1.06 (61.2) 4.38 ± 1.12 (28.6) 5.88 ± 1.58 (46.5)   1.76 ± 0.93a (16.2) 5.62 ± 0.32b (36.3) 3.18 ± 0.24ab (24.8) 
20:1n-11 17.98 ± 1.36a (48.2) 9.76 ± 0.26b (27.5) 18.94 ± 0.55a (49.4)   11.65 ± 2.12a (45.6) 1.17 ± 1.17b (5.3) 14.7 ± 0.7a (50.0) 
22:1n-11 16.81 ± 0.81a (51.6) 16.13 ± 0.48a (51.8) 10.19 ± 0.39b (35.5)   43.63 ± 0.2a (100) 43.51 ± 1.14a (100) 52.16 ± 0.5b (100) 
MUFA 791.64 ± 72.6 763.25 ± 17.92 582.65 ± 53.9   1480.15 ± 256.17ab 1830.91 ± 115.12a 1040.27 ± 63.86b 
18:2n-6 308.71 ± 26.67a (34.6) 244.45 ± 7.11a (28.3) 106.4 ± 8.77b (23.8)   395.07 ± 65.95a (51.4) 439.44 ± 31.35a (47.0) 101.73 ± 9.65b (39.8) 
20:2n-6 ─ ─ ─   ─ ─ 0.28 ± 0.15 (2.3) 
22:2n-6 ─ ─ ─   8.43 ± 0.07a (79.5) ─ 4.86 ± 0.13b (78.2) 
18:3n-6 0.28 ± 0.28a (3.9) ─ 2.87 ± 0.25b (30.2)   ─ ─ 1.23 ± 0.09b (45.0) 
20:3n-6 1.86 ± 1.31a (7.1) 0.48 ± 0.33a (2.2) 7.25 ± 0.48b (26.8)   1.11 ± 1.11a (8.9) 10.67 ± 1.72b (55.7) 11.18 ± 0.59b (77.2) 
20:4n-6 11.74 ± 1.14a (34.1) 6.97 ± 0.39b (26.1) 10.88 ± 0.47a (33.4)   10.56 ± 1.73 (51.4) 7.44 ± 0.82 (49.7) 9.53 ± 0.41 (53.6) 
22:4n-6 1.32 ± 0.17a (23.2) ─ 2.23 ± 0.1b (34.3)   1.36 ± 0.26 (56.4) 0.96 ± 0.08 (64.6) 1.05 ± 0.03 (40.6) 
22:5n-6 2.9 ± 0.12a (28.2) 1.97 ± 0.36b (20.9) 5.11 ± 0.03c (43.9)   8.43 ± 0.33a (82.7) 10.94 ± 0.43b (81.0) 8.57 ± 0.2a (74.9) 
n-6 PUFA 326.82 ± 29.01a 253.87 ± 7.46b 134.76 ± 9.75c   424.97 ± 69.13a 469.45 ± 34.11a 138.43 ± 11.14b 
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18:3n-3 59.58 ± 2.44a (39.9) 157.75 ± 5.05b (45.0) 22.71 ± 2.21c (31.1)   71.82 ± 11.97a (57.9) 211.29 ± 10.72b (51.8) 1.24 ± 1.01c (2.2) 
18:4n-3 2.92 ± 0.16a (72.2) 1.66 ± 0.18b (47.1) 0.16 ± 0.1c (0.5)   ─ ─ ─ 
20:4n-3 2.58 ± 0.43a (20.9) 0.97 ± 0.22b (8.1) 0.08 ± 0.08b (0.8)   ─ ─ ─ 
20:3n-3 ─ 44.96 ± 0 (100) ─   ─ ─ ─ 
22:3n-3 3.26 ± 0.26 (38.1) 2.5 ± 0.15 (31.8) 3.25 ± 0.2 (35.7)   11.77 ± 0.05a (100) 2.91 ± 0.08b 11.92 ± 0.11a (100) 
20:5n-3 111.97 ± 11.24ab (52.4) 89.82 ± 4.97a (44.4) 121.16 ± 4.55b (55.1)   71.55 ± 5.36 (77.8) 59.51 ± 2.56 (65.2) 66.73 ± 2.26 (67.8) 
22:5n-3 ─ ─ ─   9.02 ± 3.01 (46.8) 5.79 ± 1.07 (33.0) 7.14 ± 0.2 (31.8) 
22:6n-3 0.92 ± 0.92 (0.7) ─ 3.6 ± 1.27 (2.6)   42.64 ± 13.42 (35.9) 33.52 ± 8.41 (28.6) 35.85 ± 3.71 (26.7) 
n-3 PUFA 181.23 ± 12.7a 297.67 ± 6.85b 150.96 ± 6.34a   206.81 ± 33.63a 313.02 ± 22.38b 122.88 ± 5.05a 
Total FA 1334.52 ± 127.52a 1315.69 ± 30.19a 2138.74 ± 115.41b   2762.8 ± 476.33 2774.93 ± 201.32 2192.44 ± 109.67 
Data are expressed as mean ± S.E.M., summer phase; n = 4, N = 12, winter phase; n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's post-hoc test of multiple comparisons, 
different letters denote statistically significant difference. NB: each phase was analysed independently.  
a See Table 4.6 for experimental diet abbreviations. 
b See Table 4.6 for fatty acid classes and abbreviations. 
c Fatty acids not recording any β-oxidation are not reported in this table. 




     
The apparent in vivo fatty acid bioconversion (elongation, desaturation or chain shortening) (nmol g-1 day-1) in Atlantic salmon fed the three experimental diets for 323 
days. 
  Summer phase dietsa     Winter phase diets   
  PbOd(s) CANd(s) TALd(s)   PbOd(w) CANd(w) TALd(w) 
de novo fatty acid production             
12:0 85.21 ± 41.57 178.42 ± 11.44 ─   ─ ─ ─ 
Fatty acid elongationb               
12:0 to 14:0 86.67 ± 41.87 177.67 ± 11.53 ─   ─ ─ ─ 
14:0 to 16:0 101.37 ± 43.45 196.09 ± 11.15 ─   ─ 4.12 ± 4.12 ─ 
16:0 to 18:0 111.55 ± 11.05 105.29 ± 3.59 ─   ─ ─ ─ 
18:0 to 20:0 2.05 ± 0.70a 18.82 ± 1.56b 0.71 ± 0.37a   2.18 ± 0.52a 11.42 ± 1.23b 1.59 ± 0.05a 
18:1n-9 to 20:1n-9 9.39 ± 2.92 10.50 ± 2.73 16.5 ± 2.74   ─ ─ ─ 
20:1n-9 to 22:1n-9 ─ 0.71 ± 0.42 ─   ─ 0.67 ± 0.67 ─ 
20:0 to 22:0 ─ 22.05 ± 0.88 ─   ─ ─ ─ 
22:0 to 24:0 0.42 ± 0.04 ─ 0.49 ± 0.17   3.64 ± 0.4 ─ 4.04 ± 0.20 
18:2n-6 to 20:2n-6 19.27 ± 2.92a 15.32 ± 2.26ab 9.46 ± 0.88b   13.93 ± 4.6a 16.43 ± 0.33a 0.47 ± 0.47b 
20:2n-6 to 22:2n-6 2.72 ± 0.33a 2.67 ± 0.26a 1.63 ± 0.11b   ─ 1.58 ± 0.05 ─ 
18:3n-6 to 20:3n-6 0.50 ± 0.37 1.08 ± 0.92 ─   0.86 ± 0.67 ─ ─ 
18:3n-3 to 20:3n-3 ─ ─ ─   2.18 ± 0.58a 14.22 ± 0.23b 1.96 ± 0.12a 
20:4n-6 to 22:4n-6 ─ 0.33 ± 0.09 ─         
18:4n-3 to 20:4n-3 ─ ─ 0.29 ± 0.16   12.56 ± 1.94a 15.88 ± 0.44ab 18.55 ± 0.24b 
20:5n-3 to 22:5n-3 25.22 ± 10.32 28.18 ± 3.17 12.72 ± 1.52         
22:5n-3 to 24:5n-3 20.60 ± 9.65 21.88 ± 1.81 8.72 ± 1.04   1.51 ± 0.81 1.45 ± 0.67 1.28 ± 0.38 
Fatty acid ∆-6 desaturation              
18:2n-6 to 18:3n-6 2.60 ± 1.05 4.44 ± 1.11 ─   4.57 ± 1.72 7.33 ± 1.26 ─ 
18:3n-3 to 18:4n-3 ─ ─ 0.09 ± 0.08   9.55 ± 1.93a 15.31 ± 0.42b 31.11 ± 0.73c 
24:5n-3 to 24:6n-3 15.26 ± 8.70 17.32 ± 1.80 4.36 ± 0.52   1.52 ± 0.54 1.05 ± 0.46 1.11 ± 0.16 
Fatty acid ∆-9 desaturation               
20:0 to 20:1n-11 ─ ─ ─   ─ 1.82 ± 1.27 ─ 
Fatty acid chain shortening               
24:6n-3 to 22:6n-3 11.27 ± 8.55 12.6 ± 1.68 0.16 ± 0.16   ─ ─ ─ 
Data are expressed as mean ± S.E.M., summer phase; n = 4, N = 12, winter phase; n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's post-hoc test of multiple 
comparisons, different letters denote statistically significant difference. NB: each phase was analysed independently.  
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a See Table 4.6 for experimental diet abbreviations. 
b Fatty acids not recording any bioconversion (elongation or desaturation) are not reported in this table. 



























       
Consumer preference of Atlantic salmon products (raw salmon, cold 
smoked and hot smoked fillet) and major influential attributes (fishiness, 
saltiness and oiliness) from the three dietary treatments post-harvest. 
  Diets     
  PbO CAN TAL 
Preference; Like ( + ) or Dislike ( - )     
Raw 4.11 ± 1.18 9.85 ± 2.47 6.21 ± 0.40 
Cold smoked 14.63 ± 2.24 20.35 ± 1.35 13.16 ± 1.87 
Hot smoked 22.6 ± 1.31 19.71 ± 3.42 19.15 ± 4.02 
Influential attributes ('Just Right' scores; +/ve = too much, -/ve = too little) 
Fishiness       
Raw -0.6 ± 2.64 0.77 ± 1.02 0.5 ± 0.97 
Cold smoked 3.91 ± 0.80 -0.29 ± 3.44 3.82 ± 0.85 
Hot smoked -0.68 ± 1.71 1.49 ± 1.88 0.15 ± 2.33 
Saltiness       
Raw -20.26 ± 3.66 -18.21 ± 3.27 -21.32 ± 0.39 
Cold smoked 9.85 ± 1.57 4.97 ± 1.69 6.31 ± 0.95 
Hot smoked 5.73 ± 1.53 8.54 ± 0.83 5.66 ± 0.53 
Oiliness       
Raw -3.8 ± 1.78 -2.8 ± 1.12 -2.63 ± 2.18 
Cold smoked 3.52 ± 0.27 2.19 ± 2.58 6.02 ± 0.69 
Hot smoked -0.45 ± 1.63 -0.52 ± 2.73 -2.74 ± 0.47 
Data are expressed as mean ± S.E.M., n = 3; N = 9. P < 0.05; one-way 
ANOVA with Tukey's post-hoc test of multiple comparisons, different 
letter denote statistically significant difference. 
a See Table 4.6 for experimental diet abbreviations. 
b Salmon preferences were assessed using hedonic LMS scales. 
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5. Effects of replacing dietary n-3 LC PUFA with shorter-chain 
C18 n-3 PUFA in diets for large, seawater reared Atlantic 
salmon by an assessment of growth performance, fatty acid 




There is a growing trend of ‘replacing’ omega-3 long-chain polyunsaturated fatty acids (n-3 
LC PUFA) rich oils with C18 shorter-chain omega-3 polyunsaturated fatty acid rich oils in 
Atlantic salmon (Salmo salar) aquafeed formulations. However, n-3 LC PUFA, including 20:5n-
3 and 22:6n-3, play contrasting physiological roles and are metabolised differently in 
comparison to C18 PUFA. Hence, it is increasingly important to distinguish the effects of 
dietary lipid sources of C18, shorter-, and C20-22, long- chain fatty acids in aquafeed on the 
overall health characteristics of Atlantic salmon. Additionally, the adoption of dietary 
formulations in aquaculture clearly depends on more than the ‘healthiness’ of the fillet 
product. Indeed, overall fish performance, including growth remains a primary consideration 
of producers (Lysfjord et al. 2004; Rosenlund et al. 2016; Thorarensen et al. 2015). To date, 
few long-term growth trials have been conducted with salmon in seawater fed diets 
containing low n-3 LC PUFA concentrations, although admittedly, its dietary addition appears 
essential for optimal growth (Bell et al. 2010a; Rosenlund et al. 2016). The present Chapter 
compared three commercial-like diets containing either added n-3 LC PUFA, from fish oil (FO), 
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or added shorter-chain n-3 PUFA (at two levels), from camelina oil (CAM) to assess growth 
performance, fillet fatty acid composition, nutrient and fatty acid digestibility, in vivo fatty 
acid metabolism, and consumer acceptance in market-sized Atlantic salmon. 
 
5.2. Materials and Methods 
 
5.2.1 Location, animals, experimental design and sampling. 
The present experiment was conducted on a commercial farm, from May 24 to October 20, 
2015 (150 days) in Hideaway bay, Dover, Tasmania (Huon Tasmania, Hideaway bay site; 
43°15′ 52.2″S 147°04′37.7″E). Immediately preceding the allocation of fish into trial pens an 
initial sample of six fish were randomly taken from the trial cohort, euthanized in excess 
anaesthetic (AQUI-S, 0.5 ml L-1) and stored at −20°C until subsequent analysis. A total of 2430 
Atlantic salmon (average initial weight ~2200 g) were assigned to one of nine floating sea pens 
(5 m x 5 m x 5 m, 270 fish per pen) (n = 3, N = 9). Feeding of the three experimental diets to 
trial pens was achieved by using a Sterner feeder fitted with a 40 L hopper and spinning feed 
spreading mechanism that dispersed feed over ~80% of the cage surface. Fish were fed twice 
per day to satiation by an automated AQ1 feed system, with the first feeding programmed 
for 15 minutes before sunrise and the second feeding 15 minutes after sunset. A 0.5 m 
diameter, 0.5 m deep cone was positioned at a depth of 4 m to channel uneaten feed past an 
infrared sensor which detected uneaten pellets and automatically turned the feeder off. All 
feeding sessions were overseen by an observer to ensure the operation of all automated 
systems were correct and consistent. Feed consumption and mortalities were monitored 
throughout the trial and physico-chemical parameters were recorded, including water 
temperature (mean ± SD: 11.21 ± 0.86oC) and dissolved oxygen (mean ± SD: 7.85 ± 0.43 mg L-
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1). During the last week of feeding, 10 fish were randomly selected for faecal collection by 
hand stripping and samples were used for subsequent nutrient digestibility assessment. At 
the completion of the feeding trial, all fish were anaesthetised and weighed, and 21 fish from 
each treatment (seven fish per pen/replicate unit) were randomly selected and separated. 
These fish were allocated into 3 groups: the first group (nine fish) were used for the chemical 
analysis of whole body samples, the second group (six fish) were used for biometrical 
measurements and for the chemical analysis of fillet samples and the third group (six fish) 
were used for sensory analysis by means of a panel taste test. Sampled fish were immediately 
placed in an ice slurry, where fish used for chemical analysis were then frozen to −20°C and 
stored until subsequent analysis, while fish allocated to panel taste testing were immediately 
processed by Huon Aquaculture Company, Tasmania, as described below.  
 
5.2.2 Experimental Diets 
The experimental diets were manufactured by a commercial feed producer using a closed 
formula Atlantic salmon aquafeed formulations (Ridley Aquafeed, Australia). A single batch 
of 9mm pellets with an identical basal formulation was made, then divided into three 
separate sub-batches post extrusion and vacuum coated with different oils. The three diets 
were isoproteic, isolipidic and isoenergetic and differed only in the added oil source. All diet 
manufacturing followed normal commercial pellet production procedures at a commercial 
mill (Ridley Aquafeed, Narangba, QLD, Australia). 
Three lipid sources, TAL, FO and CAM, were used to obtain the three experimental diets. The 
FO20 diet was formulated with 20% FO and 80% TAL as the added dietary lipid. FO20 was 
therefore the diet providing dietary omega-3 fatty acids in the form of n-3 LC PUFA. The 
CAM20 diet also contained 80% TAL, however, FO was substituted by CAM resulting in dietary 
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lipid composed of 20% CAM and 80% TAL. The third treatment diet was made up of 60% TAL 
and 40% CAM as the added dietary lipid (CAM40). The CAM20 and CAM40 were therefore the 
two diets providing dietary omega-3 fatty acids in the form of the shorter, C18 n-3 PUFA, 
namely, 18:3n-3, at two different levels. 
 
5.2.3. Statistical analysis 
All data were reported as mean ± standard error; (n = 3, N = 9). After confirmation of normality 
and homogeneity of variance, data was subjected to one-way ANOVA, where significant 
differences were detected, a Tukey’s post-hoc test for homogenous subsets was performed 






Proximate composition was similar among the three treatment diets, ~420 mg g-1 diet and 
~350 mg g diet-1 for protein and lipid, respectively (Table 5.14). n-6 PUFA varied across 
treatments and was highest in CAM40, attributable to high levels of 18:2n-6. Likewise, n-3 
PUFA concentrations varied between treatments and were highest in CAM40, owing to high 
levels of 18:3n-3, and lowest in FO20. n-3 LC PUFA was highest in FO20 owing to elevated 
concentrations of 20:5n-3 and 22:6n-3. n-6:n-3 ratios were ranged from 0.9 and 1.3 in FO20 
and CAM20, respectively. 
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5.3.2. Growth, feed utilisation parameters and biometrical data 
All diets were readily accepted and mortality rates were low across treatments (<6%, over the 
entire duration of the trial, and unrelated to treatment). Fish doubled in size (2200g – 4500g), 
with an FCR ranging between 1.34 and 1.63 in FO20 and CAM20 treatments, respectively 
(Table 5.15). Both SGR and weight gain % were significantly higher in the FO20 treatment (P 
< 0.05) and fish were observably larger, however, final weights were not statistically different. 
Feed intake was reduced in the CAM40 treatment and recorded values ranged from 3203.4 
to 3700.2 (in terms of g fish-1) in CAM40 and CAM20, respectively. There were no significant 
differences in biometry measures between the treatments.  
 
5.3.3. Apparent digestibility 
High nutrient and fatty acid digestibility values (Apparent Digestibility Coefficient – ADC %) 
were observed across treatments, with only few statistically significant differences recorded 
(Table 5.16). Protein digestibility values ranged from 74.1 to 80.2 % in FO20 and CAM20, 
respectively and lipid digestibility values ranged from 78.5 to 84.8 % in FO20 and CAM40, 
respectively. Digestibility values recorded for 18:3n-3 ranged from 88.1 to 96.6 % in FO20 and 
CAM20, respectively and digestibility values for 22:6n-3 ranged from 87.8 and 93.6 % for FO20 
and CAM20, respectively. 
 
5.3.4. Tissue proximate and fatty acid composition 
Proximate composition of fillet was similar among treatments and no significant differences 
were recorded (P > 0.05) (Table 5.17). Fillet fatty acid composition, in terms of g 100g-1 of fillet 
(Table 5.18), recorded numerous statistically significant differences, including higher SFA in 
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FO20 (2814.6 mg 100g-1 fillet). n-6 PUFA differed significantly between all treatments ranging 
from 743.0 to 1276.6 mg 100g-1 of fillet in FO20 and CAM40, respectively. n-3 LC PUFA also 
varied between treatments ranging from 458.5 to 718.3 mg 100g-1 fillet in CAM20 and FO20, 
respectively, owing largely to differences in 22:6n-3 (P < 0.05). The n-6:n-3 ratio varied 
substantially between treatments, ranging from 0.9 to 1.6 in FO20 and CAM20, respectively. 
Trends were similar when expressed as µmol g-1 fillet and revealed significant differences in 
18:3n-3 content which ranged from 3.8 to 14.0 µmol g-1 in FO20 and CAM40, respectively (P 
< 0.05) (Table 5.17). 
 
5.3.5. Apparent in vivo fatty acid metabolism 
Apparent in vivo fatty acid β-oxidation and apparent in vivo fatty acid bioconversion, as 
calculated by the whole-body fatty acid balance method, are presented in Table 5.19 and Table 
5.20. Fatty acid β-oxidation (expressed as nmol of fatty acid β-oxidised per gram of fish per 
day; nmol g-1 day-1) revealed 18:1n-9 was heavily β-oxidised in all treatments. High total 
amounts of SFA were also β-oxidised, however recorded values were higher in FO20 and 
CAM20 in comparison to CAM40. Significantly more 20:5n-3 and 22:6n-3 was β-oxidised in 
fish fed FO20 in line with relatively high dietary inclusion levels. β-oxidation of 18:3n-3 also 
followed dietary inclusion levels and was significantly higher in fish fed CAM20 and CAM40 
compared to FO20, where recorded levels were minimal. However, CAM20 recorded 
proportionally higher β-oxidation of 18:3n-3 compared to CAM40. Apparent in vivo enzyme 
activity for fatty acid elongation, fatty acid desaturation and fatty acid chain shortening, 
(expressed as nmol of product per gram of fish per day; nmol g-1 day-1) varied considerably 
between treatments and numerous statistically significant differences were observed. In 
general, the highest enzymatic activity was observed in CAM40. n-3 PUFA bioconversion was 
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highest in CAM40, including ∆-5 desaturation of 20:4n-3 to biosynthesise 20:5n-3, subsequent 
elongation of 20:5n-3 and chain shortening of 24:6n-3 for 22:6n-3 production. 
 
5.3.6. Consumer preferences 
No significant difference in liking score between dietary treatments for the three preparation 
methods, (hot smoked, cold smoked and raw), was observed (Table 5.21). FO20 scored the 
highest liking score for the raw preparation method whilst CAM20 and CAM40 scored highest 
in liking scores for the hot smoked and cold smoked preparation methods, respectively. 
Overall, ‘just right’ scores were similar between treatments for the influential attributes 
analysis (fishiness, saltiness and oiliness) and trends observed appeared to be related to 
preparation method and not treatment. One significant difference was recorded; CAM20 
scored significantly higher than FO20 for the saltiness attribute for the cold smoked 




The objective of the present research Chapter was to quantify the effects of replacing n-3 LC 
PUFA with shorter-chain C18 n-3 PUFA in diets for Atlantic salmon in response to the growing 
trend of substituting FO with terrestrial alternatives containing C18 n-3 PUFA in aquafeed 
formulations. It is known that, due to functional differences, n-3 LC PUFA and C18 n-3 PUFA 
are not metabolised equally and this could potentially be affecting both fish performance and 
product quality in this species (Bell et al. 2004; Betancor et al. 2017; Hixson et al. 2014b; 
Turchini et al. 2011c; Xue et al. 2015). Accordingly, industry relevant information including an 
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analysis of growth performance, fillet nutritional quality, in vivo fatty acid metabolism and an 
evaluation of consumer taste preference were addressed in this experiment and are discussed 
herein. 
 
It is widely reported that the replacement of FO with vegetable and animal by-product oils in 
diets for salmonids has little effect on overall growth performance, even when included as 
100 % of the dietary lipid source (Bell et al. 2010a; Bransden et al. 2003; Hixson et al. 2014b; 
Karalazos et al. 2007; Menoyo et al. 2005; Torstensen et al. 2000). Despite this, a minimum 
dietary requirement for 20:5n-3 and 22:6n-3 for optimum growth in seawater for large 
Atlantic salmon has been suggested (>2.7 % of fatty acids) (Rosenlund et al. 2016). In the 
current trial the dietary treatments containing no added FO, apart from that contained within 
the fish meal, recorded ~20% lower total weight gain compared to the FO20 treatment. 
Therefore, this study supports a minimum dietary provision of FO in diets for market-sized 
Atlantic salmon reared in on-farm conditions in seawater to maintain optimum growth 
performance. In the present case, a level of 9.7 mg g-1 diets 20:5n-3 + 22:6n-3 appeared 
adequate. Alternatively, considering no other detrimental effects were observed, if the cost 
saving resulting from the exclusion of FO from feed formulation could be greater than the 
reduced revenues originating from the retarded fish growth, specific production decisions 
could be implemented accordingly. This would require a deeper and specific bio-economical 
assessment, which was not an objective of the present Chapter, but may be warranted in 
future investigations. 
 
In line with extensive research, fillet fatty acid composition reflected dietary inclusion levels 
(Bell et al. 2002; Bell et al. 2004; Bell et al. 2001a; Emery et al. 2016; Francis & Turchini 2017; 
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Friesen et al. 2008; Glencross et al. 2014a; Hixson et al. 2014a; Jobling & Bendiksen 2003; 
Karalazos et al. 2007; Robin et al. 2003; Rosenlund et al. 2001a; Tocher et al. 2003; Torstensen 
et al. 2000; Turchini et al. 2013a). As expected, fillet levels of n-3 LC PUFA were significantly 
higher in FO20, compared to the no FO treatments, and confirm that in order for farmed 
Atlantic salmon to maintain their reputation as a good source of n-3 LC PUFA, the dietary 
inclusion of n-3 LC PUFA in aquafeed is required (Henriques et al. 2014; Sargent et al. 2003; 
Tur et al. 2012). Despite higher total 22:6n-3 concentrations in the fillet of FO20 fish, the 
deposition efficiency was noticeably lower, as evidenced by the significantly higher β-
oxidation of both 20:5n-3 and 22:6n-3. Contrastingly, the β-oxidation of 20:5n-3 and 22:6n-3 
was relatively minimal in both CAM20 and CAM40, supporting previous research which 
suggests an increased retention of n-3 LC PUFA when dietary provision is limited (Codabaccus 
et al. 2012a; Francis et al. 2014b; Pratoomyot et al. 2010; Turchini et al. 2011a). 
Despite similar dietary levels of n-3 LC PUFA, CAM40 recorded higher levels of n-3 LC PUFA in 
the fillet compared to CAM20. A possible explanation may relate to the capacity of numerous 
freshwater and anadromous fish, including Atlantic salmon, to endogenously produce n-3 LC 
PUFA via the desaturation and elongation of 18:3n-3 (Nakamura & Nara 2004; Tocher 2003). 
18:3n-3 rich terrestrial oils are more readily available for the inclusion into aquafeed 
formulations compared to 22:6n-3 rich FO (Turchini et al. 2010). Hence, previous research has 
focussed on the dietary manipulation of shorter vs long-chain n-3 PUFA ratios in an attempt 
to ‘augment’ the endogenous synthesis of n-3 LC PUFA in commercially important finfish 
species such as Atlantic salmon (Betancor et al. 2014; Francis et al. 2007; Olsen & Ringø 1992; 
Ruyter & Thomassen 1999; Tocher et al. 2002; Torstensen et al. 2004a; Turchini & Francis 
2009). Marine environments contain an abundance of dietary sources of 22:6n-3 and 
accordingly endogenous production of 22:6n-3 in marine fish is limited. In contrast, dietary 
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sources of 22:6n-3 in freshwater environments are relatively scarce, where resultantly, the 
endogenous production of 22:6n-3 is believed to be an evolutionary adaptation by freshwater 
and anadromous fish to meet physiological requirements (Tocher 2003). However, research 
suggests that the activity of the ∆-6 desaturase enzyme in salmonids, which catalyses the first, 
and one of the last, steps of the n-3 bioconversion pathway, is modulated primarily by the 
provision of n-3 substrate and that the negative feedback modulation by dietary provision of 
n-3 LC PUFA may have a limited influence (Glencross et al. 2014a; Hixson et al. 2017; 
Thanuthong et al. 2011; Thomassen et al. 2012; Turchini & Francis 2009). With respect to the 
present research Chapter, CAM40 contained a two-fold higher dietary concentration of 18:3n-
3 compared to CAM20, and although not significant, recorded a higher ∆-6 desaturation of 
18:3n-3. Subsequently, CAM40 recorded a ∆-5 desaturation of 20:4n-3, an elongation of 
20:5n-3 and ultimately an endogenous production of 22:6n-3, although final amounts were 
limited. CAM20 on the other hand recorded minor production of n-3 LC PUFA beyond 20:4n-
3. Therefore, in accordance with previous research, the higher dietary provision of 18:3n-3 in 
CAM40 explains the higher enzymatic activity in the n-3 PUFA bioconversion pathway, which 
may have contributed to higher fillet levels of n-3 LC PUFA (Thanuthong et al. 2011; 
Thomassen et al. 2012; Turchini & Francis 2009). As mentioned, higher levels of n-3 LC PUFA 
were recorded in the fillet tissue of CAM40 fish compared to fish fed the CAM20 diet, despite 
similar amounts provided in the diet and limited recorded endogenous production of 22:6n-
3. The inability to detect large amounts of endogenous 22:6n-3 production in CAM40 fish 
using the whole-body fatty acid balance method may be a result of limitations when this 
method is applied to on-farm situations. These limitations may arise from a less efficient 
incorporation of dietary supplied fatty acids into the fish as is associated with a typically 
higher FCR in large fish, which in-turn, may have been compounded by an on-farm versus a 
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laboratory based trial. Concomitantly, inaccuracies associated with feed delivery and 
consumption measurements can result in a considerable over or under-estimation of feed 
inputs.  Resultantly, dietary fatty acid availability is overestimated and, therefore, contributes 
to an underestimation of final whole-body fatty acid balance. Nevertheless, the apparent 
limited biosynthesis of 22:6n-3 in CAM40 likely indicates there are other factors responsible 
for the higher fillet 22:6n-3 in CAM40 fish. The most obvious explanation relates to the 
marginally higher dietary level of n-3 LC PUFA in CAM40 treatment diets as well as the 
increased retention of 22:6n-3, as evidenced by lower a β-oxidation of this fatty acid, both in 
terms of µmol g-1 day-1 and % of net intake. Notwithstanding the aforementioned limitations, 
this research Chapter suggests that if FO is replaced by CAM, a relatively high (~40%) dietary 
addition is favourable to enhance the n-3 LC PUFA content of the fillet. Furthermore, relative 
to a 20% inclusion of CAM, a reduction in the n-6:n-3 ratio was achieved, leading to net gains 
in potential health benefits (Harris et al. 2009; Simopoulos 2008). However, due to the 
multiple explanatory factors presented herein, further investigation is required to better 
quantify the effects on endogenous production of n-3 LC PUFA in large Atlantic salmon fed 
diets containing very low n-3 LC PUFA and varied levels of 18:3n-3 as a substrate for in vivo 
bioconversion. 
 
As highlighted, dietary provision of 18:3n-3 influences the extent of n-3 PUFA bioconversion 
in salmonids, where more specifically, in vivo enzymatic activity appears proportional to 
18:3n-3 substrate availability (Glencross et al. 2014a; Hixson et al. 2017; Thanuthong et al. 
2011). However, despite a minimal dietary provision, >60 % of 18:3n-3 was either desaturated 
or elongated in the FO20 dietary treatment. Despite no dietary provision of 18:4n-3, 
endogenous synthesis of 20:4n-3 was significantly higher in the FO20 treatment, however, no 
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production of 20:5n-3 was recorded. It appears, in accordance with previous research, that 
the dietary provision of n-3 LC PUFA in the FO20 diet elicited a partial negative feedback on 
∆-5 desaturase enzyme activity, yet did not inhibit ∆-6 desaturase enzyme activity (Glencross 
et al. 2014a; Hixson et al. 2017; Thanuthong et al. 2011; Thomassen et al. 2012). However, 
considering the low dietary provision of 18:3n-3 there are likely other factors contributing to 
the high bioconversion rate. The high dietary 20:4n-6 in the FO20 diet relative to the other 
experimental diets has the potential to increase ∆-6 desaturation of 18:3n-3, as suggested by 
previous research in juvenile Atlantic salmon (Norambuena et al. 2015b). Additionally, the ∆-
6 desaturase enzyme has a higher affinity with n-3, as opposed to n-6 substrates, namely 
18:2n-6 (Vagner & Santigosa 2011). Thus, the relatively low dietary concentration of 18:2n-6 
in FO20 compared to the other treatment diets may have resulted in a preferential 
desaturation of 18:3n-3. 
 
Atlantic salmon contain a ‘healthy’ n-6:n-3 ratio, which in turn is a direct consequence of 
balanced aquafeed formulations (Bendiksen et al. 2011; Leaver et al. 2011; Strobel et al. 2012; 
Turchini et al. 2010). The present Chapter highlights the different utilisation of 18:3n-3 and 
22:6n-3 in Atlantic salmon, in turn, affecting the nutritional value of the final product. The 
dietary n-6:n-3 ratios in FO20 and CAM40 were similar (0.9 and 1.0, respectively), however, 
in FO20 this was comprised primarily of long-chain n-3 PUFA, whereas CAM40 consisted of 
mostly C18 n-3 PUFA. In accordance with previous research, 18:3n-3 was heavily β-oxidised 
and this was reflected in fillet n-6:n-3 ratios which recorded values of 0.9, 1.6 and 1.4 for 
FO20, CAM20 and CAM40, respectively (in terms of mg 100g-1 of fillet) (Bell et al. 2001a; Bell 
et al. 2003a; Bell et al. 2003b; Sinclair et al. 2002). Therefore, dietary n-6:n-3 dietary ratios in 
CAM20 and CAM40 were not reflected in the fillet.  
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From a human nutritional viewpoint, an unbalanced dietary n-6:n-3 ratio continues to be used 
as a measure of ‘healthfulness’ of the final product, owing to a purported decrease in 
occurrence of inflammatory conditions such as cardiovascular disease (Baum et al. 2012; 
Calder 2010; Harris et al. 2009; Simopoulos 2008; Valfré et al. 2003). However, the relative 
contribution of 18:3n-3 and 22:6n-3 to total n-3 PUFA is often omitted (Turchini et al. 2011c). 
To date, there is scant information available specifically linking 18:3n-3 to health benefits in 
humans, conversely, the health benefits of 22:6n-3 have been extensively reported, leading 
to a potential misinterpretation of the actual health benefit of the product (Fard et al. 2018; 
Turchini et al. 2011c). Furthermore, dependant on marketing strategy and resultant labelling 
practice, nutritional information can often be confined to total ‘omega-3’ or ‘omega-3 
polyunsaturated fatty acids’ (Turchini et al. 2011c). In the present study, fish fed the CAM40 
diet contained higher (albeit not statistically) n-3 PUFA in the fillet compared to FO20, largely 
due to high 18:3n-3, however, fish fed the FO20 diet had significantly higher n-3 LC PUFA. The 
aforementioned results exemplify the need to consider the relative contribution of 18:3n-3 
and 22:6n-3 when assessing the nutritive value of both aquafeed and the final fish product. 
Accordingly, it is suggested that products advertising levels of ‘omega-3’ contain a more 
complete set of nutritional information, specifically, elucidating the relative contribution of 
individual fatty acids, especially, shorter-chain C18 n-3 PUFA and long-chain n-3 PUFA. 
 
In addition to the nutritional value, taste and sensorial quality is also a major driver of fish 
consumption (Christenson et al. 2017). The present study indicated that consumer 
acceptance; like (+) or dislike (-) and influential attribute analysis from raw, cold and hot 
smoked fillets was largely independent of the dietary treatment. The possible exception was 
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CAM20, which was considered too salty compared to FO20 when prepared raw. These results 
are largely confirmatory with Hixson et. al., (2017), who found that consumers were unable 
to distinguish between fish fed a diet containing CAM and fish fed a FO control diet, providing 
confidence that the dietary inclusion of CAM, in the absence of FO has no measurable effect 
on major taste attributes or acceptance of market-sized Atlantic salmon. 
 
Expanding on the knowledge gained through the long-term growth trial utilising PbO, CAN 
and TAL in chapter 4, the current research chapter clearly showed that the replacement of n-
3 LC PUFA with C18 n-3 PUFA, namely, CAM in diets for Atlantic salmon resulted in a significant 
decrease in fillet n-3 LC PUFA and a reduction in growth performance. However, an improved 
n-6/n-3 ratio was achieved by the dietary inclusion of CAM at high levels (40%) in the absence 
of FO. Additionally, a 40% inclusion of CAM may partially mitigate low dietary n-3 LC PUFA by 
providing added substrate for endogenous n-3 LC PUFA synthesis. However, further 
laboratory based trials are recommended to better elucidate this potential. Finally this 
research chapter clearly asserts that consumers would benefit from a more complete 
reporting of the relative contribution of shorter-chain C18 n-3 PUFA and n-3 LC PUFA in fish 
and seafood products.  
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5.5 Figures and Tables 
TABLE 5.14 
       
Proximate composition, total fatty acids and fatty acid (mg g-1 diet) 
composition of experimental diets used in the Atlantic salmon growth trial 
for 150 days. 
  Dietsab     
  FO20 CAM20 CAM40 
Proximate composition     
Moisture  44.3 35.6 34.9 
Protein 402.6 425.6 438.8 
Lipid 358.2 349.1 354.4 
NFE 125.0 117.8 98.8 
Ash 69.9 71.8 73.2 
Energy (KJ g-1) 25.8 25.9 26.1 
Fatty acids composition 
Total FAb 250.9 250.7 253.0 
SFAc 104.1 98.7 84.1 
14:0 7.9 5.6 4.9 
16:0 60.8 57.2 48.3 
18:0 31.2 32.4 26.8 
Other SFAd 4.2 3.5 4.1 
MUFAe 115.4 113.0 110.8 
16:1n-7 10.6 9.5 6.8 
18:1n-9 86.0 89.7 82.1 
18:1n-7 5.2 4.5 4.0 
20:1n-9 4.6 6.2 11.1 
Other MUFAf 9.0 3.1 6.8 
Total trans FAg 5.2 6.0 4.1 
PUFAh 25.9 32.6 53.8 
18:2n-6 9.4 15.5 23.7 
18:3n-6 0.1 0.0 0.2 
20:2n-6 0.5 1.0 1.4 
20:3n-6 0.6 0.5 0.6 
20:4n-6 0.7 0.5 0.3 
Other n-6 PUFAi 0.9 1.2 0.6 
n-6 PUFAj 12.2 18.3 26.8 
n-6 LC PUFAn 2.7 2.7 3.1 
18:3n-3 2.0 10.9 23.4 
20:5n-3 3.9 1.2 1.0 
22:5n-3 1.0 0.3 0.3 
22:6n-3 5.8 1.6 1.6 
Other n-3 PUFAl 0.6 0.3 0.7 
n-3 PUFAk 13.3 14.3 27.0 
n-3 LC PUFAo 11.3 3.4 3.6 
LC PUFAm 14.0 6.1 6.6 
n-6:n-3 ratiop 0.9 1.3 1.0 
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a Diets: FO20 = tallow and fish oil diet, added oil 20% fish oil, 80% tallow; 
CAM20 = tallow and camelina oil diet, added oil 80% tallow, 20% camelina 
oil; CAM40 = tallow and camelina oil diet, added 60% tallow, 40% 
camelina oil. 
b Total FA = total fatty acids mg/g of diet. 
c SFA = saturated fatty acids. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 22:0 and 24:0. 
e MUFA = monounsaturated fatty acids. 
f Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-13, 20:1n-11, 
22:1n-11, 22:1n-9 and 24:1n-9. 
g Total trans FA = sum of 18:1n-9t, 18:1n-7t and 18:2n-6t. 
h PUFA = polyunsaturated fatty acids. 
i Other n-6 PUFA = sum of 20:2n-6, 22:2n-6, 22:4n-6 and 22:5n-6. 
j n-6 PUFA = omega-6 polyunsaturated fatty acids. 
k n-3 PUFA = omega-3 polyunsaturated fatty acids. 
l Other n-3 PUFA = sum of 18:4n-3, 20:3n-3, 20:4n-3, 24:5n-3 and 24:6n-3. 
m LC-PUFA = long chain (>20C) polyunsaturated fatty acids. 
n n-6 LC PUFA = omega-6 long chain polyunsaturated fatty acids. 
o n-3 LC PUFA = omega-3 long chain polyunsaturated fatty acids. 





















Growth, feed efficiency and biometry of Atlantic salmon fed the three experimental diets for 
150 days. 
  Dietsa     
  FO20 CAM20 CAM40 
Initial wt (g) 2164 ± 37 2272 ± 34 2285 ± 2 
Final wt (g) 4835 ± 67 4552 ± 39 4638 ± 49 
Feed (% body weight day-1) 0.67 ± 0.01 0.72 ± 0.01 0.62 ± 0.06 
Feed intake (g fish-1) 3522.7 ± 179.2 3700.2 ± 92.8 3203.4 ± 331.3 
Gain (g) 2670 ± 33a 2280 ± 30b 2353 ± 50ab 
Gain (%) 123 ± 1a 100 ± 2b 103 ± 2b 
FCRb 1.34 ± 0.03 1.63 ± 0.05 1.37 ± 0.13 
SGRc 0.53 ± 0.0a 0.48 ± 0.01b 0.48 ± 0.01b 
Kd 1.77 ± 0.11 1.66 ± 0.12 1.72 ± 0.07 
DP (%)e 89.71 ± 0.35 89.46 ± 0.29 89.26 ± 0.95 
FY (%)f 60.05 ± 0.67 59.02 ± 0.7 60.68 ± 0.98 
HSI (%)g 1.05 ± 0.08 1.03 ± 0.04 0.96 ± 0.02 
VSI (%)h 10.00 ± 0.38 10.21 ± 0.26 9.68 ± 0.35 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's post-
hoc test of multiple comparisons. 
a See Table 5.14 for experimental diet abbreviations. 
b FCR = food conversion ratio. 
c SGR = specific growth rate. 
d K = condition factor 
e DP (%) = dress-out percentage. 
f FY (%) = fillet yield percentage. 
g HSI (%) = hepatosomatic index. 








Nutrient and fatty acids digestibility (apparent digestibility 
coefficient - ADC %) of the three experimental diets for Atlantic 
salmon. 
 Diets   
  FO20 CAM20 CAM40 
Nutrientsb       
DMb 61.4 ± 4.0 67.2 ± 1.1 67.0 ± 1.5 
Protein 74.1 ± 3.7 80.2 ± 0.7 78.2 ± 2.1 
Lipid 78.5 ± 4.0 81.0 ± 1.0 84.8 ± 1.4 
NFEb 75.8 ± 1.8a 71.0 ± 1.4a 63.6 ± 1.7b 
Energyc 71.4 ± 4.1 75.9 ± 1.1 76.3 ± 1.6 
        
Fatty acidsd       
Total FA (mg g-1 diet) 76.9 ± 4.5 80.4 ± 1.1 83.3 ± 1.7 
12:0 84.2 ± 3.4 85.3 ± 0.3 86.0 ± 1.4 
14:0 73.3 ± 4.0 71.9 ± 1.1 72.8 ± 1.4 
16:0 68.4 ± 4.1 69.2 ± 1.6 69.0 ± 1.1 
18:0 56.9 ± 4.3 57.7 ± 3.1 53.3 ± 1.1 
16:1n-7 88.7 ± 4.2 94.6 ± 0.3 94.2 ± 1.8 
18:1n-9 84.0 ± 5.1 91.1 ± 0.4 91.6 ± 2.3 
18:1n-7 82.9 ± 5.2 89.6 ± 0.4 90.0 ± 2.3 
20:1n-9 82.4 ± 5.6 93.3 ± 0.8 92.7 ± 2.4 
18:2n-6 85.5 ± 5.3 94.7 ± 0.5 94.5 ± 2.2 
20:2n-6 85.9 ± 3.9 93.0 ± 0.6 93.0 ± 2.3 
20:4n-6 86.6 ± 5.4 93.9 ± 0.6 90.6 ± 1.5 
18:3n-3 88.1 ± 4.6 96.6 ± 0.6 95.9 ± 2.0 
20:5n-3 90.5 ± 4.4 96.5 ± 0.3 95.2 ± 1.3 
22:5n-3 86.5 ± 5.6 93.5 ± 0.7 89.9 ± 2.2 
22:6n-3 87.8 ± 5.1 93.6 ± 0.7 92.3 ± 1.4 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-
way ANOVA with Tukey's post-hoc test of multiple comparisons, 
different letters denote statistically significant difference.  
a See Table 5.14 for experimental diet abbreviations. 
b Nutrients: DM, dry matter; NFE, nitrogen-free extract. 
c Calculated on the basis of 23.6, 39.5 and 17.2 kJ g-1 of protein, fat 
and carbohydrate, respectively. 
d Total FA = total fatty acids 






Proximate (mg g-1 of tissue) and fatty acid composition (µmol g-1 tissue) of fillets of 
Atlantic salmon fed the three experimental diets for 150 days. 
  Dietsa     
  FO20 CAM20 CAM40 
Proximate composition (mg g-1 of tissue)       
Moisture 661.2 ± 5.9 657.9 ± 5.8 649.7 ± 8 
Protein  212.8 ± 5.2 219.3 ± 2.1 219.4 ± 3.5 
Lipid  122.9 ± 4.2 110.2 ± 7.4 121.6 ± 6.8 
Ash 9.5 ± 0.4 9.5 ± 0.3 10.1 ± 0.4 
        
Fatty acids (µmol g-1 of tissue)       
Total FAb 351.6 ± 6.6 313.8 ± 17.9 341.9 ± 9.5 
SFAc 108.3 ± 3a 87.8 ± 5.3b 87.5 ± 2.1b 
14:0 11.3 ± 0.2a 7.5 ± 0.5b 7.5 ± 0.3b 
16:0 69.6 ± 1.9a 57.9 ± 3.4b 58.2 ± 1.4b 
18:0 22.7 ± 0.8a 19.0 ± 1.2ab 18.0 ± 0.4b 
Other SFAd 4.6 ± 0.2a 3.4 ± 0.2b 3.8 ± 0.2ab 
MUFA 185.6 ± 3 164.1 ± 10.2 175.7 ± 5.2 
16:1n-7 17.6 ± 0.4a 14.3 ± 0.9b 14.5 ± 0.7b 
18:1n-9 141.9 ± 2.1 129.3 ± 7.9 133.1 ± 3.6 
18:1n-7 10.5 ± 0.2a 8.4 ± 0.5b 8.7 ± 0.4b 
20:1n-9 8.8 ± 0.1ab 6.7 ± 0.5a 10.7 ± 0.7b 
Other MUFAe 6.8 ± 0.2ab 5.4 ± 0.3a 8.8 ± 1b 
Total trans FA 2.5 ± 0.1a 1.6 ± 0.2b 1.5 ± 0b 
PUFA 54.9 ± 0.5a 60.0 ± 2.2a 77.1 ± 2.4b 
18:2n-6 21.1 ± 0.2a 30.2 ± 1.3b 37.3 ± 1.2c 
20:2n-6 1.9 ± 0a 2.2 ± 0.2a 2.9 ± 0.1b 
20:4n-6 1.4 ± 0.1 1.4 ± 0 1.2 ± 0.1 
Other n-6 PUFAf 2.3 ± 0.1a 3.8 ± 0.2b 4.0 ± 0.3b 
n-6 PUFA 26.7 ± 0.3a 37.6 ± 1.6b 45.4 ± 1.4b 
n-6 LC PUFA 5.2 ± 0.1a 6.2 ± 0.3b 6.7 ± 0.2b 
18:3n-3 3.8 ± 0a 6.7 ± 0.4a 14.0 ± 1.3b 
20:5n-3 4.9 ± 0.1a 3.7 ± 0.1b 4.2 ± 0.4ab 
22:5n-3 2.2 ± 0.1a 1.5 ± 0.1b 1.7 ± 0.1b 
22:6n-3 12.6 ± 0.2a 7.9 ± 0.1b 8.3 ± 0.4b 
Other n-3 PUFAg 3.6 ± 0.1a 1.8 ± 0.1b 2.6 ± 0.1c 
n-3 PUFA 27.1 ± 0.3a 21.5 ± 0.5b 30.7 ± 1.5a 
n-3 LC PUFA 22.3 ± 0.3a 14.3 ± 0.1b 16.2 ± 0.6c 
LC PUFA 27.5 ± 0.4a 20.5 ± 0.4b 23.0 ± 0.8c 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's 
post-hoc test of multiple comparisons. 
a See Table 5.14 for experimental diet abbreviations.   
b Total FA = total fatty acids µmol g-1 of tissue. 
c See Table 5.14 for fatty acid classes and abbreviations. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 21:0, 22:0 & 24:0. 
e Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-11, 22:1n-11 & 24:1n-9. 
f Other n-6 PUFA = sum of 18:3n-6, 20:3n-6, 22:2n-6, 22:4n-6, 22:5n-6. 
g Other n-3 PUFA = sum of 18:4n-3, 20:4n-3, 22:3n-3, 24:5n3 & 24:6n-3. 
133  
TABLE 5.18 
Fillet fatty acid composition (as mg 100 g-1 of edible product and % of total fatty acids in 
brackets and italics) of Atlantic salmon fillet fed the three experimental diets for 150 days. 
  Dietsa     
mg 100 g-1 of fillet FO20 CAM20 CAM40 
20:5n-3 147.9 ± 3.8a (1.5) 110.6 ± 3.8b (1.2) 127.3 ± 11.0ab (1.4) 
22:5n-3 72.9 ± 2.6a (0.8) 48.4 ± 2.4b (0.6) 55.2 ± 2.7b (0.6) 
22:6n-3 414.8 ± 7.7a (4.2) 259.9 ± 3.7b (3.0) 272.0 ± 14.4b (2.9) 
SFAb 2814.6 ± 79.5a (28.8) 2291.3 ± 138.5b (26.3) 2282.4 ± 53.9b (23.9) 
MUFA 5227.8 ± 83.0 (53.5) 4627.7 ± 286.7 (53.0) 4977.6 ± 146.5 (52.1) 
PUFA 1644.7 ± 16.1a (16.9) 1756.6 ± 62.5a (20.2) 2242.1 ± 68.5b (23.5) 
LC-PUFA 879.7 ± 12.8a (9.0) 652.8 ± 11.7b (7.5) 729.0 ± 24.0c (7.6) 
trans 71.8 ± 2.1a (0.7) 45.6 ± 5.6b (0.5) 40.9 ± 0.6b (0.4) 
n-6 PUFA 743.0 ± 8.7a (7.6) 1056.3 ± 46.5b (12.1) 1276.6 ± 38.7c (13.4) 
n-6 LC PUFA 161.4 ± 2.6a (1.7) 194.2 ± 8.0b (2.2) 209.4 ± 7.4b (2.2) 
n-3 PUFA 850.4 ± 9.6a (8.7) 660.6 ± 15.0b (7.6) 924.0 ± 41.3a (9.7) 
n-3 LC PUFA 718.3 ± 10.8a (7.4) 458.6 ± 3.9b (5.3) 519.6 ± 18.2c (5.4) 
n-6:n-3 ratio 0.9 ± 0.0a 1.6 ± 0.0b 1.4 ± 0.1c 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's 
post-hoc test of multiple comparisons. 
a See 5.14 for experimental diet abbreviations. 







The apparent in vivo fatty acid β-oxidation (nmol g-1 day-1 and % of total intake in brackets and 
italics) in Atlantic salmon fed the three experimental diets for 150 days. 
  dietsa     
  FO20 CAM20 CAM40 
12:0 5.2 ± 0.2a (64.5)  6.2 ± 0.2a (74.7)  3.7 ± 0.5b (69.5)  
14:0 104.5 ± 5.7a (40.3)  92 ± 2.3a (46.7)  55.6 ± 9.7b (39.3)  
16:0 661.3 ± 29.8a (37.2)  751.6 ± 14.5a (41.9)  380.3 ± 76.1b (30.6)  
18:0 289.3 ± 9.6a (35.2)  357.4 ± 4a (39.1)  133.4 ± 27.7b (21.4)  
22:0 8.7 ± 0.3a (25.6)  16.8 ± 0.2b (87.0)  22.9 ± 1.5c (90.5)  
SFAb,c 1068.9 ± 45.3a 1224 ± 20.3a 596.0 ± 115.3b 
14:1n-5 31.6 ± 1.5ab (58.7)  39.9 ± 1.1a (78.2)  23.3 ± 3.2b (64.4)  
16:1n-7 135.7 ± 8.7a (43.3)  158 ± 4.2a (52.9)  50.1 ± 17.3b (27.8)  
18:1n-7 31.4 ± 4.1ab (22.9)  57.7 ± 3.6a (45.1)  28.5 ± 9.3b (29.8)  
18:1n-9 765.8 ± 60.1a (33.5)  1334.8 ± 39.6b (52.3)  744.6 ± 181.1a (38.4)  
20:1n-9 6.9 ± 2.6a (6.2)  91.1 ± 1.6b (56.4)  98.1 ± 20.9b (41.3)  
22:1n-9 11.8 ± 0.9ab (40.7)  1.3 ± 0.7a (8.4)  19.1 ± 4.5b (35.7)  
24:1n-9 7.3 ± 0.3a (57.8)  1.7 ± 0.4b (37.3)  4.5 ± 0.8c (45.6)  
20:1n-11 16.5 ± 0.9 (56.7)  ─d ─ 
22:1n-11 51.7 ± 0.7a (100)  13.1 ± 0b (100)  14.2 ± 0.5b (100)  
MUFA 1058.6 ± 79.7ab 1697.5 ± 48.8a 982.3 ± 237.0b 
18:2n-6 100 ± 10.9 (39.6)  201.6 ± 18 (45.4)  219.7 ± 56.3 (38.9)  
20:2n-6 0.4 ± 0.3a (3.3)  11.8 ± 0.6b (44.3)  6.0 ± 3.2ab (18.4)  
22:2n-6 4.7 ± 0.2a (76.9)  8.1 ± 0.6b (83.1)  3.9 ± 0.8a (60.8)  
18:3n-6 0.4 ± 0.1 (16.3)  ─ ─ 
20:3n-6 11.1 ± 0.7a (77.2)  1.5 ± 0.3b (10.2)  4.4 ± 1.2b (24.6)  
20:4n-6 9.3 ± 0.6a (52.8)  2.9 ± 1.3b (22.7)  0.2 ± 0.1b (3.2)  
22:4n-6 1.1 ± 0.1a (41.3)  0.7 ± 0.1b (44.0)  ─ 
22:5n-6 8.5 ± 0.3a (73.4)  4.9 ± 0.1b (94.7)  3.0 ± 0.3c (97.3)  
n-6 PUFA 135.5 ± 12.9 231.5 ± 19.3 237.3 ± 61.7 
18:3n-3 1.2 ± 1.2a (2.1)  253.9 ± 4.8b (80.5)  348.4 ± 56.1b (63.2)  
22:3n-3 11.8 ± 0.2a (100)  5.9 ± 0b (100)  6.8 ± 0.5b (94.3)  
20:5n-3 64.5 ± 3.2a (66.4)  18.6 ± 3.1b (60.4)  1.4 ± 1.4c (5.6)  
22:5n-3 6.8 ± 0.1a (30.5)  3.3 ± 0.6b (46.2)  ─ 
24:5n-3 ─ 0.6 ± 0.3 (100)  0.3 ± 0.3 (100)  
24:6n-3 ─ ─ 0.1 ± 0.1 (100)  
22:6n-3 33.8 ± 3.9a (25.5)  8.9 ± 4.2b (23.1)  3.7 ± 3.5b (10.5)  
n-3 PUFA 118.1 ± 6.9a 291.3 ± 8.3a 360.7 ± 60.5b 
Total FA 2381.1 ± 144.1 3444.3 ± 96.1 2176.2 ± 473.6 
Data are expressed as mean ± S.E.M., winter phase; n = 3, N = 9. P < 0.05; one-way ANOVA with 
Tukey's post-hoc test of multiple comparisons, different letters denote statistically significant 
difference.  
a See Table 5.14 for experimental diet abbreviations. 
b See Table 5.14 for fatty acid classes and abbreviations. 
c Fatty acids not recording any β-oxidation are not reported in this table. 




The apparent in vivo fatty acid bioconversion (elongation, desaturation or chain shortening) 
(nmol g-1 day-1 and % of total intake either elongated or desaturated in brackets and italics) in 
Atlantic salmon fed the three experimental diets for 150 days. 
  dietsa     
  FO20 CAM20 CAM40 
Fatty acid elongationb       
18:0 to 20:0 1.6 ± 0.0a (0.2)  34.2 ± 2.2a (0.6)  44.0 ± 3.2b (7.3)  
22:0 to 24:0 4.0 ± 0.2a (57.5)  ─ ─ 
18:2n-6 to 20:2n-6 0.4 ± 0.4 (0.2)  ─ 0.1 ± 0.1 (2.4)  
20:4n-6 to 22:4n-6 ─c 0.1 ± 0.0 (0.0)  0.1 ± 0.1 (1.6)  
18:3n-3 to 20:3n-3 2.0 ± 0.2a (60.8)  4.1 ± 0.5ab (3.4)  5.7 ± 1.2b (3.5)  
18:4n-3 to 20:4n-3 18.6 ± 0.2a (100)  2.8 ± 0.2b (100)  5.2 ± 2.2b (100)  
20:5n-3 to 22:5n-3 ─ 0.9 ± 0.0 (0.0)  3.7 ± 2.5 (19.6)  
22:5n-3 to 24:5n-3 1.3 ± 0.4 (5.7)  0.1 ± 0.1 (1.7)  2.4 ± 2.4 (30.1)  
Fatty acid ∆-5 desaturation       
20:4n-3 to 20:5n-3 ─ 1.3 ± 0 (100)  3.6 ± 2.0 (100)  
Fatty acid ∆-6 desaturation       
18:2n-6 to 18:3n-6 ─ 12.7 ± 1.2 13.2 ± 1.5 
18:3n-3 to 18:4n-3 31.1 ± 0.7a 9.6 ± 0.3b 12.3 ± 2.4b 
24:5n-3 to 24:6n-3 1.1 ± 0.2 (75.7)  0.1 ± 0 (100)  2.2 ± 2.1 (100)  
Fatty acid ∆-9 desaturation       
20:0 to 20:1n-11 ─ 28.9 ± 1.9a (100)  37.1 ± 3.0b (100)  
Fatty acid chain shortening       
24:6n-3 to 22:6n-3 ─ ─ 2.0 ± 2.0 (100)  
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with Tukey's 
post-hoc test of multiple comparisons, different letters denote statistically significant 
difference. 
a See Table 5.14 for experimental diet abbreviations. 
b Fatty acids not recording any bioconversion (elongation or desaturation) are not reported in 
this table. 




Consumer acceptance of salmon products (raw salmon, cold smoked and hot smoked 
fillet) and influential attributes analysis (fishiness, saltiness and oiliness) from the three 
dietary treatments. 
  Dietsa     
  FO20 CAM20 CAM40 
Preference; Like ( + ) or Dislike ( - )b     
Raw 6.21 ± 0.4 1.77 ± 1.94 2.68 ± 0.19 
Cold smoked 13.16 ± 1.87 11.71 ± 3.19 17.52 ± 4.68 
Hot smoked 19.15 ± 4.02 19.61 ± 1.55 18.95 ± 2.66 
Influential attributesc       
Fishinessc       
Raw 0.5 ± 0.97 1.13 ± 0.74 -1.21 ± 3.48 
Cold smoked 3.82 ± 0.85 3.94 ± 1.06 2.52 ± 0.69 
Hot smoked 0.15 ± 2.33 -1.69 ± 0.39 -0.48 ± 2.76 
Saltinessc       
Raw -21.32 ± 0.39 -20.12 ± 1.54 -20.08 ± 3.06 
Cold smoked 6.31 ± 0.95a 11.04 ± 0.8b 7.17 ± 0.36ab 
Hot smoked 5.66 ± 0.53 6.84 ± 0.55 6.39 ± 3.45 
Oilinessc       
Raw -2.63 ± 2.18 -4.02 ± 0.71 -4.2 ± 0.62 
Cold smoked 6.02 ± 0.69 3.03 ± 4.23 5.27 ± 2.3 
Hot smoked -2.74 ± 0.47 -3.75 ± 1.4 -4.27 ± 1.89 
Data are expressed as mean ± S.E.M., n = 3, N = 9. P < 0.05; one-way ANOVA with 
Tukey's post-hoc test of multiple comparisons. 
a See Table 5.14 for experimental diet abbreviations. 
b Salmon acceptance was assessed using hedonic LMS scales. 
c Attributes analysis using Just Right scale.  Negative values indicate the sample has too 
little of the attribute, a positive value indicates too much of the attribute. A zero value 
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6. The impact of dietary protein: lipid ratio on growth 
performance, fatty acid metabolism, product quality and 




A common strategy for aquafeed manufacturers has been the utilisation of relatively large 
amounts of terrestrial oil sources to produce diets with a high energy content. The provision 
of high fat diets promotes the utilisation of energy from lipid, thus increasing the amount of 
dietary protein used for tissue synthesis. However, in recent years the cost of dietary lipid has 
risen, at the same time, farming operations are under increasing pressure to limit 
environmental degradation associated with nitrogenous waste effluent. Despite the clear 
environmental and economic importance of this topic, published information quantifying the 
effect of an altered dietary protein: lipid ratio in grow-out diets for Atlantic salmon (Salmo 
salar) on fish nutritional quality, fatty acid metabolism and protein utilisation, remains sparse, 
especially in relation to the farming conditions of the southern hemisphere. Furthermore, the 
extent of possible omega-3 long-chain polyunsaturated fatty acids (n-3 LC PUFA) sparing 
remains unclear. Thus, the adoption of modified dietary formulations which limit the negative 
environmental impact of Atlantic salmon aquaculture may be impeded by a lack of available 
research data. This is compounded by the lack of data with specific regard to large, seawater 
reared Atlantic salmon, whose physiological requirements, including protein and lipid 
utilisation change with life history stage (Handeland et al. 2003; Rosenlund et al. 2016). Therefore, 
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this research Chapter aimed to compare two commercial-like, iso-energetic diets, both 
containing the same raw materials and dietary oil blend (80% poultry by-product oil [PbO] 
and 20% fish oil [FO]), but with varied protein: lipid ratios; one containing 40% protein and 
33% lipid (40:33) and the other containing 36% protein and 36% lipid (36:36). These diets 
were tested on-farm, in a real-word/commercial environment over a five month grow-out 
period, involving an assessment of industry relevant production performance indicators, such 
as: nutrient digestibility, fillet fatty acid composition and utilisation, taste evaluation of fillets 
and an evaluation of undigested protein output. Furthermore, the potential disparity 
between feed related production costs between the two diets was assessed through a 
preliminary bio-economic analysis. 
   
6.2. Materials and methods 
 
6.2.1. Location, animals, experimental design and sampling. 
The present trial was conducted from May 24 to October 20, 2015 (150 days) on a commercial 
Atlantic salmon (Salmo salar)  farm in Hideaway bay, Dover, Tasmania (Huon Tasmania, 
Hideaway bay site; 43°15′  52.2″S 147°04′37.7″E). Immediately preceding the 
allocation of fish for the trial, an initial sample of 6 fish was randomly selected from the trial 
cohort, euthanized in excess anaesthetic (AQUI-S, 0.5 ml L-1) and stored at −20°C until 
subsequent analysis. One-thousand six hundred and twenty Atlantic salmon (average initial 
weight ~2250 g) were distributed among six floating sea pens (5m x 5m x 5m, 270 fish per 
pen), with each feed being fed to triplicate sea pens of fish (n = 2, N = 6). Feeding of the two 
experimental diets to the fish was achieved by using a Sterner feeder fitted with a 40 L hopper 
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and spinning feed spreading mechanism that dispersed feed over ~80% of the cage surface. 
Fish were fed twice per day to satiation by an automated AQ1 feed system (AQ1 Systems Pty. 
Ltd. Tasmania, Australia), with the first feeding programmed for 15 minutes before sunrise 
and the second feeding 15 minutes after sunset. A 0.5 m diameter, 0.5 m deep cone was 
positioned at a depth of 4 m to channel uneaten feed past an infrared sensor which detected 
uneaten pellets and automatically turned the feeder off. All feeding sessions were overseen 
by an observer to ensure uneaten feed was kept to a minimum and the operation of all 
automated systems were correct and consistent. Feed consumption, fish mortalities and 
physico-chemical parameters were monitored throughout the trial and remained within 
acceptable limits, including water temperature (mean ± SD: 11.21 ± 0.86oC) and dissolved 
oxygen (mean ± SD: 7.85 ± 0.43 mg L-1). In the final week of feeding, 10 fish per pen were 
selected and hand stripped for faecal collection before being returned to the trial pens. Faecal 
samples were used for an estimation of feed digestibility. At the completion of the feeding 
trial, all fish were anaesthetised and weighed and 21 fish from each treatment (seven fish per 
pen) were randomly selected and separated into 3 groups: the first group (nine fish) were 
used for the chemical analysis of whole body, the second group (six fish) were used for the 
chemical analysis of fillet and the third group (six fish) were used for sensory analysis by 
means of a panel taste test, as described below. These separated fish were immediately 
placed in an ice slurry before freezing fish destined for chemical analysis to −20°C. Fish 
allocated to panel taste testing were taken from the slurry to be processed by Huon 
Aquaculture Company, Tasmania (as described below).  
 
6.2.2. Experimental Feeds 
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The experimental feed were manufactured by a commercial feed producer (Ridley Aquafeed, 
Australia). The detailed composition of the feeds is not presented herein as it is commercial-
in-confidence. The dietary lipid for both feeds consisted of poultry by-product oil and fish oil 
and the dietary protein consisted of majority poultry by-product meal. Two separate batches 
of 9 mm pellets differing in their protein: lipid ratio were extruded and vacuum coated with 
lipid, using identical raw materials varying only in their respective inclusion levels of protein 
and lipid. The dietary lipid source used was identical for the two diets, consisting of a blend 
of 20% fish oil and 80% poultry by-product oil. The 40:33 treatment was formulated with 40% 
protein and 33% lipid, while the 36:36 treatment was formulated with 36% protein and 36% 
lipid. Both diets were formulated to be iso-energetic.  
 
6.2.7. Protein utilisation, assimilation and nitrogenous waste output 
The amount of feed and protein required to produce one tonne of fish, as well as the amount 
of undigested nitrogenous waste subsequently produced was calculated for the two dietary 
treatments. Calculations were based on parameters already described, including; FCR, dietary 
protein content and ADC % of protein in the diet. Additionally, undigested protein was 
converted to undigested nitrogen utilising a conversion factor of 6.25 (AOAC 2000). Hence, it 
was possible to calculate the amount of: i) feed required ii) protein required, iii) digested 
protein and iv) undigested nitrogen for each of the two dietary treatments (in terms of kg 
tonne-1 of fish produced). It should be noted that although ammonia excretion through the 
gills is a major source of nitrogenous waste from fish (Cho & Bureau 1997; Lazzari & 
Baldisserotto 2008), the present study makes no attempt to quantify the total amount of 
nitrogenous waste produced by the fish, including nitrogen excretion via the gills or any 
additional nitrogen loss from the surface of the fish (eg scale loss). 
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Nitrogen assimilation, in terms of % assimilation, g fish-1 and kg tonne-1 of fish was calculated 
using a mass balance approach, whereby, initial and final weights of fish, feed intake, nitrogen 
content of diets and initial and final nitrogen content of whole fish were used to calculate the 
percentage of nitrogen assimilated into fish fed the dietary treatments. From this it was 
possible to calculate the amount of nitrogen assimilated in terms of both g fish-1 and kg tonne-
1 of fish. 
 
2.8. Statistical analysis 
All data were reported as mean ± standard error; (n = 2, N = 6). After confirmation of normality 
and homogeneity of variance, data was subjected to an independent samples T-test. 
Significance was accepted at P < 0.05, and P-values were reported utilising the following 
denotation; * P < 0.05, ** P < 0.01 and *** P < 0.001. All statistical analyses were performed 




6.3.1. Feed composition 
The feeds were formulated to be iso-energetic and proximate analysis confirmed this (~25.5 
KJ g-1) (Table 6.22). In-line with the feed formulations the protein concentration differed 
between the two feeds (403.9 and 357.0 mg g-1 diet in 40:33 and 36:36, respectively). The 
lipid concentration of the feeds also represented the feed formulations (330.5 and 367.7 mg 
g-1 diet in 40:33 and 36:36, respectively). Accordingly, the protein: lipid ratio of the two 
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experimental feeds were 1.2 and 1.0 in 40:33 and 36:36, respectively. A small disparity in 
moisture content between the two diets was also recorded. Major fatty acid classes including; 
saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), polyunsaturated fatty acids 
(PUFA), omega-3 polyunsaturated fatty acids (n-3 PUFA) and omega-6 polyunsaturated fatty 
acids (n-6 PUFA) were comparable between diets, however total MUFA and PUFA 
concentrations were numerically higher in the 36:36 diet. n-3 LC PUFA levels (mg g-1 diet) 
were comparable (10.9 and 11.1 mg g-1 diet for 40:33 and 36:36, respectively). Additionally, 
the n-6: n-3 ratio was 2:1 in both diets owing to high dietary 18:2n-6 relative to 18:3n-3. 
 
6.3.2. Fish growth and feed utilisation efficiency 
Each diet was readily accepted by fish and mortality rates were within acceptable limits and 
unrelated to treatment. Fish in both treatments more than doubled in size, gaining over 2800g 
(Table 6.23). Overall, fish growth and feed utilisation efficiency was similar and there were no 
statistically significant differences between treatments. However, FCR was numerically lower 
in 40:33 compared to 36:36 (1.26 and 1.38, respectively), although differences were not 
significant. Additionally, net protein utilisation (NPU %) was numerically higher in 36:36 
compared to 40:33 (32.42 and 37.12 %, respectively), again, differences were not significant 
between the two feeds (P > 0.113). 
 
6.3.3. Apparent nutrient digestibility 
Apparent nutrient digestibility values (ADC %) were high across treatments (Table 6.23), and 
although not significantly different (P > 0.05), protein digestibility differed slightly (75.5 and 
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80.1% in 40:33 and 36:36, respectively).  Individual fatty acid apparent digestibility results 
were similar between treatments and there were no statistically significant differences (P > 
0.05), however, there was a general trend of decreased digestibility of SFA compared to 
unsaturated fatty acids. 
 
6.3.4. Fillet proximate and fatty acid composition 
Fillet proximate composition (g 100g-1 fillet) (Table 6.26) was similar between treatments with 
no significant differences were recorded (P > 0.05). Fillet fatty acid composition, both in terms 
of µmol g-1 tissue (Table 6.25) and g 100g-1 of edible fillet (Table 6.26) reflected the make-up 
of dietary lipid profile (P > 0.05), including, n-3 LC PUFA levels, were identical between 
treatments (21.2 µmol g-1 fillet tissue). Fillet n-6: n-3 ratios (in terms of g 100g-1 of edible fillet) 
were lower than the dietary ratios (1.7 and 1.8 in 40:33 and 36:36, respectively). 
 
6.3.6. Apparent in vivo fatty acid metabolism 
Total apparent in vivo fatty acid β-oxidation (Table 6.27) were similar between treatments (P 
> 0.05). There were few differences between fish fed the two feeds in terms of individual fatty 
acid β-oxidation and both groups of fish heavily utilised 18:1n-9 for catabolism. β-oxidation 
of 22:6n-3 was recorded in both treatment groups of fish however, differences were not 
significant (P > 0.05) (35.9 and 29.0 % of intake β-oxidised in 40:33 and 36:36, respectively). 
Apparent in vivo enzymatic activity, desaturation, elongation or chain shortening, (Table 6.28) 
was low and similar between fish fed the two feeds, with the exception of the ∆-6 
desaturation of 18:3n-3, which was higher in 36:36 compared to 40:33 (20.0 and 9.6 nmol g-1 
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day-1, respectively) (P < 0.05). Despite some recorded ∆-6 desaturation of 24:5n-3, no de novo 
production of 22:6n-3 was recorded in fish fed either of the two experimental feeds. 
 
6.3.6. Consumer preferences 
There were no differences in liking score between the dietary treatments across all three 
preparation methods; cold-smoked, hot-smoked and raw (Table 6.29) (P > 0.05). However, 
the 36:36 treatment scored slightly higher than 40:33 for the cold smoked fillet (18.7 ± 0.5 
and 14.6 ± 2.2, respectively), conversely, the 40:33 treatment scored slightly higher for the 
hot smoked fillet than 36:36 (22.6 ± 1.3 and 18.5 ± 5.4, respectively). No differences were 
recorded between treatments for any influential attributes (fishiness, saltiness and oiliness) 
(P > 0.05). Moreover, both fishiness and oiliness recorded scores close to zero on the ‘Just 
About Right’ scale. For both dietary treatments, the raw fish lacked saltiness as indicated by 
scores of -20.3 ± 3.7 and -18.3 ± 1.3 for 40:33 and 36:36, respectively.  
 
6.3.8. Feed, protein usage and nitrogenous waste output from feed 
The amount of feed required to produce one tonne of fish differed slightly between 
treatments, although not significantly (P > 0.05) (Figure 6.13a). The amount of protein 
required to produce one tonne of fish was similar between treatments (~500 kg tonne-1 fish) 
(Figure 6.12b). Additionally, there was no difference in the amount of digested protein 
between treatments (P > 0.05) (Figure 6.12c). Nitrogenous waste from undigested protein 
was significantly different between treatments (20.0 and 15.8 kg tonne-1 fish) for the 40:33 
and 36:36 diets, respectively (P = 0.009). Nitrogen assimilation (Figure 6.13) was higher in the 
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36:36 treatment (in terms of % assimilated, g fish-1 and kg tonne-1 fish), however, results were 
not significantly different (P > 0.05).  
 
6.3.7. Bioeconomic assessment of fish production 
Results of estimated feed-related production costs for a) feed, b) whole fish and c) fillet are 
presented in Figure 6.11 and expressed as i) $US tonne-1 and ii) % difference in cost between 
treatments. Costs of feed production for the two experimental treatment diets were similar 
and differed by < 1 cent kg-1 (Figure 6.11ai). However, cost of fish production showed 40:33 to 
be more cost effective than 36:36 (2.05 and 2.23 $US kg-1 of fish, respectively) (Figure 6.11bi). 
Consequently, 40:33 remained the more cost effective diet in terms of $US kg-1 of fillet (Figure 
6.11ci). When expressed as % difference in cost, feed formulation costs differed by < 1 %, 
whilst the cost of fish and fillet production was 8.9 and 8.6 % cheaper in 40:33, respectively 




This research Chapter has clearly demonstrated that a variation in the dietary protein: lipid 
ratio, at the range examined in this study, has no significant effect on growth performance, 
fatty acid metabolism or final product quality. However, a reduction in the dietary protein: 
lipid ratio reduced the amount of undigested protein resulting in a reduction in nitrogenous 
waste. However, the bio-economical analysis revealed that due to small, yet important, 
differences in growth parameters, an increased cost of fish production was incurred. 
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Previous research has led to the widespread implementation of nutritional strategies aiming 
to spare protein for growth (Karalazos et al. 2011a; Weihe et al. 2018), minimise nitrogenous 
waste (Bendiksen et al. 2011; Bureau 2004) and efficiently incorporate health promoting fatty 
acids into the fillet tissue (Francis & Turchini 2017). Previous research suggests an increased 
dietary protein: lipid ratio may affect the n-3 LC PUFA sparing capacity and the growth 
performance of Atlantic salmon (Francis & Turchini 2017; Weihe et al. 2018). On the other 
hand, reductions in nitrogenous waste outputs are achievable through a decreased dietary 
protein: lipid ratio. However, to date there remains a paucity of published information 
specifically relating to market sized Atlantic salmon reared in seawater. The results discussed 
herein aim to provide added commercial relevance to existing available information.    
 
The present feeding trial lasted 150 days and fish grew in-line with commercial expectations, 
where they more than doubled in size to a final weight in excess of 5000 g. Despite a numerical 
disparity in FCR between the two treatments, no statistical differences in growth or 
biometrical parameters were observed. Considering the deposition of protein is responsible 
for the majority of weight gain in fish (Sveier et al. 2000), the numerically higher net protein 
utilisation % in the 36:36 treatment may have compensated for the slight reduction in food 
conversion efficiency. Although not pronounced in the present study, previous research has 
supported an increase in protein utilisation efficiency in Atlantic salmon fed diets with a 
reduced protein: lipid ratio (Einen & Roem 1997; Francis & Turchini 2017; Hardy & Gatlin 
2002; Karalazos et al. 2011a). Ultimately, these findings support previous work that suggest 
growth is not negatively affected when the protein: lipid ratio is reduced in diets for Atlantic 
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salmon (Azevedo et al. 2004; Bendiksen et al. 2003a; Einen & Roem 1997; Karalazos et al. 
2011b; Solberg 2004).  
 
A reduction in the dietary protein: lipid ratio, concomitant with a high dietary lipid 
concentration (39%) has previously been found to increase lipid content and result in obesity 
in large Atlantic salmon (Refstie et al. 2001). However, in the present study, fillet proximate 
composition was highly comparable between treatments, suggesting that, under near optimal 
growing conditions (Handeland et al. 2008; Kullgren et al. 2013) an alteration in the dietary 
protein: lipid ratio within the limits tested in the present experiment has little effect on fillet 
composition. High levels of MUFA, namely 18:1n-9, were present in the fillet tissue owing to 
the high dietary inclusion of poultry by-product oil. In addition to high fillet levels, in vivo fatty 
acid β-oxidation results demonstrated that 18:1n-9 was heavily β-oxidised in both treatments, 
consistent with previous literature demonstrating the suitability of 18:1n-9 as a good source 
of metabolic energy (Bell et al. 2003a; Torstensen et al. 2000; Turchini et al. 2009). 
 
The protein sparing effect has been well described in numerous fish species and supports the 
use of high energy diets in aquafeed to conserve protein for growth, whilst utilising lipid for 
metabolic energy (Einen & Roem 1997; Hemre & Sandnes 1999; Karalazos et al. 2011b; 
Kaushik & de Oliva Teles 1985). However, market volatility and escalating scarcity of dietary 
lipids rich in n-3 LC PUFA (i.e. fish oil), has led to efforts to conserve valuable n-3 LC PUFA via 
manipulation of the dietary protein: lipid ratio. Specifically, it was hypothesised that a higher 
protein: lipid ratio could preserve n-3 LC PUFA from catabolism and resultantly increase 
retention (Francis & Turchini 2017). Consistent with previous research, the digestibility of 
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polyunsaturated fatty acids, including 20:5n-3 and 22:6n-3 was high in both treatments 
(Turchini et al. 2009). Additionally, similar and relatively low, concentrations of 22:6n-3 were 
β-oxidised and almost identical amounts were present in the edible fillet. This suggests, in 
accordance with prior research in juvenile salmon, that the alteration in dietary protein: lipid 
ratio in the present study has little effect on the deposition of nutritionally valuable n-3 LC 
PUFA, provided dietary supply is surplus to physiological requirement (Francis & Turchini 
2017). A greater alteration of the dietary protein: lipid ratio may have enhanced the potential 
of the n-3 LC PUFA sparing effect and is, therefore, a warranted pathway for future research.  
 
Sub-optimal dietary formulations elicit measurable metabolic effects, potentially resulting in 
deleterious outcomes for the health and nutritional quality of farmed fish (Sargent et al. 
1999).  An analysis of in vivo fatty acid bioconversion, as recorded by the whole-body fatty 
acid balance method, was used in the present study to elucidate metabolic responses to diets 
with altered protein: lipid ratios. Atlantic salmon have a recorded capacity for endogenous n-
3 and n-6 PUFA synthesis, furthermore, the actual extent of de novo production is heavily 
modulated by dietary fatty acid provision (Bell et al. 2001c; Giri et al. 2016; Martinez-Rubio 
et al. 2013; Tocher 2003; Turchini & Francis 2009). With respect to the present study, ∆-6 
desaturation of 18:3n-3 and 18:2n-6 was recorded in both treatments as was the endogenous 
production of 20:3n-6 and 20:4n-3. Despite a higher dietary provision of 18:2n-6 relative to 
18:3n-3, greater levels of bioconversion were recorded for n-3 PUFA in comparison to n-6 
PUFA, supporting previous research showing that ∆-6 desaturation of 18:3n-3 is not limited 
by presence of 18:2n-6 (Emery et al. 2013; Vagner & Santigosa 2011). Despite the observed 
endogenous bioconversion of n-3 and n-6 PUFA into n-3 and n-6 LC-PUFA, no endogenous 
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production of either 20:4n-6 or 20:5n-3 was recorded. It appears, therefore, that ∆-5 
desaturase activity may have been supressed by a negative feedback mechanism owing to 
the dietary provision of 22:6n-3, as previously shown in Atlantic salmon (Jordal et al. 2005; 
Tocher et al. 2003; Zheng et al. 2005). Additionally, evidence suggests that the synthesis of 
20:4n-6 is correlated with inflammatory responses at sub-optimal water temperatures 
(Norambuena et al. 2015b). Therefore, the near optimal water temperature experienced 
during the present trial (Handeland et al. 2008; Stehfest et al. 2017) was not expected to elicit 
endogenous 20:4n-6 synthesis in response to temperature stress. Ultimately, the dietary 
provision of fish oil in both treatments appears to have been sufficient to satiate physiological 
requirements under the present experimental conditions. Furthermore, the differences in in 
vivo bioconversion resulting from an alteration to the dietary protein: lipid ratio had little 
effect on the final fatty acid composition of the fillet.  
 
As well as fillet nutritional quality, taste is a major determinant of seafood consumption 
(Christenson et al. 2017). Previous research suggests taste and sensorial attributes of Atlantic 
salmon products are influenced by the dietary lipid level and fatty acid composition of 
aquafeed (Waagbø et al. 1993). The present study, therefore, investigated whether an 
alteration to the dietary protein: lipid ratio incurred any effect on overall liking or sensorial 
attributes when the fillet was prepared as three commercially available products, namely, hot 
smoked, cold smoked and raw. Dietary lipid level is a significant predictor of taste preference 
in both smoked and raw salmonid products (Einen & Skrede 1998; Johansson et al. 2000). 
Despite a higher dietary lipid level in the 36:36 treatment (albeit a marginal increase), there 
were no significant differences in either preference (like or dislike) or sensorial attributes, 
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including: fishiness, saltiness or oiliness. Hence, it appears that the overall liking and sensory 
attributes of salmon products are unaffected by an alteration of the protein: lipid ratio in diets 
for Atlantic salmon.  
 
From an economic perspective, market forces inevitably influence dietary formulations in 
aquafeed, however, analysis of costs are seldom considered in published literature (Turchini 
et al. 2013c). The present study includes a preliminary assessment of feed and fish production 
costs associated with the ingredients used in the treatment diets. As stated, this analysis 
should be considered indicative only as it omits associated costs such as transport and 
handling of raw dietary ingredients. As expected, the cost of ingredients used in the treatment 
diets were very similar and could be considered negligible for the present study. However, 
despite not being significantly different, the numerically lower FCR in the 40:33 treatment 
resulted in an appreciably lower cost of fish production. Due to similar FY % in both 
treatments, differences in cost of fillet production still reflect the aforementioned numerical, 
albeit, not statistically significant differences in FCR. The present bioeconomic analysis 
highlights the potential for considerable economic repercussions, despite no statistical 
difference in FCR between the treatments. Thorarensen (2015) describes the difficulty a large 
number of fish growth studies have in detecting a statistically significant difference in growth 
parameters due to experimental design constraints. In light of this, enhanced scrutiny of even 
small differences in growth parameters is suggested to better understand practically 
significant effect sizes which may relate to large differences in on-farm production costs for 
commonly farmed aquaculture species. Regardless of statistical interpretation, aquaculture 
operations are heavily reliant on the cost-effectiveness of aquafeed (Liu et al. 2016; Turchini 
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et al. 2013c). Therefore, results from the present study indicate that, in a commercial sense, 
alterations to dietary formulations such as a reduction in the dietary protein: lipid ratio should 
unequivocally apply cost-benefit analyses based on pre-production research. 
 
Environmental degradation, resulting from nitrogenous waste output from aquaculture 
operations, has necessitated the development of feed related mitigation measures (Bureau 
2004; Cho & Bureau 1997; Crab et al. 2007; Hardy & Gatlin 2002; Kaushik & Cowey 1991). It 
is well established, that when protein, or more specifically, amino acids are catabolised for 
metabolic energy rather than utilised for tissue synthesis, nitrogen is excreted via the gills and 
via the urine, primarily, in the form of ammonia (Crab et al. 2007; Hardy & Gatlin 2002; 
Kaushik & Cowey 1991). Decreasing the digestible protein: digestible energy ratio of the 
aquafeed allows for the utilisation of dietary lipids for the majority of metabolic energy 
requirements, and as a result, sparing protein for growth (Francis & Turchini 2017; Grisdale-
Helland et al. 2008; Karalazos et al. 2011a; Kaushik & Cowey 1991). Similarly, high protein 
digestibility is crucial in limiting excess nitrogen effluent. Nitrogen is the primary factor 
responsible for the eutrophication of temperate coastal marine environments (Howarth & 
Marino 2006), leading to, among other outcomes, toxic phytoplankton blooms, reduced 
water clarity, elevated pH and the depletion of dissolved oxygen in the water column, as 
reviewed by Smith (1999). Both protein and lipid digestibility are purported to be largely 
unaffected by variations in the dietary protein: lipid ratio and remain highly digestible, 
providing they are kept within practical limits (Bendiksen et al. 2003b; Einen & Roem 1997; 
Francis & Turchini 2017; Solberg 2004). However, in the present study a 5 % higher protein 
digestibility was recorded in the 36:36 treatment. This resulted in significant differences in 
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terms of undigested nitrogenous waste effluent. Despite a numerically lower FCR in the 40:33 
treatment, the reduction in dietary protein digestibility resulted in both treatments having 
similar total amounts of digested protein (in terms of kg tonne-1 fish produced). Thus, given 
the higher level of dietary protein in the 40:33 diet, the amount of undigested protein, was 
significantly higher (in terms of kg tonne-1 fish produced). However, it should be noted that 
the results presented in this study focus on the amount of nitrogenous waste entering the 
aquatic environment from undigested protein only. In fact, despite an increased 
understanding of factors affecting ammonia excretion from fish in recent years (Bucking 2017) 
a precise, reliable method to quantify nitrogenous waste as a result of catabolised protein is 
not available (Bureau 2004; Houlihan et al. 1993). In consideration of this, a parallel approach 
was implemented to assess the differences in nitrogen assimilation between treatments 
through simple mass balance calculations. Although not significantly different, results were 
complimentary to the analysis of undigested protein, in that, the 36:36 treatment recorded 
higher nitrogen assimilation compared to the 40:33 treatment. To the best of the authors’ 
knowledge, published literature examining the effect of varying the protein: lipid ratio of iso-
energetic diets fed to seawater reared Atlantic salmon on the digestibility of protein and 
subsequent nitrogenous waste, has been confined to juvenile fish (Dessen et al. 2017). Given 
the reduced digestible protein: digestible energy ratio in the 36:36 diet, the aforementioned 
results were expected. Importantly, however, there was minimal effect on fatty acid 
utilisation between the treatments, as evidenced by comparable: i) fillet fatty acid 
composition, ii) fatty acid β-oxidation iii) taste quality of the final fillet product and, iv) growth 




Concurrent with the increased scrutiny on aquaculture operations to limit their potential to 
environmental degradation, the current research Chapter has focussed on the increasingly 
relevant aspect of protein utilisation and nitrogenous waste in aquaculture. Maintaining a 
strong emphasis on farm-reared fish to enhance commercial relevance it was demonstrated 
that a reduction in the protein: lipid ratio in aquafeed formulations for market-sized Atlantic 
salmon had only minimal effects on lipid and fatty acid utilisation and ultimately incurred no 
reduction in product nutritional quality, including fillet levels of n-3 LC PUFA. Furthermore, 
taste quality was not compromised. Of clear importance it was demonstrated that a 
significant reduction in undigested nitrogenous waste was can be achieved when the dietary 
protein: lipid ratio is decreased. However, despite overall performance remaining largely 
unaffected, a marginally higher FCR was reflected in the bioeconomic analysis by an increased 
cost of fish and fillet production. Therefore, these findings showed that there is a conflict 




6.5 Figures and Tables 
 
Figure 6.11; Preliminary assessment of feed related production costs associated with the 
ingredients used to formulate two commercial-like diets for large Atlantic salmon, one 
containing 40 % protein and 33 % lipid (40:33) and the other containing 35 % protein and 36 
% lipid (36:36), including ai) Cost of feed ingredients in $US kg-1 of diet, bi) cost of fish 
production in $US kg-1 of fish based on feed ingredients and food conversion ratio for the 
respective diets, ci) cost of fillet production in $US kg-1 of fillet based on cost of diet 
ingredients, food conversion ratio and fillet yield for the respective diets. aii), bii) and cii) 
represent percentage differences between the two treatments for the cost of feed 
ingredients, fish production and fillet production, respectively. 
 
Figure 6.12; Feed, protein usage and nitrogenous waste from undigested protein; associated 
with two commercial-like diets for large Atlantic salmon, one containing 40 % protein and 33 
% lipid (40:33) and the other containing 35 % protein and 36 % lipid (36:36), including a) feed 
tonne-1 fish produced (kg) based on FCR, b) protein used tonne-1 fish produced (kg), based on 
FCR and protein content of the treatment diets, c) retained protein tonne-1 of fish produced 
(kg), based on FCR, protein content of diet and ADC % of protein for the two treatment diets 
and d) undigested nitrogen tonne-1 fish produced (kg), based on FCR, protein content of diet, 
ADC % of protein and converting undigested protein to nitrogen for the two treatment diets. 
 
Figure 6.13; Nitrogen assimilation or ‘loss’ based on mass balance calculations in large Atlantic 
salmon associated with two commercial-like diets, one containing 40 % protein and 33 % lipid 
(40:33) and the other containing 35 % protein and 36 % lipid (36:36), including a) Nitrogen 
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assimilation / loss (%), based on initial and final fish weights, protein intake and protein 
content of the diets and whole-body of fish from respective treatments, b) Nitrogen 
assimilation / loss (g fish-1), based on total protein  intake and % assimilation and c) Nitrogen 
assimilation / loss (kg tonne-1 fish), based on % assimilated, protein was converted to nitrogen 





Proximate and fatty acid composition (mg g-1 diet) of experimental diets 
  Dietsa   
  40:33 36:36 
Proximate composition (mg g-1)     
Moisture  28.9 43.6 
Protein 403.9 357.0 
Lipid 330.5 367.7 
Protein: lipid ratio 1.2 1.0 
NFE 164.6 162.7 
Ash 72.2 69.0 
Energy (KJ g-1) 25.4 25.7 
Total FA (mg g-1 diet)b 253.1 267.7 
SFAc 78.7 81.8 
14:0 4.1 4.3 
16:0 54.1 56.1 
18:0 18.7 19.6 
Other SFAd 1.8 1.9 
MUFAe 123.8 132.1 
16:1n-7 12.2 12.5 
18:1n-9 95.9 103.4 
18:1n-7 6.2 6.5 
20:1n-9 4.2 4.4 
Other MUFAf 5.3 5.3 
Total trans FAg 1.2 1.2 
PUFAh 49.2 52.4 
18:2n-6 29.9 32.5 
20:2n-6 0.4 0.5 
20:4n-6 0.9 1.0 
Other n-6 PUFAi 1.8 1.4 
n-6 PUFAj 33.0 35.4 
n-6 LC PUFAn 2.9 2.6 
18:3n-3 4.8 5.6 
18:4n-3 0.2 0.2 
20:4n-3 0.0 0.0 
20:5n-3 3.9 3.8 
22:5n-3 0.9 0.9 
22:6n-3 5.4 5.6 
Other n-3 PUFAl 1.0 0.7 
n-3 PUFAk 15.9 16.7 
n-3 LC PUFAo 10.9 11.1 
LC PUFAm 13.8 13.7 
n-6:n-3 ratiop 2.1 2.1 
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a Diets: 40:33 = poultry by-product oil and fish oil diet consisting of 40% protein and 
33% lipid, added oil consists of 20% fish oil, 80% poultry by-product oil; 36:36 = 
poultry by-product oil and fish oil diet consisting of 36% protein and 36% lipid, 
added oil consists of 20% fish oil, 80% poultry by-product oil 
b Total FA = total fatty acids mg g-1 of diet. 
c SFA = saturated fatty acids. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 22:0 & 24:0. 
e MUFA = monounsaturated fatty acids. 
f Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-13, 20:1n-11, 22:1n-11, 
22:1n-9 & 24:1n-9. 
g Total trans FA = sum of 18:1n-9t, 18:1n-7t & 18:2n-6t. 
h PUFA = polyunsaturated fatty acids. 
i Other n-6 PUFA = sum of 18:3n-6, 20:2n-6, 20:3n-6, 22:2n-6, 22:4n-6 and 22:5n-6. 
j n-6 PUFA = omega-6 polyunsaturated fatty acids. 
k n-3 PUFA = omega-3 polyunsaturated fatty acids. 
l Other n-3 PUFA = sum of 20:3n-3, 24:5n-3 and 24:6n-3. 
m LC-PUFA = long chain (>20C) polyunsaturated fatty acids. 
n n-6 LC PUFA = omega-6 long chain polyunsaturated fatty acids. 
o n-3 LC PUFA = omega-3 long chain polyunsaturated fatty acids. 









Growth, feed efficiency and biometry of Atlantic salmon fed the two 
experimental diets for 150 days. 
  Dietsa       
  40:33 36:36 P-value 
Initial wt (g) 2219 ± 7 2290 ± 21     
Final wt (g) 5053 ± 33 5096 ± 83 ns 0.995 
Gain (g) 2834 ± 28 2806 ± 63 ns 0.913 
Gain (%) 127.7 ± 1.1 122.5 ± 1.7 ns 0.991 
Feed rationb 0.65 ± 0.02 0.69 ± 0.02 ns 0.244 
FCRc 1.26 ± 0.04 1.38 ± 0.05 ns 0.130 
SGRd 0.53 ± 0.00 0.54 ± 0.01 ns 0.187 
Ke 1.82 ± 0.10 1.79 ± 0.05 ns 0.799 
DP (%)f 90.41 ± 0.52 90.84 ± 0.9 ns 0.700 
FY (%)g 60.47 ± 0.73 60.66 ± 0.57 ns 0.849 
HSI (%)h 1.02 ± 0.01 1.09 ± 0.10 ns 0.538 
VSI (%)i 9.26 ± 0.45 9.77 ± 0.21 ns 0.360 
NPU (%)j 32.42 ± 1.05 37.12 ± 2.07 ns 0.113 
PGRk 0.48 ± 0.01 0.51 ± 0.02 ns 0.259 
FDRl 0.70 ± 0.04 0.72 ± 0.02 ns 0.730 
Data are expressed as mean ± S.E.M., n = 3, N = 6. P < 0.05; an independent T-
test: ns = not significant (P > 0.05). 
a See 6.22 for experimental diet abbreviations. 
b Feed ration (% BW day-1) 
c FCR = food conversion ratio. 
d SGR = specific growth rate. 
e K = Fulton’s condition factor 
f DP (%) = dress-out percentage. 
g FY (%) = fillet yield percentage. 
h HSI (%) = hepatosomatic index. 
i VSI (%) = viscerosomatic index. 
j NPU (%) = net protein utilisation 
k PGR = protein growth rate 









Nutrient and fatty acids digestibility (apparent digestibility coefficient - ADC %) 
of the two experimental diets in Atlantic salmon 
  Dietsa       
  40:33 36:36 P-value 
Nutrientsb         
DMb 66.3 ± 3.9 67.1 ± 2.1 ns 0.860 
Protein 75.5 ± 3.1 80.1 ± 1.8 ns 0.260 
Lipid 88.8 ± 3.3 90.7 ± 1.2 ns 0.604 
Total fatty acidsd 89.4 ± 4.2 90.2 ± 1.6 ns 0.840 
NFEb 78.3 ± 2.3 83.2 ± 1.2 ns 0.134 
Energyc 76.8 ± 3.8 79.5 ± 1.9 ns 0.556 
          
Fatty acids         
12:0 91.8 ± 3.1 92.5 ± 1.1 ns 0.791 
14:0 87.6 ± 4.1 89.2 ± 1.6 ns 0.665 
16:0 79.8 ± 5.0 81.1 ± 1.7 ns 0.783 
18:0 65.8 ± 8.0 64.8 ± 1.8 ns 0.888 
16:1n-7 96.4 ± 2.9 97.1 ± 1.2 ns 0.795 
18:1n-9 94.7 ± 3.9 95.5 ± 1.7 ns 0.818 
18:1n-7 93.9 ± 3.8 94.9 ± 1.7 ns 0.801 
20:1n-9 92.9 ± 4.4 93.7 ± 1.9 ns 0.846 
18:2n-6 96.1 ± 3.2 96.5 ± 1.6 ns 0.891 
20:2n-6 93.0 ± 3.1 92.5 ± 2.4 ns 0.897 
20:4n-6 95.7 ± 2.6 96.7 ± 1.3 ns 0.690 
18:3n-3 96.7 ± 2.8 97.3 ± 1.3 ns 0.836 
20:5n-3 97.6 ± 2.0 97.6 ± 1.2 ns 0.986 
22:5n-3 96.1 ± 3.1 96.3 ± 1.6 ns 0.951 
22:6n-3 96.3 ± 2.6 96.1 ± 1.5 ns 0.927 
Data are expressed as mean ± S.E.M., n = 3, N = 6. P < 0.05; an independent T-
test: ns = not significant (P > 0.05). 
a See Table 6.22 for experimental diet abbreviations. 
b DM, dry matter; NFE, nitrogen-free extract. 
c Calculated on the basis of 23.6, 39.5 and 17.2 kJ g-1 of protein, fat and 
carbohydrate, respectively. 





Proximate (mg g-1 of tissue) and fatty acid composition (µmol g-1 tissue) of fillets of 
Atlantic salmon fed the three experimental diets for 150 days 
  Dietsa       
  40:33 36:36 P-value 
Proximate composition (mg g-1 of tissue)       
Moisture 644.5 ± 6.2 635.8 ± 9.3 ns 0.480 
Protein  219.7 ± 5.2 219.8 ± 3.3 ns 0.991 
Lipid  132.2 ± 5.9 134.1 ± 6.9 ns 0.845 
Ash 9.9 ± 0.2 9.7 ± 0.2 ns 0.614 
          
Fatty acids (µmol g-1 of tissue)         
Total FAb 394.5 ± 18.4 396.0 ± 33.1 ns 0.971 
SFAc 102.2 ± 5.8 101.1 ± 9.2 ns 0.926 
14:0 8.2 ± 0.4 7.8 ± 0.7 ns 0.639 
16:0 71.5 ± 4.4 71.2 ± 6.6 ns 0.974 
18:0 19.0 ± 0.9 18.7 ± 1.6 ns 0.904 
Other SFAd 3.5 ± 0.1 3.4 ± 0.3 ns 0.654 
MUFA 204.3 ± 9.2 206 ± 16.9 ns 0.936 
16:1n-7 19.1 ± 0.9 19.4 ± 1.7 ns 0.901 
18:1n-9 158.6 ± 7.6 160.3 ± 12.9 ns 0.913 
18:1n-7 11.7 ± 0.7 11.8 ± 1.0 ns 0.930 
20:1n-9 8.9 ± 0.0 8.5 ± 0.8 ns 0.680 
Other MUFAe 6.0 ± 0.2 5.9 ± 0.6 ns 0.838 
Total trans FA 1.7 ± 0.1 1.7 ± 0.2 ns 0.959 
PUFA 86.1 ± 3.4 87 ± 6.8 ns 0.910 
18:2n-6 46.7 ± 2.5 48.5 ± 3.9 ns 0.713 
20:2n-6 3.3 ± 0.2 3.3 ± 0.3 ns 0.932 
20:4n-6 1.6 ± 0.1 1.6 ± 0.1 ns 0.976 
Other n-6 PUFAf 4.1 ± 0.2 4.1 ± 0.4 ns 0.978 
n-6 PUFA 55.6 ± 2.8 57.5 ± 4.7 ns 0.756 
n-6 LC PUFA 7.8 ± 0.3 7.8 ± 0.7 ns 0.928 
18:3n-3 7.8 ± 0.7 7.0 ± 0.5 ns 0.405 
18:4n-3 0.3 ± 0.0 0.3 ± 0.0 ns 0.209 
20:4n-3 1.5 ± 0.2 1.7 ± 0.2 ns 0.522 
20:5n-3 4.5 ± 0.1 4.4 ± 0.4 ns 0.767 
22:5n-3 2.0 ± 0.1 2.1 ± 0.2 ns 0.867 
22:6n-3 12.0 ± 0.7 12.1 ± 0.7 ns 0.979 
Other n-3 PUFAg 2.9 ± 0.1 3.0 ± 0.2 ns 0.837 
n-3 PUFA 29.3 ± 0.7 28.4 ± 2.1 ns 0.717 
n-3 LC PUFA 21.2 ± 1.1 21.2 ± 1.5 ns 0.997 
LC PUFA 29.0 ± 1.3 29.0 ± 2.2 ns 0.981 
Data are expressed as mean ± S.E.M., n = 3, N = 6. P < 0.05; an independent T-test: 
ns = not significant (P > 0.05). 
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a See Table 6.22 for experimental diet abbreviations. 
b Total FA = total fatty acids µg g-1 of tissue 
c See Table 6.22 for fatty acid classes and abbreviations. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 21:0, 22:0 & 24:0. 
e Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-11, 22:1n-11 & 24:1n-9. 
f Other n-6 PUFA = sum of 18:3n-6, 20:3n-6, 22:2n-6, 22:4n-6, 22:5n-6. 









Fillet fatty acid composition (as mg 100 g-1 of edible fillet) of Atlantic salmon fillet fed the two 
experimental diets for 150 days 
  Dietsa       
mg 100 g-1 of fillet 40:33 36:36 P-value 
20:5n-3 136.1 ± 3.7 131.7 ± 13.5 ns 0.767 
22:5n-3 66.9 ± 3.0 68.1 ± 6.3 ns 0.867 
22:6n-3 395.1 ± 22.5 396.0 ± 23.8 ns 0.979 
SFAb 2658.8 ± 151.2 2631.0 ± 239.4 ns 0.926 
MUFA 5762.5 ± 256.1 5806.6 ± 476.7 ns 0.939 
PUFA 2521.6 ± 100.8 2547.6 ± 199.2 ns 0.913 
LC-PUFA 925.8 ± 43.2 924.0 ± 68.5 ns 0.983 
trans 47.2 ± 2.1 47.5 ± 4.4 ns 0.958 
n-6 PUFA 1561.8 ± 77.4 1612.0 ± 131.1 ns 0.758 
n-6 LC PUFA 244.2 ± 9.7 241.9 ± 21.1 ns 0.925 
n-3 PUFA 907.1 ± 24.1 883.4 ± 64.1 ns 0.747 
n-3 LC PUFA 681.6 ± 34.2 682.1 ± 48.8 ns 0.994 
n-6:n-3 ratio 1.7 ± 0.1 1.8 ± 0.0 ns 0.176 
Data are expressed as mean ± S.E.M., n = 3, N = 6. P < 0.05; an independent T-test: ns = not 
significant (P > 0.05); * = P < 0.05; ** = P < 0.01; *** = P < 0.001. 
a See Table 6.22 for experimental diet abbreviations. 










The apparent in vivo fatty acid β-oxidation (nmol g-1 day-1 and % of total intake in brackets and 
italics) in Atlantic salmon fed the two experimental diets for 150 days. 
  Dietsa       
  40:33 36:36 P-value 
12:0 3.3 ± 0.8 (56.1) 4.2 ± 0.2 (69.0) ns 0.310 
14:0 57.8 ± 10.8 (44.2) 65.7 ± 5.2 (47.3) ns 0.546 
16:0 501.1 ± 83.6 (33.0) 536.0 ± 44.1 (33.0) ns 0.731 
18:0 82.7 ± 22.1 (17.5) 87.8 ± 10.7 (17.2) ns 0.846 
22:0 6.0 ± 0.6 (0.6) 5.7 ± 0.5 (0.0) ns 0.676 
SFAb,c 650.9 ± 117.8 699.4 ± 60.5 ns 0.733 
14:1n-5 9.1 ± 0.7 (65.6) 9.7 ± 0.4 (66.5) ns 0.509 
16:1n-7 180.3 ± 26.2 (52.2) 159.7 ± 12.0 (43.8) ns 0.515 
18:1n-7 62.0 ± 15.1 (39.2) 60.9 ± 7.2 (35.4) ns 0.949 
18:1n-9 1145.9 ± 198.0 (46.8) 1215 ± 86.6 (44.7) ns 0.765 
20:1n-9 17.6 ± 11.6 (18.2) 17.9 ± 6.1 (17.0) ns 0.984 
22:1n-9 8.3 ± 2.3 (30.9) 4.8 ± 1.3 (18.1) ns 0.267 
24:1n-9 1.8 ± 0.9 (16.2) 3.0 ± 0.3 (26.5) ns 0.268 
20:1n-11 11.7 ± 2.1 (45.6) 9.7 ± 1.335.9 ns 0.486 
22:1n-11 43.6 ± 0.2 (100) 43.9 ± 0.0 (100) ns 0.277 
MUFA 1480.2 ± 256.2 1524.6 ± 115.0 ns 0.882 
18:2n-6 395.1 ± 66.0 (51.5) 347.8 ± 30.5 (40.4) ns 0.551 
22:2n-6 8.4 ± 0.1 (79.5) ─d     
20:3n-6 1.1 ± 1.1 (8.9) 0.8 ± 0.8 (5.7) ns 0.841 
20:4n-6 10.6 ± 1.7 (51.4) 11.9 ± 0.8 (48.7) ns 0.515 
22:4n-6 1.4 ± 0.3 (56.4) 0.8 ± 0.1 (29.2) ns 0.104 
22:5n-6 8.4 ± 0.3 (81.7) 8.0 ± 0.2 (76.3) ns 0.275 
n-6 PUFA 425.0 ± 69.1 369.3 ± 31.8 ns 0.505 
18:3n-3 71.8 ± 12.0 (57.9) 84.0 ± 5.4 (56.1) ns 0.406 
22:3n-3 11.8 ± 0.1 (100) 12.0 ± 0.0 (100) * 0.010 
20:5n-3 71.6 ± 5.4 (77.9) 66.5 ± 3.8 (71.0) ns 0.479 
22:5n-3 9.0 ± 3.0 (46.8) 5.0 ± 1.9 (24.2) ns 0.319 
22:6n-3 42.6 ± 13.4 (35.9) 37.0 ± 4.3 (29.0) ns 0.711 
n-3 PUFA 206.8 ± 33.6 204.5 ± 14.4 ns 0.953 
Total FA 2762.8 ± 476.3 2797.7 ± 221.4 ns 0.950 
Data are expressed as mean ± S.E.M., n = 3, N = 6. P < 0.05; an independent T-test: ns = not 
significant (P > 0.05); * = P < 0.05. 
a See Table 6.22 for experimental diet abbreviations. 
b See Table 6.22 for fatty acid classes and abbreviations. 
c Fatty acids not recording any β-oxidation are not reported in this table. 





The apparent in vivo fatty acid bioconversion (elongation, desaturation or chain 
shortening) (nmol g-1 day-1) in Atlantic salmon fed the two experimental diets for 150 days. 
  Dietsa       
  40:33 36:36 P-value 
Fatty acid elongationb         
18:0 to 20:0 2.2 ± 0.5 1.6 ± 0.2 ns 0.397 
22:0 to 24:0 3.6 ± 0.4 4.3 ± 0.4 ns 0.300 
18:2n-6 to 20:2n-6 13.9 ± 4.6 20.0 ± 2.3 ns 0.301 
20:2n-6 to 22:2n-6 ─c 2.2 ± 0.1 ns   
18:3n-6 to 20:3n-6 0.9 ± 0.7 1.9 ± 1.0 ns 0.448 
18:3n-3 to 20:3n-3 2.2 ± 0.6 ─     
18:4n-3 to 20:4n-3 12.6 ± 1.9 17.1 ± 1.2 ns 0.117 
22:5n-3 to 24:5n-3 1.5 ± 0.8 3.0 ± 0.4 ns 0.178 
Fatty acid ∆-6 desaturation         
18:2n-6 to 18:3n-6 4.6 ± 1.7 8.6 ± 2.2 ns 0.226 
18:3n-3 to 18:4n-3 9.6 ± 1.9 20.0 ± 1.6 * 0.014 
24:5n-3 to 24:6n-3 1.5 ± 0.5 1.7 ± 0.1 ns 0.785 
Data are expressed as mean ± S.E.M., n = 3, N = 6. P < 0.05; an independent T-test: ns = not 
significant (P > 0.05); * = P < 0.05. 
a See Table 6.22 for experimental diet abbreviations. 
b Fatty acids not recording any bioconversion (elongation or desaturation) or chain-
shortneing are not reported in this table. 









Consumer preference of salmon products (raw salmon, cold smoked and hot smoked fillet) and 
major influential attributes (fishiness, saltiness and oiliness) from the fish fed two dietary 
treatments. 
  Dietsa       
  40:33 36:36 P-value 
Preference; Like ( + ) or Dislike ( - )b         
Raw 4.1 ± 1.2 3.5 ± 1.7 ns 0.797 
Cold smoked 14.6 ± 2.2 18.7 ± 0.5 ns 0.220 
Hot smoked 22.6 ± 1.3 18.5 ± 5.4 ns 0.535 
Influential attributesc         
Fishinessc         
Raw -0.6 ± 2.6 0.1 ± 0.3 ns 0.816 
Cold smoked 3.9 ± 0.8 3.2 ± 1.9 ns 0.759 
Hot smoked -0.7 ± 1.7 1.1 ± 0.7 ns 0.435 
Saltinessc         
Raw -20.3 ± 3.7 -18.3 ± 1.3 ns 0.670 
Cold smoked 9.8 ± 1.6 9.1 ± 0.4 ns 0.694 
Hot smoked 5.7 ± 1.5 6.3 ± 0.5 ns 0.755 
Oilinessc         
Raw -3.8 ± 1.8 -3.5 ± 0.1 ns 0.902 
Cold smoked 3.5 ± 0.3 4.4 ± 1.6 ns 0.640 
Hot smoked -0.5 ± 1.6 -1.2 ± 2 ns 0.810 
Data are expressed as mean ± S.E.M., n = 3, N = 6. P < 0.05; an independent T-test: ns = not 
significant (P > 0.05); * = P < 0.05; ** = P < 0.01; *** = P < 0.001. 
a See Table 6.22 for experimental diet abbreviations. 
b Salmon preferences were assessed using hedonic LMS scales. 
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7. Quantifying in vivo metabolism in post-smolt Atlantic 
salmon fed diets containing varied ratios of shorter vs longer 




Currently, commercial aquafeed formulations for Atlantic salmon (Salmo salar) contain a 
physiological excess of omega-3 long-chain polyunsaturated fatty acids (n-3 LC PUFA) to 
ensure a high-level of deposition of these fatty acids into the fillet tissue (Turchini et al. 2010). 
Atlantic salmon, in particular, are popular with consumers, in part, due to historically high 
levels of n-3 LC PUFA (Christenson et al. 2017; Strobel et al. 2012; Tocher 2010). However, 
this is becoming increasingly difficult to achieve due to mounting market pressure from both 
within and outside the aquaculture industry for n-3 LC PUFA rich oil sources. Levels of n-3 LC 
PUFA in farmed Atlantic salmon have followed a declining trend (Nichols et al. 2014; Sprague 
et al. 2016) and are approaching the minimal levels needed to satisfy both the physiological 
needs of the animal, and consumer expectation (Christenson et al. 2017; Rosenlund et al. 
2016). Therefore, novel approaches to maximise the deposition efficiency of nutritionally 
valuable fatty acids in this popular table fish are increasingly sought after (Francis & Turchini 
2017; Tacon & Metian 2015; Tocher 2015). In the future, a more efficient utilisation of n-3 LC 
PUFA in cultured salmonids may rely on dietary strategies that maximise the bioconversion 
of shorter-chain n-3 PUFA into n-3 LC PUFA (Giri et al. 2016; Hixson et al. 2017; Tocher 2010). 
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Hence, further research that elucidates the potential to exploit fatty acid metabolism, namely, 
n-3 LC PUFA biosynthesis in large Atlantic salmon is warranted. 
  
To date, the majority of laboratory based fish trials have focussed on smaller sub-market sized 
fish due to logistical constraints. This limits commercial relevance as physiological fatty acid 
requirements, and by extension in vivo fatty acid metabolism, change in response to 
ontogenic development (Tocher 2010). Research chapter 5 addressed this by demonstrating 
the potential for high dietary inclusion of 18:3n-3 rich oils to partially ameliorate a dietary 
lipid reduction in n-3 LC PUFA rich fish oil (FO), including recording the endogenous 
production of n-3 LC PUFA, albeit to a limited extent. However, trials conducted on-farm may 
compromise the accuracy of feed and fatty acid uptake measurements due to a typically 
higher food conversion ratio and difficulties quantifying uneaten feed (Talbot et al. 1999). 
Accordingly, the current experiment was conducted in a laboratory set-up with fish grown up 
to a marketable size. The trial utilised three oil sources, namely, FO, poultry by-product oil 
(PbO), typically rich in saturated (SFA) and monounsaturated fatty acids (MUFA), and 
camelina oil (CAM), typically rich in 18:3n-3, to create four experimental diets with varying 
levels of shorter-chain and long-chain n-3 PUFA. The objective, therefore, was to provide 
altered substrate (18:3n-3) and end-product (20:5n-3 and 22:6n-3) ratios along the n-3 LC 
PUFA bioconversion pathway and subsequently quantify the extent of n-3 LC PUFA 
biosynthesis, towards enhancing current knowledge, and industry relevance, regarding the 
potential for endogenous production of n-3 LC PUFA in market-sized Atlantic salmon. 
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7.2. Materials and Methods 
 
7.2.1. Ethics statement 
All animals and procedures in this experiment were approved by the Deakin University Animal 
Welfare Committee (B25-2015). All possible steps to minimise animal suffering and provide 
an enriched environment were taken. 
 
7.2.2. Animals, trial facility and sampling 
Juvenile Atlantic salmon were sourced from a commercial producer (Mountain Fresh Trout 
and Salmon Farm, Harrietville, VIC, Australia) and transported to the Deakin Aquaculture 
Futures Facility (Deakin University, Warrnambool campus, VIC, Australia). Juvenile fish were 
acclimatised to the facility in freshwater before gradually being exposed to saltwater. 
Smoltification of fish was confirmed by plasma chloride analysis. Following smoltification, fish 
were acclimatised to the experimental conditions and maintained on a commercial 6mm 
salmonid diet (Ridley Aquafeed Pty. Ltd.) prior to the commencement of the trial period.  The 
experiment was conducted in a closed-loop, thermostatically controlled, recirculating 
aquaculture system containing eight (5000 L) rearing tanks. Physical and biological filtration 
(drum filter fitted with a 60 µm screen; Hydrotech, Vellinge, Sweden) and UV disinfection, 
maintained water quality throughout the experiment. The system was maintained on a 12:12 
hour light:dark cycle and temperature was kept at 15.0 ± 0.5 °C for the duration of the 
experiment. Dissolved oxygen was maintained at optimal conditions and levels of metabolic 
waste, total ammonia, phosphorus, nitrite and nitrate were monitored daily using Aquamerck 
test kits (Merck, Darmstadt, Germany) and remained within acceptable limits throughout the 
trial. Immediately preceding the trial, an initial sample of six fish were euthanised in excess 
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anaesthetic (AQUI-S, 0.05  ml L-1) and stored at -20 °C until analysis. Initially, 272 fish were 
distributed amongst eight tanks (34 fish per tank) and assigned one of four dietary treatments 
in duplicate (two tanks per treatment; n = 2, N = 8). After 14 and 28 weeks, weight checks 
were performed and fish removed to reduce stocking densities. Fish were fed to apparent 
satiation twice a day at 0900 and 1600 h for the entire (40 week) grow-out period. Feed 
consumption and mortalities were recorded throughout the trial and remained low (three 
mortalities across all treatments). Faeces were collected two weeks prior to final sampling for 
the estimation of digestibility of nutrients. At the completion of the grow-out phase, all fish 
were euthanised in excess anaesthetic (AQUI-S, 0.05 ml/L) and weighed. Subsequently, 18 
fish per treatment (nine fish per tank) were selected and stored at -20 °C until analysed. The 
sampled fish were separated into two groups: the first group (10 fish per treatment; five fish 
per tank) were used for analysis of biometry and for chemical analysis of whole-body, the 
second group (eight fish per treatment; four fish per tank) were used for biometry and 
chemical analysis of fillet. 
 
7.2.3. Experimental diets 
Four experimental diets were formulated to be iso-lipidic (310 mg g-1), iso-proteic (440 mg g-
1) and iso-energetic (26 kJ g-1) (Table 7.30). For manufacturing the four experimental diets, a 9 
mm extruded pellet for Atlantic salmon was produced by a commercial feed producer (Ridley 
Aquafeed Pty. Ltd) and removed from the production process at the feed mill post-extrusion, 
before oil coating, and delivered to Deakin University for subsequent vacuum oil coating of 
the experimental oils. A small scale, laboratory based, vacuum coater equipped with a 
vacuum pump and rotation mechanism was used to add the dietary lipid. The four 
experimental diets were achieved by using three different lipid sources; poultry by-product 
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oil (PbO), fish oil (FO) and camelina oil (CAM), to create varied ratios of short-chain to long-
chain omega-3 fatty acids and therefore four varied compositions of ‘substrate’ (18:3n-3) and 
‘end-product’ (20:5n-3 and 22:6n-3) in terms of the omega-3 in vivo bioconversion pathway. 
The experimental oil blends were added to the ‘uncoated’ pellets and resulted in the following 
four diets:  
• Low substrate : Low end-product (Low:Low), where added oil consisted of 100 % 
poultry by-product oil;  
• Low substrate: High end-product (Low:High), where added oil consisted of 80 % 
poultry by-product oil and 20 % fish oil;  
• High substrate: Low end-product (High: Low), where added oil consisted of 80 % 
camelina oil and 20 % poultry by-product oil; and  
• High substrate: High end-product (High:High), where added oil consisted of 80 % 
camelina oil and 20 % fish oil. 
 
7.2.4. Statistical analysis 
All data were reported as mean ± standard error; (n = 2, N = 8). After confirmation of normality 
and homogeneity of variance, data was subjected to two-way ANOVA to assess the effects of 
dietary substrate, dietary end-product and dietary substrate by end-product interactions. A 
Tukey’s post-hoc test determined statistical significance between homogenous subsets and 
was performed where statistical significant differences were identified. The analysis was 
performed using IBM SPSS Statistics v24.0 (SPSS Inc., Chicago, IL, USA). Significance was 






The four experimental diets were iso-energetic and proximate compositions were similar 
(Table 7.30). Total fatty acid concentration ranged from 247.4 to 272.6 mg g-1 diet in High:Low 
and Low:Low, respectively. Levels of individual fatty acids varied according to lipid source. 
Accordingly, Low:Low and Low:High were characterised by numerically higher levels of both 
SFA and MUFA due to typically high 18:1n-9 concentrations in PbO. Total PUFA levels were 
numerically higher in High:Low and High:High, however, omega-6 polyunsaturated fatty acids 
(n-6 PUFA) was relatively consistent between dietary treatments. Levels of n-3 PUFA were 
markedly higher in High:Low and High:High, owing to high levels of 18:3n-3. Diet n-3 LC PUFA 
levels were predictably dictated by FO inclusion and the was distinctly more in Low:High and 
High:High owing to high concentrations of 22:6n-3. The ratio of n-6 to n-3 fatty acids varied 
considerably between treatments ranging from 0.8 to 4.1 in High:High and Low:Low, 
respectively (P < 0.05). 
 
7.3.2. Growth, feed utilisation parameters and biometric data 
Mortality rates were low during the trial and unrelated to diet. Feeds were generally well 
accepted by fish. However, some maturation of fish occurred in the latter stages of the trial, 
which led to poorer than expected growth and food conversion. Fish gained ~2000g and grew 
to weights in excess of 3000g with no statistical differences evident between treatments. FCR 
ranged from 1.14 to 1.26 in Low:Low and High:High, respectively (Table 7.31). Overall, there 
were no significant differences in either growth or biometry measures between dietary 
treatments, including SGR, FCR, feed ration % (relative to body mass), K, FY% HSI% and VSI%. 
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There were no significant effects of dietary omega-3 substrate, end-product or substrate by 
end-product interactions recorded with regard to any growth performance parameters.  
 
7.3.3. Apparent nutrient and fatty acid digestibility 
High nutrient digestibility values (Apparent Digestibility Coefficient – ADC %) were observed 
across treatments with only one significant difference recorded, where Nitrogen free extract 
(NFE) digestibility was higher in Low:Low in comparison to High:High (Table 7.32). Fatty acid 
digestibility values were high with no significant differences recorded between treatments, 
although there was a significant effect of end-product recorded for the digestibility of 20:5n-
3. 
 
7.3.4. Tissue proximate and fillet fatty acid composition 
No significant differences in fillet proximate composition were evident (Table 7.33), even if 
fillet lipid concentrations varied between treatments, ranging from 75.1 to 104.7 mg g-1 tissue 
in Low:High and High:High, respectively. Owing to differences in fillet lipid, total fatty acid 
concentration was lowest in Low:High and highest in High:High, although differences were 
not significant. Expectedly, fillet levels of 22:6n-3 were higher in High:High compared to 
Low:Low in terms of both µmol g-1 of fillet tissue and mg 100g-1 of fillet (Table 7.33 and Table 
7.34, respectively). However, High:Low had comparable levels of 22:6n-3 compared to both 
Low:High and High:High. Furthermore, High:Low had numerically higher levels of total n-3 LC 
PUFA compared to Low:High despite the latter treatment diet containing no added FO, 
although  results were not statistically different. As expected, High:High had higher levels of 
n-3 LC PUFA compared to Low:Low. The n-6 to n-3 PUFA ratios varied across treatments and 
followed dietary trends, ranging from 1.0 to 2.7 in High:High and Low:Low, respectively (P < 
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0.05). Across treatments, there was a clear effect of substrate and end-product recorded for 
20:5n-3, 22:5n-3 and total n-3 LC PUFA in terms of both µmol g-1 of fillet tissue and mg 100g-
1 of fillet , however, no significant substrate by end-product interaction was recorded. 
 
7.3.5. Apparent in vivo fatty acid metabolism 
Apparent in vivo fatty acid β-oxidation (expressed as nmol of fatty acid β-oxidised, per gram 
of fish per day; nmol g-1 day-1 and as % of net intake) (Table 7.35 and Figure 7.14, respectively) 
as calculated by the whole-body fatty acid balance method was highest in 16:0 and 18:1n-9 
across all treatments, relative to high dietary inclusion levels. Accordingly, there was a 
significant effect of substrate and end-product concentration on the β-oxidation of SFA (P < 
0.001 and P < 0.01, respectively). MUFA was β-oxidised to a similar extent as SFA where 
treatments demonstrated a similar trend, however, no significant differences were recorded 
between treatments. Substrate concentration had a clear effect of the β-oxidation of 18:3n-
3 (P < 0.001), where the High:Low and High:High treatments recorded significantly higher β-
oxidation of 18:3n-3. However, in terms of β-oxidation calculated on the basis % of net intake, 
both the low substrate treatments (Low:Low and Low:High) recorded higher values (~70%). 
Notably, 22:6n-3 was highly conserved across treatments and recorded low β-oxidation 
values.  
 
Apparent in vivo fatty acid bioconversion (expressed as nmol of fatty acid bioconverted per 
gram of fish per day; nmol g-1 day-1 and as % of net intake) (Table 7.36 and Figure 7.14 1, 
respectively) highlighted the elongation of 18:0 in three of the four treatments (Low:Low, 
High:Low and High:High), with the highest values recorded in the High:Low treatment (P < 
0.05).  There was a significant effect of end-product concentration on the ∆-6 desaturation of 
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18:2n-6 (P < 0.001) with Low:Low recording the highest level of activity (P < 0.05). Elongation 
of 18:3n-6 was noted in all treatments, however, this was significantly higher in Low:Low (P < 
0.05). Likewise, ∆-5 desaturation of 20:3n-6 was highest in Low:Low (P < 0.05) whilst ∆-5 
desaturation of 20:4n-3 was highest in High:Low, with negligible activity recorded in the other 
treatments (P > 0.05). The High:Low treatment recorded the highest level of ∆-6 desaturation 
of 18:3n-3 (P < 0.05) and numerically higher levels of 24:6n-3 desaturation. Additionally, there 
was a significant effect of substrate, end-product and a substrate by end-product interaction 
recorded for the ∆-6 desaturation of 18:3n-3. The High:Low treatment recorded significantly 
higher levels of elongation of 20:5n-3 and also higher elongation of 22:5n-3, although results 
for the latter were not significant. Recorded levels of 24:6n-3 chain shortening, the final step 
of endogenous 22:6n-3 production, was highest in High:Low, although, despite relatively 




While previous research has highlighted the capacity for endogenous n-3 LC PUFA production 
in salmonid species, the extent of this metabolic activity has, up until now, not been well 
quantified in post-smolt Atlantic salmon (Tocher 2015). In this respect, the present research 
Chapter demonstrates a potential capacity for the endogenous synthesis of n-3 LC PUFA in 
post-smolt Atlantic salmon via in vivo fatty acid bioconversion. Moreover, when provided with 
abundant dietary supply of 18:3n-3, the extent of endogenous production may considerably 
enhance fillet concentrations of n-3 LC PUFA, complementing, and independent of, dietary n-
3 LC PUFA provision. Furthermore, the present research Chapter highlights the positive effect 
184  
high dietary substrate inclusion (18:3n-3), concomitant with the supply of dietary FO, may 
have on the final concentration of fillet n-3 LC PUFA, attributable to the provision of a suitable 
substrate for β-oxidation, thus, sparing n-3 LC PUFA from catabolism. These important 
findings are discussed in further detail herein.  
 
The effect of various lipid sources used in aquafeed on the nutritional value of the fish 
understandably garners substantial research attention. Nevertheless, growth performance 
remains a key indicator of the suitability of aquafeed formulations for the use in commercial 
aquaculture operations (Føre et al. 2016). As reviewed by Glencross (2009) and Turchini 
(2009), the substitution of FO with terrestrial based oils has been widely reported to have 
minimal effect on the growth of salmonids, even at high inclusion levels. Moreover, it has 
been reported that an excessive inclusion level of LC-PUFA may elicit detrimental effects on 
fish performance in several species (Betancor et al. 2011; Glencross & Rutherford 2011; 
Ostbye et al. 2011; Ruyter et al. 2000). However, currently used levels of dietary n-3 LC PUFA 
in commercial aqufeed are unlikely to elicit any negative effects on growth performance given 
the low levels of marine sourced oils presently utilised. Recent research advocates dietary n-
3 LC PUFA at an inclusion level in excess of 2.7% of fatty acids is necessary for optimal growth 
in post-smolt Atlantic salmon (Hixson et al. 2017; Rosenlund et al. 2016). With respect to the 
present research Chapter, there was no difference between major growth parameters 
between any of the treatments, despite no added FO in the dietary lipid fraction in two of the 
four dietary treatments; hence, it cannot support this minimum recommended requirement 
for dietary n-3 LC PUFA in terms of growth performance.  
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Despite apparent contention regarding growth performance, it is widely accepted that the 
amount of n-3 LC PUFA in the fillet is a reflection of the dietary inclusion level, as reviewed by 
(Bendiksen et al. 2011; Sales & Glencross 2011a; Tocher 2015; Turchini et al. 2009). However, 
given the demonstrated, albeit in most cases limited, capacity of Atlantic salmon to 
endogenously synthesise 22:6n-3 from dietary precursors, the mirroring effect between diet 
and fillet fatty acid compositions may be partially obscured, especially when diets are devoid 
of added FO (Miller et al. 2008; Tocher 2015). Despite this, the biosynthesis of n-3 LC PUFA 
from 18:3n-3 in salmonids is recognised as a mechanism to satiate the fundamental 
physiological minimal requirements of n-3 LC PUFA and is generally insufficient to enrich fillets 
with n-3 LC PUFA to the same extent as dietary added FO and in line with consumer 
expectations (Bell et al. 2004; Turchini et al. 2009). Therefore, the marginally higher fillet 
levels of n-3 LC PUFA, expressed as both µmol g-1 and mg 100 g-1 of fillet tissue recorded in 
fish fed the High:Low diet compared to the Low:High diet was somewhat unexpected 
considering the High:Low diet contained no added FO in the added oil fraction of the diet. As 
will be discussed, these differences are a clear result of differences in lipid metabolism, 
namely, β-oxidation, bioconversion and deposition of fatty acids, specifically, 18:3n-3, 20:5n-
3 and 22:6n-3.  
 
It is well understood that dietary fatty acids provide the vast majority of metabolic energy for 
salmonids (Tocher 2003). In particular, MUFA, including 18:1n-9 and SFA, including 16:0, are 
known to be readily catabolised for this specific purpose (McKenzie et al. 1998; Sargent et al. 
2003). However, due to the increasing commercial utilisation of dietary oils rich in C18 n-3 
PUFA in aquafeed formulations (eg. canola oil, linseed oil and potentially in the future, CAM) 
18:3n-3 is increasingly relied upon by farmed salmon as a dietary energy substrate (Bell et al. 
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2010b; Hixson et al. 2014b; Hixson et al. 2017; Turchini et al. 2011c). Research suggests 18:3n-
3 is readily catabolised in fish, including salmonids, proportional to dietary inclusion levels 
(Mourente et al. 2005; Stubhaug et al. 2007; Tocher et al. 2002; Turchini et al. 2011a). With 
respect to the present study, dietary n-3 PUFA substrate level had a significant effect on the 
β-oxidation of 18:3n-3 (P < 0.001). Specifically, an increase in dietary 18:3n-3 led to a 
proportional decrease in β-oxidation of 18:3n-3 (in terms of % of net intake). However, 
considering the enhanced dietary supply of 18:3n-3 in the high substrate treatments, 
quantitatively more 18:3n-3 was β-oxidised in both high dietary 18:3n-3 treatments (in terms 
of nmol g-1 day-1). Furthermore, the deposition of 18:3n-3 proportionally increased with an 
increased dietary supply. This is in contrast to the notion of decreasing deposition efficiency 
of n-3 PUFA with increased dietary supply (Bell et al. 2002; Budge et al. 2011; Francis et al. 
2014b; Stubhaug et al. 2007). However, considering the increased total amount of 18:3n-3 in 
the high dietary 18:3n-3 treatments, the actual amount β-oxidised was greater compared to 
the low dietary 18:3n-3 treatments.  
 
In addition to providing a suitable substrate for β-oxidation in salmonids, the first step of n-3 
PUFA bioconversion has been shown to be primarily modulated by the availability of C18 n-3 
PUFA by providing a substrate for ∆-6 desaturase activity (Glencross et al. 2014a; Hixson et 
al. 2017; Thanuthong et al. 2011; Turchini & Francis 2009; Xue et al. 2015). The findings of the 
present research Chapter support this and found that the ∆-6 desaturation of 18:3n-3 was 
significantly enhanced by the dietary addition of 18:3n-3 (both in terms of nmol g-1 day-1 and 
% of net intake). Additionally, and in accordance with previous research, the absence of added 
dietary n-3 LC PUFA appeared to further enhance bioconversion activity relative to the high 
dietary n-3 LC PUFA treatments owing to the absence of a previously identified negative 
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feedback mechanism acting upon the n-3 LC PUFA bioconversion pathway in both mice and 
Atlantic salmon (Raz et al. 1997; Tocher et al. 2003).  
 
Further to 18:3n-3 bioconversion, there were observable differences between treatments in 
relation to the metabolism of 20:5n-3. Previous research has suggested n-3 LC PUFA can be 
preserved from catabolism by careful manipulation of the dietary fatty acid composition, 
termed ‘n-3 LC PUFA sparing’ (Codabaccus et al. 2012b; Eroldoğan et al. 2013; Rombenso et 
al. 2015; Trushenski et al. 2013; Turchini et al. 2011a). Specifically, the dietary addition of SFA 
and MUFA has been shown to enhance the retention efficiency of n-3 LC PUFA (Emery et al. 
2016; Francis et al. 2014b; Turchini et al. 2011a). With respect to the present research 
Chapter, dietary treatement had a clear effect on the deposition of 20:5n-3. Fish fed the 
Low:High dietary treatment appeared to favour the catabolism of longer, more unsaturated 
fatty acids, namely, 20:5n-3. In contrast, the fish fed the High:High treatment diet had a lesser 
reliance on n-3 LC PUFA β-oxidation and instead appeared to preferentially β-oxidise 18:3n-
3. These findings support previous research advocating the suitability of 18:3n-3 as a dietary 
energy substrate (Bell et al. 2001a; Bell et al. 2003a; Bell et al. 2003b; Hixson et al. 2014b; 
Sinclair et al. 2002). Moreover, they agree with findings in juvenile salmon advocating the 
potential for added dietary 18:3n-3 to spare n-3 LC PUFA from catabolism (Berge et al. 2004). 
 
Despite no provision of n-3 LC PUFA in the dietary lipid fraction in the High:Low treatment, 
virtually all endogenously synthesised 20:5n-3 was further bioconverted, culminating in a 
recorded chain-shortening of 24:6n-3 - the final step in n-3 LC PUFA biosynthesis - to produce 
22:6n-3. In accordance with previous research, it therefore appears that a production of 
22:6n-3 was favoured over 20:5n-3 deposition which appears to be present predominately as 
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an intermediate step toward the de novo biosynthesis of 22:6n-3 (Codabaccus et al. 2011; 
Stubhaug et al. 2007; Tocher 2010). Furthermore, in accordance with previous research, the 
presence of dietary n-3 LC PUFA appeared to negatively affect the bioconversion of 20:5n-3 
(Raz et al. 1997; Thomassen et al. 2012; Tocher 2003).  
 
In general, dietary 22:6n-3 is well conserved from catabolism in Atlantic salmon, resulting in 
similar fillet levels to those provided by the diet (Bell et al. 2003b; Bransden et al. 2003; 
Mourente et al. 2005; Pratoomyot et al. 2010; Torstensen et al. 2004a). The present research 
Chapter largely confirms this and high retention of 22:6n-3 was recorded in all treatments. 
However, a significant effect of dietary substrate level (18:3n-3) on the β-oxidation of 22:6n-
3 was recorded. Specifically, the β-oxidation of 22:6n-3 was reduced in both high dietary 
substrate (18:3n-3) treatments. Resultantly, a high dietary 18:3n-3 content provided i) a 
suitable and highly available β-oxidation substrate that, consequently, enabled the sparing of 
n-3 LC PUFA from β-oxidation, ii) an enhanced substrate for bioconversion and iii) in contrast 
to high end-product treatments, did not inhibit n-3 LC PUFA biosynthesis via the presence of 
end-product desaturase inhibitors. Consequently, the addition of abundant dietary 18:3n-3 
in diets devoid of added FO had a positive effect on the final n-3 LC PUFA level in the fillet of 
post-smolt Atlantic salmon. 
 
The present research chapter attempted to solidify findings presented in Chapter 5 by 
presenting the results of a laboratory based trial. It was demonstrated that in the absence of 
dietary added FO, a high dietary provision of 18:3n-3 rich oil has the potential to facilitate an 
increased deposition of n-3 LC PUFA in to the fillet tissue. Specifically, the preferential β-
oxidation of dietary C18 n-3 PUFA resulted in an apparent conservation of n-3 LC PUFA from 
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catabolism by providing sufficient substrate for n-3 LC PUFA biosynthesis. Therefore the 
results presented in Chapters 5 and 7 provide complimentary evidence to support the 
relatively high dietary addition of C18 PUFA in diets for post-smolt Atlantic salmon with 
respect to fillet nutritional quality.  
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7.5. Figures and Tables 
 
Figure 7.14; Metabolic fate of dietary 18:3n-3, 20:5n-3 and 22:6n-3 (β-oxidation, 
bioconversion and deposition, expressed as % of net intake) in post-smolt Atlantic salmon fed 
experimental diets with altered dietary substrate (18:3n-3) and end-product (20:5n-3 and 
22:6n-3) ratios for 283 days. Values in the same row (either 18:3n-3, 20:5n-3 or 22:6n-3) and 
for the same category (β-oxidation, bioconversion and deposition) with different superscripts 
are significantly different (P < 0.05) and P-values relative to the two-way ANOVA comparing 
substrate, end-product and substrate by end-product interactions are reported on the right 
(ns = not significant; * P < 0.05; ** P < 0.01 and *** P < 0.001). See 7.30 for experimental 
dietary abbreviations.  
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TABLE 7.30 
Proximate composition, total fatty acids and fatty acid (mg g-1 diet) composition of the four 
experimental diets. 
  Dietsa       
  Low : Low Low : High High : Low High : High 
Proximate composition (mg g-1)       
Moisture  39.8 39.0 38.6 45.7 
Protein 430.6 432.8 440.7 446.4 
Lipid 320.2 328.3 311.8 322.4 
NFE 176.4 165.6 173.4 155.8 
Ash 71.8 72.5 72.8 74.3 
Energy (kJ g-1) 25.8 26.0 25.7 26.0 
Total FA (mg g-1 diet)b 272.6 270.6 247.4 253.7 
SFAc 83.2 86.4 55.8 61.8 
14:0 3.3 5.8 2.0 4.4 
16:0 59.8 59.6 38.3 40.1 
18:0 17.7 17.5 12.2 12.7 
Other SFAd 2.4 3.6 3.3 4.6 
MUFAe 143.0 132.7 115.3 108.1 
16:1n-7 14.1 14.7 8.2 9.0 
18:1n-9 118.9 105.6 82.7 71.5 
18:1n-7 6.6 6.9 4.6 5.0 
20:1n-9 1.7 2.4 14.8 16.2 
Other MUFAf 1.7 3.0 4.9 6.3 
Total trans FAg 1.7 1.5 0.8 0.6 
PUFAh 44.7 49.9 75.5 83.2 
18:2n-6 34.1 29.7 36.3 33.2 
20:2n-6 0.3 0.3 1.8 1.9 
20:4n-6 0.6 1.3 0.4 1.0 
Other n-6 PUFAi 0.8 1.2 0.6 1.1 
n-6 PUFAj 35.8 32.6 39.2 37.3 
18:3n-3 5.3 4.7 32.3 33.5 
20:5n-3 1.0 4.6 0.8 4.2 
22:5n-3 0.4 1.0 0.3 0.9 
22:6n-3 1.5 5.5 1.2 4.9 
n-3 PUFAk 8.7 16.6 36.2 45.2 
Other n-3 PUFAl 0.5 0.8 1.6 1.7 
LC PUFAm 4.6 14.2 6.5 15.5 
n-6 LC PUFAn 1.4 2.5 2.7 3.9 
n-3 LC PUFAo 3.2 11.7 3.8 11.6 
n-6:n-3 ratiop 4.1 2.0 1.1 0.8 
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a Diets: Low : Low = low substrate, low end-product diet consisting of 43% protein and 32% lipid, 
added oil consists of 100% poultry by-product oil; Low : High = low substrate, high end-product diet 
consisting of 43% protein and 33% lipid, added oil consists of 80% poultry by-product oil and 20% fish 
oil; High : High = high substrate, high end-product diet consisting of 44% protein and 31% lipid, 
added oil consists of 80% camelina oil and 20% fish oil;  
b Total FA = total fatty acids mg g-1 of diet. 
c SFA = saturated fatty acids. 
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 22:0 & 24:0. 
e MUFA = monounsaturated fatty acids. 
f Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-13, 20:1n-11, 22:1n-11, 22:1n-9 & 24:1n-9. 
g Total trans FA = sum of 18:1n-9t, 18:1n-7t & 18:2n-6t. 
h PUFA = polyunsaturated fatty acids. 
i Other n-6 PUFA = sum of 18:3n-6, 20:2n-6, 20:3n-6, 22:2n-6, 22:4n-6 & 22:5n-6. 
j n-6 PUFA = omega-6 polyunsaturated fatty acids. 
k n-3 PUFA = omega-3 polyunsaturated fatty acids. 
l Other n-3 PUFA = sum of 20:3n-3, 20:4n-3, 24:5n-3 & 24:6n-3. 
m LC-PUFA = long chain polyunsaturated fatty acids. 
n n-6 LC PUFA = omega-6 long chain polyunsaturated fatty acids. 
o n-3 LC PUFA = omega-3 long chain polyunsaturated fatty acids. 





Growth, feed efficiency and biometry of Atlantic salmon fed the four experimental diets for 283 days. 
  Dietsa       
Effect of substrate, end-product and substrate / end-
product interaction 
  Low : Low Low : High High : Low High : High Substrate End-product Interaction 
Initial wt (g) 1116 ± 1 1126 ± 3 1118.7 ± 1 1128 ± 1 ns ns ns 
Final wt (g) 3283 ± 171 3227 ± 14 3308 ± 237 3049 ± 110 ns ns ns 
Gain (g) 2167 ± 171 2102 ± 17 2190 ± 236 1921 ± 109 ns ns ns 
Gain (%) 194.1 ± 15.5 186.7 ± 1.9 195.7 ± 20.9 170.3 ± 9.5 ns ns ns 
Feed rationb 0.40 ± 0.01 0.40 ± 0.00 0.44 ± 0.03 0.41 ± 0.00 ns ns ns 
FCRb 1.14 ± 0.06 1.16 ± 0.01 1.18 ± 0.01 1.26 ± 0.04 ns ns ns 
SGRc 0.36 ± 0.01 0.35 ± 0.00 0.35 ± 0.00 0.34 ± 0.00 ns ns ns 
Kd 1.6 ± 0.1 1.5 ± 0.0 1.9 ± 0.4 1.4 ± 0.1 ns ns ns 
DP (%)e 90.2 ± 0.5 90.7 ± 0.3 90.8 ± 1.5 91.0 ± 0.9 ns ns ns 
FY (%)f 52.2 ± 5.2 55.7 ± 0.8 57.1 ± 0.3 52.0 ± 3.5 ns ns ns 
HSI (%)g 1.2 ± 0.1 1.4 ± 0.0 1.4 ± 0.1 1.3 ± 0.0 ns ns ns 
VSI (%)h 9.8 ± 0.5 9.3 ± 0.3 9.2 ± 1.5 9.0 ± 0.9 ns ns ns 
Data are expressed as mean ± S.E.M., n = 2, N = 8. P < 0.05; Treatment means analysed by one-way ANOVA with Tukey's post-hoc test of multiple 
comparisons. Effect of substrate, end-product and substrate / end-product interaction analysed by two-way ANOVA (ns = not significant). 
a See Table 7.30 for experimental diet abbreviations.         
bFeed ration (% bw day-1)             
c FCR = food conversion ratio.         
d SGR = specific growth rate.         
e K = condition factor.         
f DP (%) = dress-out percentage.         
g FY (%) = fillet yield percentage.         
h HSI (%) = hepatosomatic index.         




Nutrient and fatty acids digestibility (apparent digestibility coefficient - ADC %) of the four experimental 
diets in Atlantic salmon. 
  Dietsa       
Effect of substrate, end-product and 
substrate / end-product interaction 
  Low : Low Low : High High : Low High : High Substrate End-product Interaction 
Nutrientsb               
DMb 86.2 ± 0.2 84.6 ± 0.3 85.0 ± 0.2 83.9 ± 1.1 ns ns ns 
Protein 94.8 ± 0.0 93.3 ± 0.4 93.5 ± 0.3 93.3 ± 0.8 ns ns ns 
Lipid 79.9 ± 3.2 82.3 ± 2.3 84.7 ± 0.3 81.7 ± 3.4 ns ns ns 
NFEb 81.9 ± 0.1a 76.6 ± 0.1ab 78.4 ± 1.6ab 73.7 ± 2.1b ns ns ns 
Energyc 94.1 ± 0.3 92.8 ± 0.4 93.3 ± 0.2 92.2 ± 1.2 ns ns ns 
Total FAd 96.8 ± 0.6 96.5 ± 0.1 97.2 ± 0.4 96.1 ± 0.9 ns ns ns 
               
Fatty acids               
14:0 96.5 ± 0.3 95.7 ± 0.1 96.0 ± 0.3 95.3 ± 0.5 ns ns ns 
16:0 94.7 ± 0.2 93.8 ± 0.2 94.6 ± 0.3 94.2 ± 0.3 ns ns ns 
18:0 92.8 ± 0.1 91.8 ± 0.3 92.4 ± 0.3 92.6 ± 0.1 ns ns * 
16:1n-7 98.8 ± 0.5 98.7 ± 0.2 98.9 ± 0.2 98.0 ± 0.8 ns ns ns 
18:1n-9 97.5 ± 0.9 97.6 ± 0.1 97.9 ± 0.4 96.3 ± 1.4 ns ns ns 
18:1n-7 97.3 ± 0.9 97.3 ± 0.1 97.5 ± 0.4 95.8 ± 1.5 ns ns ns 
20:1n-9 95.9 ± 0.8 96.0 ± 0.1 96.6 ± 0.6 94.4 ± 1.9 ns ns ns 
18:2n-6 98.5 ± 0.7 98.7 ± 0.1 98.7 ± 0.3 97.7 ± 0.8 ns ns ns 
20:2n-6 95.8 ± 0.9 95.4 ± 0.5 97.4 ± 0.5 95.5 ± 1.6 ns ns ns 
20:4n-6 97.8 ± 0.7 98.8 ± 0.2 96.5 ± 1.3 98.3 ± 0.1 ns ns ns 
18:3n-3 98.8 ± 0.6 98.9 ± 0.1 98.9 ± 0.2 98.0 ± 0.7 ns ns ns 
20:5n-3 98.8 ± 0.3 99.5 ± 0.0 98.2 ± 0.4 99.1 ± 0.1 ns * ns 
22:5n-3 96.9 ± 0.0 98.6 ± 0.0 96.2 ± 1.1 97.7 ± 0.3 ns ns ns 
22:6n-3 97.0 ± 1.0 98.7 ± 0.2 95.0 ± 1.8 97.7 ± 0.1 ns ns ns 
Data are expressed as mean ± S.E.M., n = 2, N = 8. P < 0.05; Treatment means analysed by one-way ANOVA 
with Tukey's post-hoc test of multiple comparisons. Effect of substrate, end-product and substrate / end-
product interaction analysed by two-way ANOVA (ns = not significant) * = P < 0.05. 
a See Table 7.30 for experimental diet abbreviations. 
b Nutrients: DM, dry matter; NFA, nitrogen-free extract. 
c Calculated on the basis of 23.6, 39.5 and 17.2 kJ g-1 of protein, fat and carbohydrate, respectively. 
d Total FA = total fatty acids 





Proximate (mg g-1 of tissue) and fatty acid composition (µmol g-1 tissue) of fillets of Atlantic salmon fed the four experimental diets for 283 days. 
          
Effect of substrate, end-product and substrate / 
end-product interaction 
  Low : Low Low : High High : Low High : High Substrate End-product Interaction 
Proximate composition (mg g-1 of tissue)               
Moisture 692.4 ± 13.9 699.3 ± 5.8 683.8 ± 18.2 677.9 ± 6.6 ns ns ns 
Protein  207.9 ± 1.9 214.0 ± 2.3 206.5 ± 1.3 205.5 ± 5.2 ns ns ns 
Lipid  92.1 ± 17.3 75.1 ± 3.7 97.9 ± 16.6 104.7 ± 3.1 ns ns ns 
Ash 8.1 ± 0.5 8.7 ± 0.1 9.4 ± 0.1 8.7 ± 1.1 ns ns ns 
                
Fatty acids (µmol g-1 of tissue)               
Total FAb 277.1 ± 52.4 221.9 ± 10.0 296.6 ± 54.7 321.4 ± 11.5 ns ns ns 
SFAc 61.5 ± 10.8 50.2 ± 0.6 59.6 ± 10.9 66.1 ± 3.0 ns ns ns 
14:0 3.8 ± 0.7 4.0 ± 0.0 3.4 ± 0.7 5.4 ± 0.3 ns ns ns 
16:0 43.1 ± 7.5 34.3 ± 0.2 41.0 ± 7.8 44.7 ± 2.4 ns ns ns 
18:0 13.1 ± 2.2 10.2 ± 0.4 12.8 ± 2.0 13.2 ± 0.2 ns ns ns 
Other SFAd 1.6 ± 0.3 1.6 ± 0.0 2.3 ± 0.4 2.8 ± 0.1 * ns ns 
MUFA 161.5 ± 32.3 120.9 ± 6.7 153.4 ± 28.0 155 ± 4.1 ns ns ns 
16:1n-7 14.5 ± 3.3 11.9 ± 0.2 11.6 ± 2.3 13.4 ± 0.7 ns ns ns 
18:1n-9 129.2 ± 25.8 94.2 ± 5.5 111.1 ± 20.0 107.9 ± 2.3 ns ns ns 
18:1n-7 8.7 ± 1.7 7.3 ± 0.5 7.1 ± 1.3 7.9 ± 0.2 ns ns ns 
20:1n-9 6.0 ± 0.9a 5.0 ± 0.5a 13.9 ± 2.2b 17.0 ± 0.1b ** ns ns 
Other MUFAe 3.2 ± 0.6ab 2.4 ± 0.0a 9.7 ± 2.2b 8.8 ± 1.0ab ** ns ns 
Total trans FA 1.2 ± 0.2 0.8 ± 0.0 0.9 ± 0.2 0.9 ± 0.0 ns ns ns 
PUFA 52.8 ± 9.1 49.9 ± 2.7 82.6 ± 15.6 99.3 ± 4.3 * ns ns 
18:2n-6 27.7 ± 5.0 23.3 ± 1.3 36.7 ± 7.8 39.2 ± 1.7 ns ns ns 
20:2n-6 1.9 ± 0.2ab 1.7 ± 0.2a 2.9 ± 0.6ab 3.6 ± 0b * ns ns 
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20:4n-6 2.8 ± 0.5 2.0 ± 0.1 1.9 ± 0.2 2.0 ± 0.1 ns ns ns 
Other n-6 PUFAf 6.1 ± 1.3 3.4 ± 0.3 5.7 ± 0.8 4.4 ± 0.0 ns ns ns 
n-6 PUFA 38.5 ± 7.0 30.3 ± 1.8 47.1 ± 9.4 49.2 ± 1.8 ns ns ns 
n-6 LC PUFA 8.8 ± 1.5 6.3 ± 0.5 8.0 ± 1.0 8.6 ± 0.1 ns ns ns 
18:3n-3 2.2 ± 0.4a 2.3 ± 0.1a 17.3 ± 4.4b 24.2 ± 2.2b ** ns ns 
20:5n-3 1.5 ± 0.3a 2.2 ± 0.0a 3.1 ± 0.5ab 4.3 ± 0.3b ** * ns 
22:5n-3 0.8 ± 0.1a 1.3 ± 0.1ab 1.5 ± 0.0b 2.1 ± 0.0c ** ** ns 
22:6n-3 9.0 ± 1.0a 12.3 ± 0.7ab 10.4 ± 0.7ab 14.1 ± 0.1b ns ** ns 
Other n-3 PUFAg 0.7 ± 0.1a 0.9 ± 0.0a 3.0 ± 0.5b 4.7 ± 0.1b *** * * 
n-3 PUFA 14.1 ± 1.9a 19 ± 0.9ab 35.2 ± 6.1bc 49.4 ± 2.4c ** ns ns 
n-3 LC PUFA 11.8 ± 1.5a 16.7 ± 0.8a 17.9 ± 1.6a 25.1 ± 0.2b ** ** ns 
LC PUFA 20.6 ± 3.0a 23.0 ± 1.4ab 25.9 ± 2.7ab 33.7 ± 0.3b * ns ns 
Data are expressed as mean ± S.E.M., n = 2, N = 8. P < 0.05; Treatment means analysed by one-way ANOVA with Tukey's post-hoc test of multiple comparisons. 
Effect of substrate, end-product and substrate / end-product interaction analysed by two-way ANOVA (ns = not significant) * = P < 0.05; ** = P < 0.01; *** = P < 
0.001. 
a See Table 7.30 for experimental diet abbreviations.           
b Total FA = total fatty acids µg g-1 of tissue         
c See Table 7.30 for fatty acid classes and abbreviations.         
d Other SFA = sum of 12:0, 15:0, 17:0, 20:0, 21:0, 22:0 & 24:0.         
e Other MUFA = sum of 14:1n-5, 15:1n-5, 17:1n-7, 20:1n-11, 22:1n-11 & 24:1n-9.       
f Other n-6 PUFA = sum of 18:3n-6, 20:3n-6, 22:2n-6, 22:4n-6, 22:5n-6.         
g Other n-3 PUFA = sum of 18:4n-3, 20:4n-3, 22:3n-3, 24:5n3 & 24:6n-3.         
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TABLE 7.34 
Fillet fatty acid composition (as mg 100 g-1 of edible product) of Atlantic salmon fillet fed the four experimental diets for 283 days.  
  Dietsa       
Effect of substrate, end-product and substrate / 
end-product interaction 
mg 100 g-1 of fillet Low : Low Low : High High : Low High : High Substrate End-product Interaction 
20:5n-3 44.2 ± 7.9a 67.1 ± 1.1a 93.0 ± 13.8ab 130.5 ± 7.8b ** * ns 
22:5n-3 27.2 ± 4.6a 42.8 ± 2.8a 48.7 ± 0.7a 69.8 ± 0.6b ** ** ns 
22:6n-3 294.5 ± 31.7a 404.9 ± 24.5ab 340.8 ± 23.4ab 462.1 ± 4.4b ns ** ns 
SFAb 1607.2 ± 282.1 1307.9 ± 16.2 1561.2 ± 283.6 1725.3 ± 78.4 ns ns ns 
MUFA 4548 ± 906.1 3404.8 ± 189.4 4376.3 ± 797.9 4423.2 ± 118.2 ns ns ns 
PUFA 1557.5 ± 265.3 1490.3 ± 81.3 2408.6 ± 444.2 2906.6 ± 120.8 * ns ns 
LC-PUFA 656.4 ± 95.3a 738.7 ± 44.3a 821.9 ± 83.6ab 1072.5 ± 10.3b * ns ns 
Trans 33.1 ± 6.6 22.7 ± 0.9 25.2 ± 6.4 24.1 ± 0.4 ns ns ns 
n-6 PUFA 1074.3 ± 196.2 841.8 ± 50.1 1324.6 ± 263.5 1377.0 ± 50.8 ns ns ns 
n-6 LC PUFA 271.9 ± 46.6 195.4 ± 16.6 246.9 ± 31.5 266.5 ± 2.3 ns ns ns 
n-3 PUFA 446.3 ± 60.1a 607.2 ± 29ab 1056.8 ± 175.6bc 1482 ± 68.8c ** * ns 
n-3 LC PUFA 384.5 ± 48.8a 543.2 ± 27.7a 575.1 ± 52.1a 806.0 ± 8.0b ** ** ns 
n-6:n-3 ratio 2.4 ± 0.1c 1.4 ± 0.0a 1.2 ± 0.0ab 0.9 ± 0.0b *** *** ** 
Data are expressed as mean ± S.E.M., n = 2, N = 8. P < 0.05; Treatment means analysed by one-way ANOVA with Tukey's post-hoc test of multiple 
comparisons. Effect of substrate, end-product and substrate / end-product interaction analysed by two-way ANOVA (ns = not significant) * = P < 
0.05; ** = P < 0.01; *** = P < 0.001. 
a See Table 7.30 for experimental diet abbreviations. 
b See Table 7.30 for fatty acid classes and abbreviations. 
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TABLE 7.35 
The apparent in vivo fatty acid β-oxidation (nmol g-1 day-1) in Atlantic salmon fed the four experimental diets for 283 days. 
  Dietsa 
    
  
Effect of substrate, end-product and substrate / end-
product interaction 
  Low : Low Low : High High : Low High : High Substrate End-product Interaction 
12:0 2.7 ± 0.0a 2.8 ± 0.1a 1.2 ± 0.0b 1.9 ± 0.1b *** * ns 
14:0 34.1 ± 0.5a 60.7 ± 0.4b 18.9 ± 1.0c 49.3 ± 3.5d ** *** ns 
16:0 526.5 ± 2.9a 537.8 ± 2.7a 293.8 ± 2.2b 367.5 ± 23.4b *** * ns 
18:0 121.3 ± 2.3a 130.4 ± 0.4a 42.4 ± 5.7b 85.7 ± 6.4b *** ** * 
20:0 ─d 5.0 ± 0.0 ─ ─ ─ ─ ─ 
22:0 1.0 ± 0a 2.0 ± 0.0b 3.1 ± 0.2c 4.6 ± 0.2d *** ** ns 
24:0 1.3 ± 0.1a 2.0 ± 0.1bc 2.3 ± 0.1c 5.3 ± 0.2b *** *** ** 
SFAb,c 686.9 ± 0.3a 740.7 ± 2.7a 361.8 ± 7.1b 514.3 ± 33.8b *** ** * 
14:1n-5 5.9 ± 0.1a 5.3 ± 0.1b 3.2 ± 0.0c 2.8 ± 0.1c *** ** ns 
16:1n-7 99.6 ± 0.6a 109.0 ± 1.3a 54.7 ± 2.5b 71.0 ± 6.5b *** * ns 
18:1n-7 26.5 ± 1.0 30.2 ± 1.0 21.5 ± 0.2 28.0 ± 3.5 ns ns ns 
18:1n-9 556.0 ± 38.3 551.6 ± 11.4 382.5 ± 12.7 371.6 ± 56.3 ** ns ns 
20:1n-9 ─ ─ 69.3 ± 5.9 85.0 ± 13.1 ─ ─ ─ 
22:1n-9 ─ ─ 15.8 ± 1.3a 25.3 ± 1.7b ─ ─ ─ 
24:1n-9 ─ 1.2 ± 0.2a 1.9 ± 0.5ab 4.0 ± 0.6a ** * ns 
20:1n-11 ─ 3.5 ± 0.1 ─ ─ ─ ─ ─ 
22:1n-11 3.6 ± 0.1a 6.0 ± 0.2b 3.0 ± 0.0a 5.8 ± 0.5b ns ** ns 
MUFA 691.6 ± 40.1 706.7 ± 14.1 551.9 ± 18.2 593.6 ± 82.5 ns ns ns 
18:2n-6 179.2 ± 8.6 170.8 ± 0.2 203.1 ± 12.2 197.8 ± 22.1 ns ns ns 
20:2n-6 ─ ─ 1.0 ± 1.0 1.9 ± 1.9 ─ ─ ─ 
22:2n-6 ─ ─ 0.4 ± 0.1 0.5 ± 0.2 ─ ─ ─ 
20:4n-6 ─ 1.7 ± 0.3 ─ 2.4 ± 0.8 ─ ─ ─ 
22:4n-6 ─ 0.4 ± 0a 0.1 ± 0.1a 0.6 ± 0.1b ns ** ns 
22:5n-6 ─ 1.5 ± 0.1a 0.1 ± 0.1b 1.7 ± 0.2a ns *** ns 
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n-6 PUFA 179.2 ± 8.6 174.4 ± 0.1 204.7 ± 13.1 204.8 ± 23.6 ns ns ns 
18:3n-3 50.6 ± 2.6a 41.9 ± 0.1a 251.6 ± 0.2b 273.5 ± 16.6b *** ns ns 
18:4n-3 0.9 ± 0.9 1.3 ± 0.0 ─ ─ ─ ─ ─ 
20:4n-3 0.3 ± 0.3 1.2 ± 0.1 ─ ─ ─ ─ ─ 
20:3n-3 0.1 ± 0.1 ─ 3.0 ± 0.8 1.0 ± 1.0 * ns ns 
22:3n-3 ─ ─ 2.6 ± 0.1 2.8 ± 0.2 ─ ─ ─ 
20:5n-3 5.7 ± 5.7 42.3 ± 0.1 ─ 28.0 ± 1.7 * *** ns 
22:5n-3 1.8 ± 1.8 4.3 ± 0.1 ─ ─ ─ ─ ─ 
22:6n-3 0.2 ± 0.2 3.2 ± 1.0 ─ 0.2 ± 0.2 * * ns 
n-3 PUFA 59.4 ± 11.3a 94.2 ± 1.5a 257.2 ± 1.1b 305.5 ± 15.8b *** * ns 
Total FA 2549.7 ± 75.2 2700.3 ± 33.7 2394.7 ± 72.1 2731.8 ± 278 ns ns ns 
Data are expressed as mean ± S.E.M., n = 2, N = 8. P < 0.05; Treatment means analysed by one-way ANOVA with Tukey's post-hoc test of 
multiple comparisons. Effect of substrate, end-product and substrate / end-product interaction analysed by two-way ANOVA (ns = not 
significant) * = P < 0.05; ** = P < 0.01; *** = P < 0.001. 
a See Table 7.30 for experimental diet abbreviations. 
b See Table 7.30 for fatty acid classes and abbreviations. 
c Fatty acids not recording any β-oxidation are not reported in this table. 








The apparent in vivo fatty acid bioconversion (nmol g-1 day-1) in Atlantic salmon fed the four experimental diets for 283 days. 
  Dietsa 
    
  
Effect of substrate, end-product and 
substrate / end-product interaction 
  Low : Low Low : High High : Low High : High Substrate End-product Interaction 
Fatty acid elongationb               
18:0 to 20:0 1.28 ± 0.06a ─c 31.56 ± 5.72b 9.83 ± 1.27a ** * * 
18:1n-9 to 20:1n-9 20.15 ± 4.38 10.68 ± 2.25 ─ ─ ─ ─ ─ 
20:1n-9 to 22:1n-9 2.06 ± 0.60 0.25 ± 0.24 ─ ─ ─ ─ ─ 
22:1n-9 to 24:1n-9 0.27 ± 0.07 ─ ─ ─ ─ ─ ─ 
18:2n-6 to 20:2n-6 10.31 ± 1.87a 10.82 ± 0.80a 0.26 ± 0.26b 0.55 ± 0.55b ** ns ns 
20:2n-6 to 22:2n-6 0.85 ± 0.13 0.92 ± 0.07 ─ ─ ─ ─ ─ 
18:3n-6 to 20:3n-6 39.18 ± 5.31a 9.84 ± 0.77b 21.19 ± 0.77b 8.71 ± 1.10b * ** * 
20:4n-6 to 22:4n-6 2.31 ± 0.11 ─ 0.08 ± 0.08 ─ ─ ─ ─ 
22:4n-6 to 24:4n-6 1.73 ± 0.11 ─ 0.03 ± 0.03 ─ ─ ─ ─ 
18:3n-3 to 20:3n-3 0.02 ± 0.02 0.10 ± 0.10 ─ 0.50 ± 0.50 ns ns ns 
18:4n-3 to 20:4n-3 4.23 ± 4.23a ─ 43.64 ± 6.44b 13.48 ± 0.33a ** * * 
20:5n-3 to 22:5n-3 8.10 ± 8.10a ─ 24.82 ± 5.51b 2.22 ± 1.02a ns * ns 
22:5n-3 to 24:5n-3 8.58 ± 8.53 0.36 ± 0.09 20.76 ± 4.19 1.85 ± 0.80 ns * ns 
Fatty acid ∆-9 desaturation               
20:0 to 20:1n-11 3.67 ± 0.13a ─ 43.24 ± 5.13b 26.37 ± 0.45c *** * ns 
Fatty acid ∆-6 desaturation               
18:2n-6 to 18:3n-6 52.74 ± 4.75a 13.28 ± 0.69b 36.79 ± 1.12c 15.26 ± 1.31bc ns *** * 
24:4n-6 to 24:5n-6 1.73 ± 0.11 ─ 0.03 ± 0.03 ─ ─ ─ ─ 
18:3n-3 to 18:4n-3 3.31 ± 3.31a ─ 43.02 ± 6.52b 13.16 ± 0.33a ** * * 
24:5n-3 to 24:6n-3 8.59 ± 8.45 0.38 ± 0.04 20.40 ± 4.16 1.52 ± 0.91 ns * ns 
Fatty acid ∆-5 desaturation               
20:3n-6 to 20:4n-6 15.91 ± 2.61a ─ 5.07 ± 0.41b ─ ─ ─ ─ 
20:4n-3 to 20:5n-3 4.00 ± 4.00a ─ 31.50 ± 6.16b ─ ─ ─ ─ 
Fatty acid chain shortening               
24:5n-6 to 22:5n-6 1.73 ± 0.11a ─ 0.03 ± 0.03b ─ ─ ─ ─ 
24:6n-3 to 22:6n-3 8.45 ± 8.45 ─ 19.89 ± 4.26 1.02 ± 1.02 ns * ns 
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Data are expressed as mean ± S.E.M., n = 2, N = 8. P < 0.05; Treatment means analysed by one-way ANOVA with Tukey's post-hoc test of 
multiple comparisons. Effect of substrate, end-product and substrate / end-product interaction analysed by two-way ANOVA (ns = not 
significant) * = P < 0.05; ** = P < 0.01; *** = P < 0.001. 
a See Table 7.30 for experimental diet abbreviations. 
b Fatty acids not recording any bioconversion (elongation or desaturation) are not reported in this table. 













a ab b b





8. General Discussion 
 
The sustainable development of the aquaculture industry, in particular the Atlantic salmon 
aquaculture industry, will inevitably require the development of adaptive, seasonally tailored 
nutritional solutions. In order to achieve this an understanding of the effects of different 
dietary formulations in aquafeed for Atlantic salmon is urgently needed. However, the future 
growth of the industry may be negatively impacted by the current paucity of information 
available, particularly, concerning large post-smolt Atlantic salmon reared in sub-optimally 
high environmental conditions. Accordingly, the thesis is a summary of investigations into the 
effects of varied dietary fatty acid composition on growth performance, fatty acid 
metabolism, nutritional quality, economic impact and environmental analysis in post-smolt 
Atlantic salmon. It is envisaged that the results obtained and discussed within this thesis will 
provide a sound scientific basis contributing to the ongoing and future development of 
modern sustainable aquafeed for the use in the Atlantic salmon aquaculture industry. This 
section (Chapter 8) discusses each of the experimental chapters presented in research 
chapters 3 to 7. Finally, Chapter 9 will provide conclusions and suggested directions to 
enhance the further research and development of the Atlantic salmon aquaculture industry. 
 
Owing to the expectation of aquaculture and, in particular, Atlantic salmon to provide 
consumers with a highly nutritious product, specifically, high levels of n-3 LC PUFA 
(Christenson et al. 2017; Leaver et al. 2011; Meyer et al. 2003; Sprague et al. 2016) a major 
focus of this PhD thesis was the effect of different dietary lipids and environmental conditions 
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on n-3 LC PUFA in the fillet of Atlantic salmon. Therefore the first experimental chapter 
(Chapter 3) provided a summary of the current body of research with regard to long-term 
nutritional growth trials focusing on seawater reared Atlantic salmon. This chapter identified 
some major dietary drivers of fillet 22:6n-3 and n-3 LC PUFA via a systematic review and 
subsequent analysis of published data. Specifically, multiple regression models revealed 
several biologically intuitive variables as having a significant effect on the dependent 
variables, namely, fillet 22:6n-3 and n-3 LC PUFA. It is clear, however, and in agreement with 
Sales and Glencross (2011a), that the conclusiveness of these findings is limited by a relatively 
small dataset and incomplete or inconsistent data reporting in some studies. Furthermore, it 
is envisaged that continued cooperation between industry and academia will serve to 
increase the transparency of available nutritional data. This cooperation may enable the 
development of more sophisticated mechanistic modelling techniques that rely on a suite of 
environmental and nutritional information to quantitatively predict fillet n-3 LC PUFA in 
Atlantic salmon. Nevertheless, a snapshot of the current state of published information 
identified the major drivers of fillet n-3 LC PUFA in post-smolt Atlantic salmon - an important 
task, given the increasing value of these fatty acids in aquaculture. 
 
Given the aforementioned paucity of published data from long-term nutritional growth trials 
focussing on Atlantic salmon, particularly in sub-optimally high environmental conditions  
Chapter 4 presented the results of one of few long-term farm based growth trials in the 
southern hemisphere. The effects of climate change are having an increasing effect on sea 
surface temperatures in the southern hemisphere (Last et al. 2011; Oliver et al. 2017) and 
recent, unprecedented marine heatwaves have forced ecosystem changes in waters 
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surrounding Tasmania (Last et al. 2011). Therefore the effects of different dietary lipid sources 
on growth, fillet nutritional quality, fatty acid metabolism and taste characteristics of Atlantic 
salmon were elucidated with an emphasis on seasonal differences in lipid utilisation. From a 
nutritional quality point of view, the diet consisting of 80% TAL as the added dietary lipid 
(TALd) demonstrated several benefits, including an increased deposition of fillet n-3 LC PUFA 
in the summer phase and a lower fillet n-6:n-3 ratio in both phases owing primarily to low 
concentrations of n-6 fatty acids. Additionally, the high dietary provision of SFA in TALd 
provided an enhanced substrate for metabolic energy in the sub-optimal conditions of the 
summer phase.  This observation was supported by an elevated β-oxidation of SFA and a 
higher total β-oxidation of fatty acid in fish receiving TALd. Additionally, dietary treatments 
providing limited SFA, such as the CAN and PbO treatments (CANd and PbOd, respectively) 
clearly showed that fish need to increase their overall SFA status via the metabolically 
expensive process of de novo production (liponeogensis) during the summer phase. However, 
these beneficial effects of increased dietary SFA supply are counterbalanced by other 
negative effects. Consistent with previous research, TALd exhibited a reduction in lipid 
digestibility (Emery et al. 2016; Emery et al. 2014; Trushenski & Lochmann 2009), which 
resulted in reduced overall fish growth, and CANd produced better overall results and fish 
were significantly larger in the summer phase. In the winter phase, the lack of de novo fatty 
acid production of SFA and β-oxidation of n-3 LC PUFA suggested that all dietary treatments 
more adequately provided for the fishes physiological fatty acid requirements at these 
environmental conditions. Whilst a trend similar to that recorded during the summer period 
was observed in winter, results were not significant, likely due to reduced replication and a 
resultant decrease in statistical power. PbOd appeared a middle point between CANd and 
TALd in terms of nutritional quality and growth. Accordingly, by the time fish were market 
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size (~5kg), PbOd was the most cost effective owing to the low cost of dietary oil, good growth 
efficiency and high fillet yield. As water temperatures increase and heatwave events become 
more prevalent, further research is required to better elucidate cost-effective, seasonally 
tailored aquafeed formulations. This may require multiple dietary lipid sources in order to 
mitigate potential negative effects of reduced digestibility and sub-optimal growth whilst 
simultaneously fulfilling the resulting modified metabolic requirements of fish and 
maximising final product quality, including final n-3 LC PUFA content. This chapter also 
revealed an additional, yet unintended, consequence of reducing replication in fish nutritional 
growth studies, specifically, a reduction in replication from n = 4 to n = 3 on-farm resulted in 
a reduced ability to detect statistical significance in important outcomes such as final weight. 
Given the vast majority studies employ triplicate replication (Thorarensen et al. 2015) this is 
an important consideration for future on-farm, and in-lab as well, trials where statistical 
significance should be relied upon.   
 
The demand for highly nutritious fish is increasing, however, at the same time global markets 
for health beneficial dietary ingredients in aquaculture, such as fish meal and FO are 
increasingly volatile (Oglend 2013; Sprague et al. 2016; Troell et al. 2014; Turchini 2013). 
Therefore, improving dietary ingredient utilisation efficiency for the use of these valuable 
resources is imperative if the aquaculture industry is to maintain its reputation as the major 
provider of n-3 LC PUFA to humans (Christenson et al. 2017; Tur et al. 2012; Turchini et al. 
2011b). Atlantic salmon are known to possess a capacity to endogenously produce n-3 LC 
PUFA under certain dietary and environmental conditions, however, the extent of production 
is poorly understood in large, seawater reared fish (Glencross et al. 2015). Considering this, 
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Chapter 5 focussed on fatty acid metabolism and revealed the effects of replacing dietary FO 
with CAM at two dietary inclusion levels. The results clearly showed that the replacement of 
n-3 LC PUFA with C18 n-3 PUFA in diets for Atlantic salmon resulted in a significant decrease 
in fillet n-3 LC PUFA and a reduction in growth performance. However, in the absence of FO, 
the inclusion of CAM at high levels (40 %) contributed to an improved n-6:n-3 ratio and may 
partially ameliorate low dietary n-3 LC PUFA by providing added substrate for endogenous n-
3 LC PUFA synthesis in comparison to 20% CAM inclusion. Furthermore, in agreeance with 
previous research, taste quality was largely unaffected by the dietary addition of CAM (Hixson 
et al. 2014b) providing confidence to producers that its addition will exert few, if any, negative 
effects on consumer acceptance. Additionally, owing to the physiologically distinct roles of 
shorter-chain C18 n-3 PUFA and n-3 LC PUFA in human nutrition this research Chapter added 
to a small chorus of fish nutrition research advocating for a more complete reporting of their 
relative contribution in fish and seafood products (Turchini et al. 2011c). Ultimately, this is 
expected to benefit health conscious consumers. 
 
Understandably, nutritional based solutions that aim to improve the long-term sustainably of 
the aquaculture industry must consider environmental effects (Amirkolaie 2011; Wu 1995). 
Indeed the environmental impacts of Atlantic salmon aquaculture operations are under 
increasing scrutiny, including the Tasmanian Atlantic salmon aquaculture industry (Australian 
Government  2015). Accordingly, Chapter 6 addressed the important topic of protein 
utilisation and nitrogenous waste in aquaculture. Specifically, it was demonstrated that a 
reduction in the protein: lipid ratio in aquafeed formulations for market-sized Atlantic salmon 
elicits minimal effects on lipid and fatty acid utilisation and ultimately found no reduction in 
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fillet nutritional quality including levels of n-3 LC PUFA. Additionally, taste quality was not 
compromised. Importantly, a significant reduction in undigested nitrogenous waste was 
observed when the dietary protein: lipid ratio was decreased.  However, whereas overall 
performance was unaffected, a slight, albeit non-statistically significant increase in FCR, was 
reflected in the bioeconomic analysis by an increased cost of fish and fillet production.  
Therefore, the present study shows that the cost of fish production and the ability to decrease 
the potential for environmental degradation are in antagonism. 
 
The final experimental chapter (Chapter 7) complemented the on-farm experiments 
presented in Chapters 4 and 5 by further elucidating the potential to manipulate the inherit 
capacity of large Atlantic salmon to endogenously produce n-3 LC PUFA. As mentioned, 
market supply of n-3 LC PUFA rich fish meal and FO are subject to strict market restrictions, 
resultantly, the use of these valuable dietary ingredients for the use in aquaculture is severely 
limited (Hixson et al. 2017; Subasinghe et al. 2009; Tocher 2015; Ytrestøyl et al. 2015). 
Therefore, the continual improvement in resource utilisation by the aquaculture industry, 
specifically, the Atlantic salmon industry may be, in part, facilitated by elucidating the 
potential for de novo synthesis of n-3 LC PUFA. However, farm-based studies are less precise 
in terms of their ability to estimate uneaten feed and by extension measure fatty acid intake. 
Accordingly, Chapter 7 presented the results of a laboratory based trial that attempted to 
quantify the potential for n-3 LC PUFA biosynthesis to elicit a measurable, positive impact on 
the fillet nutritional of Atlantic salmon. It was shown that in the absence of added FO, the 
high dietary provision of 18:3n-3 provided multiplicative benefits in terms of facilitating the 
deposition of n-3 LC PUFA in to the fillet tissue. This was shown to be a result of preferential 
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β-oxidation of dietary C18 n-3 PUFA resulting in an apparent conservation of n-3 LC PUFA from 
catabolism and by providing sufficient substrate for n-3 LC PUFA biosynthesis. These findings 
demonstrated the capacity for endogenous n-3 LC PUFA synthesis in post-smolt Atlantic 
salmon to ameliorate the potential negative consequences on fillet nutritional quality often 
attributed to a severe reduction or removal of dietary provided FO. This chapter provided a 
commercially relevant platform for the further development of tailored diets with respect to 
production stage to ensure Atlantic salmon are highly nutritious at the time of harvest. 
Complementary methods, such as real-time polymerase chain reaction and stable isotope 
analysis are suggested in future trials on post-smolt Atlantic salmon to elucidate further both 
enzymatic expression of elongase and desaturase enzymes as well as tracing the origin and 
fate of individual fatty acids along the n-3 bioconversion pathway. This will enable a better 
quantification of the possible modulation of known genes associated with n-3 LC PUFA 
bioconversion processes and a more accurate trace of individual fatty acids along the n-3 LC 
PUFA bioconversion pathway, and in particular the ability to differentiate from de novo 
synthesised LC-PUFA vs LC-PUFA spared from catabolic processes. Nevertheless, the 
information provided in Chapter 7, scant for post-smolt Atlantic salmon, appears essential in 




9. Concluding remarks and directions for further research 
 
This PhD thesis provides a considerable and novel contribution in the understanding of the 
effect of diet on fatty acid metabolism and nutritional quality in farmed Atlantic salmon. The 
results generated in this thesis clearly show that environmental conditions and aquafeed 
composition, including dietary lipid source has a profound effect on nutritional quality, 
metabolic performance, production cost and environmental impact of farmed Atlantic 
salmon. 
 
Firstly, it was revealed in Chapter 3 that there are relatively few published long-term 
nutritional growth trials focussing on Atlantic salmon. Considering the importance of Atlantic 
salmon as an aquaculture species this is a potential impediment to the further development 
of sophisticated nutritional models. Furthermore, it was surmised that the continued 
cooperation between industry and academia will enhance the transparency of collected 
nutritional information. This, in turn, may enhance the predictability of the consequences of 
evolving aquafeed formulations on the health quality of Atlantic salmon products. 
 
Secondly, results from experimental Chapter 4, explicitly detailed the advantages and 
disadvantages of PbO, CAN and TAL as primary dietary oil sources in aquafeed formulations 
for large Atlantic salmon. Specifically, it was revealed that TAL provides several advantages in 
sub-optimal water temperatures. The high concentrations of SFA present in TAL provided 
better for the energy requirements of the fish and, importantly, spared n-3 LC PUFA from β-
oxidation. However, considering the observed decrease in digestibility in TAL diets and the 
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relatively good performance of both CAN and PbO in the winter phase it is suggested that 
diets must be specifically formulated with respect to growing season. Ultimately, the results 
presented in Chapter 4 suggest that, in order to maximise the advantages and minimise the 
potential disadvantages of various lipid sources for the use in Atlantic salmon aquafeed, 
optimal, seasonally tailored dietary formulations should utilise multiple types of dietary lipid. 
Therefore, this exploration of fish performance in relation to dietary lipid source and season 
will help protect the industry from the predicted impacts of climate change, specifically, the 
increased water temperatures of Atlantic salmon farms. Considering the occurrence and 
intensity of marine heatwave events are likely to increase (Last et al. 2011; Murphy & Timbal 
2008), further research is warranted that investigates the growth performance and fatty acid 
metabolism of Atlantic salmon reared on-farm in response to more extreme, specifically, sub-
optimally high, water temperatures than presented in this thesis. This may aid in the 
development of diets specifically formulated to mediate the adverse impacts of forecast 
marine heatwaves on the product quality of farmed Atlantic salmon. 
 
The results of another long-term trial conducted on-farm with post-smolt Atlantic salmon was 
presented in Chapter 5. It was shown that dietary provision of C18 n-3 PUFA in the absence of n-
3 LC PUFA for Atlantic salmon resulted in a significant decrease in levels of fillet n-3 LC PUFA 
and an elicited a negative impact on growth performance. However, the higher dietary 
inclusion of CAM used in this experiment (40% of added dietary lipid) contributed to an 
improved n-6:n-3 ratio and may have partially mitigated low dietary n-3 LC PUFA by providing 




    
Penultimately, the enhanced scrutiny on aquaculture operations to limit their potential for 
environmental degradation was addressed in Chapter 6 by an attempt to assess the impact 
of an altered protein: lipid ratio in diets for large Atlantic salmon. This chapter clearly showed 
that whilst a reduction in the protein: lipid ratio decreases the amount of nitrogenous waste 
entering the surrounding aquatic environmental with minimal impact on the product quality 
of market-sized Atlantic salmon it inevitably incurs a greater cost of diet production. This 
research chapter can be used as a benchmark to demonstrate the inexorable ‘trade-offs’ that 
producers must consider when implementing nutritional solutions to environmental 
problems. However, given the cost of raw dietary ingredients often fluctuates (Bendiksen et 
al. 2011; Tacon & Metian 2015) the results presented by this experiment may, and should, be 
continually referenced to make informed economic and environmental decisions with respect 
to individual aquaculture operations. 
 
Finally, the capacity for endogenous n-3 LC PUFA production by large, seawater reared, 
Atlantic salmon further was elucidated by a laboratory based experiment presented in 
Chapter 7 to complement the on-farm results presented in Chapter 5. Fundamentally, it was 
shown that a relatively high substrate of 18:3n-3 facilitated by the high (80%) dietary inclusion 
of CAM oil can both i) elicit a higher degree of final n-3 LC PUFA production and ii) spare 
dietary provided n-3 LC PUFA from catabolism without demonstrably negative effects on 
growth performance. As detailed in this thesis, further research that employs complementary 
methods will aid in elucidating the absolute potential for endogenous n-3 LC PUFA production 
in large, post-smolt Atlantic salmon. Nevertheless, valuable information was provided to 
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producers that the presumed negative consequences with regard to nutritional quality often 
associated with diets containing a substantially reduced level of fish meal and FO can be, 
partially, mitigated with the high dietary addition of 18:3n-3 rich oils in diets for market-sized 
Atlantic salmon. 
 
The consolidation of research presented within this thesis as illuminated areas that warrant 
further research within the aquaculture sector and, specifically, the Atlantic salmon 
aquaculture industry. Research Chapters 4-7 highlighted the valuable contribution of long-
term nutritional growth trials in furthering the optimisation of aquafeed formulations for 
post-smolt Atlantic salmon reared in Australian environmental conditions. Although it should 
be noted that the diets used in these trials, although experimental, utilised commercial-like 
ingredients and a relatively narrow spectrum of proximate composition. Considering this, 
future experimental trials that push the boundaries of environmental extremes, dietary lipid 
source and dietary proximate composition are recommend. Accordingly, trials conducted 
under relatively extreme sub-optimally high water temperatures or in geographical areas 
more susceptible to warming waters may aid in understanding the future predicted impacts 
of climate change on dietary lipid utilisation and product quality in Atlantic salmon. 
Furthermore, the results presented in Chapter 6 would be complemented by trials that 
further explore the effects of very high, or conversely, very low dietary protein: lipid ratios. 
Specifically, a greater understanding of protein utilisation efficiency and related impact on 
fish growth could be achieved. Finally, there is a growing amount of research attention being 
afforded to non-marine derived sources of n-3 LC PUFA. For example, transgenic oilseed 
crops, particularly, those containing 20:5n-3 and 22:6n-3 are being investigated, however, 
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currently a high cost of production and ethical considerations provide impediments to their 
widespread use. (Betancor et al. 2015; Betancor et al. 2017; Robert 2006; Ruiz-Lopez et al. 
2014). Therefore, further quantitative data similar to that presented in this thesis in research 
Chapters 5 and 7 are expected to expedite their potential future use in aquafeed for Atlantic 
salmon in Australia.  
 
Ultimately, this thesis has provided tangible, quantifiable information on many aspects of 
Atlantic salmon nutrition and product quality, specifically, in the area of fatty acid metabolism 
with particular reference to fillet levels of health beneficial n-3 LC PUFA. It is intended that 
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